Evidence-based prevention of healthcare-associated infection by Labeau, Sonia
  
 
  
 
 
 
EVIDENCE-BASED PREVENTION OF  
HEALTHCARE-ASSOCIATED INFECTION 
SONIA LABEAU 
 
 
 
 
 
SUPERVISORS 
PROFESSOR STIJN BLOT 
PROFESSOR KOENRAAD VANDEWOUDE 
THESIS SUBMITTED IN FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF 
DOCTOR IN MEDICAL SCIENCES
  
  
  
 
 
 
 
 
 
 
 
EVIDENCE-BASED PREVENTION OF  
HEALTHCARE-ASSOCIATED INFECTION 
SONIA LABEAU 
 
 
 
 
 
 
SUPERVISORS 
PROFESSOR STIJN BLOT 
PROFESSOR KOENRAAD VANDEWOUDE 
THESIS SUBMITTED IN FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF 
DOCTOR IN MEDICAL SCIENCES
  
Labeau, Sonia 
 
Evidence-based prevention of healthcare-associated infections 
 
Doctoraatsthesis Universiteit Gent 
Copyright © 2013 
 
Niets uit deze uitgave mag worden verveelvoudigd en/of openbaar gemaakt door middel van 
druk, fotokopie, microfilm, of op welke andere wijze ook, zonder voorafgaande schriftelijke 
toestemming van de auteur 
 
ISBN: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dit project werd financieel mogelijk gemaakt door 
 
Hogeschool Gent 
Kortrijksesteenweg 14 
9000 Gent 
www.hogent.be 
   
     
 
 
 
 
 
 
 
 
 
 
 
Aan mijn ouders, 
Suzanne Satijn en Jozef Labeau  
     
SUPERVISORS: Professor Stijn BLOT 
 Department of Internal Medicine 
 Ghent University 
     
 Professor Koenraad VANDEWOUDE 
 Department of Internal Medicine 
 Ghent University 
 
GUIDANCE COMMITTEE: Professor Anselme DERESE 
 Department of General Practice and Primary Health Care 
 Ghent University 
 
 Professor Renaat PELEMAN 
 Department of Internal Medicine, 
 Knowledge Management Centre Ghent 
 Ghent University 
 
 
  
  
     
EXAMINATION COMMITTEE:  Doctor Dimitri BEECKMAN 
 Department of Public Health 
 Ghent University 
  
 Professor Luc DE BAERDEMAEKER 
 Department of Anaesthesiology 
 Ghent University 
 
 Doctor Marie-Laurence LAMBERT 
Public Health and Surveillance, 
Healthcare-associated Infections & Antimicrobial Resistance 
 Wetenschappelijk Instituut Volksgezondheid 
  
 Professor Mirko PETROVIC 
 Department of Internal Medicine 
 Ghent University 
 
 Professor Herbert SPAPEN 
 Faculty of Medicine and Pharmacy 
 Vrije Universiteit Brussel 
 
 Professor Johan VANDE WALLE 
 Department of Pediatrics and Medical Genetics 
 Ghent University 
  
 Professor Rik VERHAEGHE 
 Department of Public Health 
 Ghent University 
 
  Professor Dirk VLASSELAERS 
  Faculty of Medicine 
  Katholieke Universiteit Leuven 
 
 
 
 
  
     
TABLE OF CONTENTS  
 
SUMMARY .......................................................................................................................................................... 1 
SAMENVATTING ................................................................................................................................................. 3 
GENERAL INTRODUCTION .................................................................................................................................. 5 
 
I. EVIDENCE-BASED PREVENTION OF HEALTHCARE-ASSOCIATED INFECTION 
 Introduction .............................................................................................................................................. 11 
 1. Healthcare-associated Infections .......................................................................................................... 11 
 1.1. Definitions ................................................................................................................................... 12 
 1.2. Epidemiological data ................................................................................................................... 13 
 1.3.  Impact ........................................................................................................................................ 14  
 1.4. Prevention .................................................................................................................................. 15 
 2. Evidence-based Guidelines ................................................................................................................... 17 
 2.1. Definition .................................................................................................................................... 17 
 2.2. Guideline implementation .......................................................................................................... 18 
 2.2.1. Implementation strategies ............................................................................................... 18 
 2.2.2. Implementation of infection prevention guidelines ......................................................... 22 
 2.2.3. Evaluating the implementation ........................................................................................ 26 
 2.2.4. Sustainability of implementations .................................................................................... 27 
 2.2.5. Cost considerations .......................................................................................................... 29 
 2.2.6. Methodological considerations ........................................................................................ 30 
 3. Determining the Evidence Base of Recommendations and Strategies ................................................. 32 
 3.1. Grading the evidence of interventions ....................................................................................... 32 
 3.2. A systematic review and meta-analysis of randomised controlled trials ................................... 42 
 4. Clinicians’ Adherence to Guidelines ...................................................................................................... 64 
 4.1. Do healthcare workers adhere to evidence-based guidelines? .................................................. 64 
 4.2. Barriers and facilitators for adherence ....................................................................................... 65 
 4.2.1. Facilitators ........................................................................................................................ 66 
 4.2.2. Barriers ............................................................................................................................. 67 
 Conclusion of Part One ............................................................................................................................. 68 
 
II. INTENSIVE CARE NURSES’ KNOWLEDGE OF INFECTION PREVENTION GUIDELINES 
 Introduction .............................................................................................................................................. 71 
 1. Knowledge about the prevention of ventilator-associated pneumonia ............................................... 72 
1.1. Development of an evaluation questionnaire ............................................................................ 72 
1.2. Flemish ICU nurses’ knowledge of evidence-based VAP prevention .......................................... 79 
1.3. European ICU nurses’ knowledge of evidence-based VAP prevention ....................................... 85 
 2. Knowledge about the prevention of central venous catheter-related infection .................................. 91 
2.1. Development of an evaluation questionnaire ............................................................................ 91 
2.2. European ICU nurses’ knowledge of evidence-based CVC-RI prevention .................................. 97 
 3. Knowledge about the prevention of surgical site infection ................................................................ 103 
 Conclusion of Part Two ........................................................................................................................... 113 
     
III. E-LEARNING   
Introduction ............................................................................................................................................ 119 
1. The concept of e-learning ................................................................................................................... 120 
1.1. Definition .................................................................................................................................. 120 
1.2. A brief history of e-learning ...................................................................................................... 120 
1.3. Advantages and disadvantages of e-learning ........................................................................... 121 
 1.3.1. Advantages ..................................................................................................................... 121 
 1.3.2. Disadvantages ................................................................................................................. 123 
2. E-learning and healthcare ................................................................................................................... 124 
2.1. The value of e-learning for healthcare professionals ................................................................ 124 
2.2. E-learning for critical care providers ......................................................................................... 125 
2.3. E-learning in the field of infection prevention and control ....................................................... 126 
 3. The EVIDENCE Crash Course  .............................................................................................................. 132 
Conclusion of Part Three ......................................................................................................................... 148 
 
EPILOGUE ....................................................................................................................................................... 149 
REFERENCES ................................................................................................................................................... 157 
ADDENDA 
ADDENDUM 1: LIST OF ABBREVIATIONS ................................................................................................ 177 
ADDENDUM 2: LIST OF TABLES ............................................................................................................... 178 
ADDENDUM 3: LIST OF FIGURES ............................................................................................................. 179 
ADDENDUM 4: DUTCH COCHRANE CENTER CHECKLIST FOR THE QUALITY ASSESSMENT OF  
                      RANDOMISED CONTROLLED TRIALS .............................................................................. 180 
ACKNOWLEDGEMENTS – DANKWOORD ........................................................................................................ 191 
 
  
     
 
 
 1 
SUMMARY 
 
Healthcare workers’ adherence to evidence-based guidelines for the prevention of 
healthcare-associated infections is reported to be restricted. Numerous barriers to guideline 
compliance have been self-reported. A lack of knowledge of the guidelines’ contents has 
nevertheless not been included in the extensive list of self-reported hindrances to 
adherence. The goal of the EVIDENCE-project was to determine the level of knowledge 
about evidence-based guidelines for the prevention of healthcare-associated infection 
among healthcare workers, and to help enhancing awareness if deficiencies would be 
detected. 
As a first step towards identifying potential gaps in healthcare workers’ knowledge about 
this important topic, a needs analysis was conducted. Thereto, multiple choice 
questionnaires concerning the prevention of ventilator-associated pneumonia, central 
venous catheter-related infection and surgical site infection were developed. The reliability 
of these questionnaires was tested by means of item analysis and their contents were 
submitted to a panel of experts in order to obtain content validity. Subsequently, they were 
used to conduct surveys among intensive care nurses. The results of these surveys, of which 
two were conducted on a European scale, revealed overall disappointing scores below the 
conventional 50% threshold to pass a test. 
In order to meet the needs detected, e-learning was chosen as an educational tool as it 
allows adult distant learners to study at times and places according to their own 
preferences, and at their own pace. Using open source software, a comprehensible Web-
based Crash Course bundling the essentials on the prevention of healthcare-associated 
infections was developed. Various exercises allowing learners to self-evaluate their study 
progress were integrated. In order to facilitate access to the course worldwide, the only 
requirements for access are a computer with internet browser; no additional plug-ins or 
downloads are required. The course’s contents were validated by a team of experts in the 
field of infection prevention, and its usability was tested and approved by means of the 
Software Usability Measurement Inventory (SUMI®).  
To assess whether the course succeeds in increasing and sustaining knowledge among 
learners, a study website was created where all voluntary learners involved with patient care 
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could enroll. After submission of a pre-test, they were granted access to the course for a 
maximal period of eight weeks, which was followed by a first post-test to assess the 
immediate learning effect of the course. Actual study time was automatically logged. During 
the twelve weeks following this post-test, access to the course was denied. Subsequently, 
participants were invited to take a second post-test in order to measure their level of 
knowledge retention.   
We found that limited time invested in studying the EVIDENCE Crash Course yielded 
significant increases in immediate (+24%) and residual (+18%) learning effects among nurses, 
physicians, students and allied healthcare professionals. Although the course was originally 
developed for ICU clinicians, healthcare professionals working outside the ICU also showed 
significant benefit from studying the course.  
Additional research comparing different Web-based interventions is needed to elucidate 
how to implement e-learning most effectively. In the meantime, the results of the 
EVIDENCE-project strongly suggests that moderate time invested in a low-cost e-course with 
good usability features and exercises for self-evaluation can significantly enhance knowledge 
about the prevention of healthcare-associated infection.  
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SAMENVATTING 
 
Talrijke publicaties rapporteren dat zorgverleners evidence-based richtlijnen voor de 
preventie van zorginfecties slechts in beperkte mate navolgen. Op basis van 
onderzoeksresultaten met een zelf-rapporteringsdesign werden reeds talrijke hinderpalen 
voor compliantie gerapporteerd. Een gebrek aan kennis ontbreekt echter op deze lijst met 
zelf-gerapporteerde barrières. Met het EVIDENCE-project beoogden we het kennisniveau 
van zorgverleners over evidence-based richtlijnen voor de preventie van zorginfecties na te 
gaan, en deze te helpen verbeteren indien deficiënties zouden worden gedetecteerd. 
Als eerste stap in het identificeren van potentiële tekorten in de kennis van zorgverleners 
over dit belangrijk onderwerp werd een behoeftenanalyse uitgevoerd. Daartoe 
ontwikkelden we meerkeuzevragenlijsten aangaande de preventie van 
ventilatorgeassocieerde pneumonie, infecties gerelateerd aan het gebruik van centrale 
veneuze katheters, en chirurgische wondinfecties. De betrouwbaarheid van deze 
vragenlijsten werd nagegaan door middel van item analyse, en hun inhoud werd ter 
validering voorgelegd aan een panel experts. Vervolgens werden ze aangewend in een 
aantal surveys onder intensievezorgenverpleegkundigen. De resultaten van deze 
onderzoeken, waarvan twee gevoerd werden op Europese schaal, brachten algemene 
ontgoochelende test scores aan het licht die lager lagen dan de conventionele 50% drempel 
om te slagen voor een test. 
E-learning werd gekozen als onderwijsmiddel om aan de geïdentificeerde noden tegemoet 
te komen. E-learning laat volwassen afstandsleerders immers toe te studeren waar en 
wanneer men verkiest, en aan eigen tempo. Door middel van open source software en in 
een begrijpelijke taal werd een op een website geënte Crash Course ontwikkeld die de 
basisbeginselen van de preventie van zorginfecties bundelt. Verschillende soorten 
oefeningen die studenten toelaten hun leerevolutie te evalueren werden in de cursus 
geïntegreerd. Om de toegankelijkheid van de cursus wereldwijd te faciliteren, is toegang tot 
een computer met internetbrowser de enige vereiste; bijkomende plug-ins of het 
downloaden van additionele software is onnodig. De inhoud van de cursus werd gevalideerd 
door een team experts op het gebied van infectiepreventie en de gebruiksvriendelijkheid en 
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technische adequaatheid werden getest en goed bevonden door middel van de Software 
Usability Measurement Inventory (SUMI®). 
Om na te gaan of de cursus er daadwerkelijk in slaagt blijvende kennis bij te brengen, werd 
een studie-website gecreëerd waar alle betrokkenen in patiëntenzorg zich vrijwillig voor het 
studeren van de module konden registreren. Na het afleggen van een pretest werd hen 
gedurende een maximale periode van acht weken toegang tot de cursus verleend. De 
feitelijke studietijd van de participanten werd automatisch geregistreerd. Meteen volgend 
op de studieperiode werd een eerste posttest afgelegd om het onmiddellijk leereffect van de 
cursus na te gaan. Gedurende de twaalf weken na deze posttest werd aan de studenten de 
toegang tot de cursus ontzegd. Vervolgens werden de participanten uitgenodigd een tweede 
posttest af te leggen om de mate van kennisretentie te evalueren. 
We vonden dat een beperkte tijdsinvestering in het studeren van de EVIDENCE Crash Course 
een significante onmiddellijke gemiddelde stijging van de kennis (+24%) en residueel 
leereffect (+18%) teweegbracht bij verpleegkundigen, artsen, studenten en andere 
zorgverleners. Hoewel de cursus oorspronkelijk ontwikkeld was voor zorgverleners 
tewerkgesteld in een setting voor kritieke zorg, bleken ook andere gezondheidswerkers er 
significant baat van te hebben.  
Verder onderzoek dat focusseert op het vergelijken van verschillende e-learning interventies 
is nodig om klaarheid te scheppen in de vraag wat de beste manier is om e-learning te 
implementeren. Ondertussen zijn onze onderzoeksresultaten sterk suggestief voor het feit 
dat een matige tijdsinvestering in het instuderen van een met beperkte middelen 
gerealiseerde e-cursus met adequate gebruiksvriendelijkheid en geïntegreerde oefeningen 
voor zelfevaluatie de kennis over de preventie van zorginfecties significant kan verbeteren.  
 5 
GENERAL INTRODUCTION 
 
Healthcare-associated infections, and nosocomial infections in particular, constitute an 
important problem in acute care hospitals, and in the intensive care unit in particular. They 
are associated with significant excess morbidity and mortality, and generate additional costs 
for both the individual patient and society.1 In recent years, the staggering gravity of the 
problem of healthcare-associated infections has led to a transition from accepting them as 
an inevitable outcome of hospital admission toward a goal of zero tolerance. Prevention of 
healthcare-associated infections has thus become a priority for which each healthcare 
professional is personally held accountable.2-6 
Although not all healthcare-associated infections are preventable, many can be avoided. Up 
to 65%–70% of cases of central line-associated bloodstream infection and catheter-related 
urinary tract infection, and 55% of cases of ventilator-associated pneumonia and surgical site 
infection are esteemed to be preventable if current evidence-based strategies are applied.7  
Striving to raise awareness of these important strategies, various authoritative organisations 
have graded their underpinning level of evidence, rephrased them into recommendations, 
and aggregated them into evidence-based guidelines, which were made widely available and 
easily accessible.8-20 Unsolicited distribution of guidelines as such has however been proven 
not to change clinicians’ practice,21 which is reflected by the wide range of publications 
reporting on a lack of guideline compliance among healthcare professionals.22-34  
The reasons for healthcare providers’ non-adherence have mostly been investigated by 
means of surveys with a self-reporting design.23, 34 As such, a large number of self-perceived 
barriers have been identified. Strikingly, a lack of knowledge of the guidelines’ contents 
appears not to be part of the long list of self-reported hindrances. Knowledge gaps may 
however seriously jeopardize adherence. For, while knowledge does not open the door 
directly to compliance, it is undeniably a conditio sine qua non, a first requirement that is to 
be fulfilled.35, 36  As such, education of healthcare personnel is widely acknowledged to be a 
fundamental and primordial measure to successfully reduce healthcare-associated infection 
rates.37-43 
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Scope and aim of the thesis 
The present thesis reports on the EVIDENCE-project, a study that aimed to evaluate 
clinicians’ knowledge of evidence-based guidelines for the prevention of nosocomial 
infection, and to help increasing the level of knowledge in case deficiencies were detected. 
As the focus was on the promotion of evidence-based care, the project was simply called 
EVIDENCE. It comprised a six-years period, starting on 1 November 2006 and ending on 15 
July 2012.  
 
The EVIDENCE-project included three major stages.  
Phase 1: 2006 - 2009 
In a first phase, we conducted a needs analysis in order to assess knowledge about evidence-
guidelines for the prevention of ventilator-associated pneumonia, central venous catheter-
related infection and surgical site infection among European intensive care nurses. For this 
purpose, we developed multiple choice knowledge tests that we took through the processes 
of validation and reliability testing. Subsequently, a network of national representatives was 
set up. These co-workers distributed the tests among nurses in their respective countries 
and mailed us all completed copies. Thus we obtained the test results of 3405 intensive care 
nurses from 22 European countries. Regrettably, the results revealed substantial knowledge 
gaps, illustrated by overall test scores below the conventional 50% threshold to pass a test. 
Phase 2: 2009 - 2010 
Alarmed by these poor results, we reflected about which resource could effectively and 
efficiently help enhancing knowledge. The literature revealed that e-learning has recently 
been acknowledged to be an important educational tool, which led us to develop a concise 
and interactive Web-based e-learning course that bundles the essentials on infection 
prevention in a comprehensible way. Thus, the EVIDENCE Crash Course saw the light. 
Phase 3: 2010 - 2012 
In the third and last phase of the EVIDENCE-project, we assessed whether our Crash Course 
would actually contribute to enhancing knowledge among distant learners by developing a 
study website and gathering an international sample of healthcare professionals who 
volunteered to study the course. Participants took three multiple choice tests: (1) a pre-test, 
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before accessing the course that aimed to measure baseline knowledge; (2) a first post-test, 
immediately after studying the course to evaluate the immediate learning effect; and (3) a 
second post-test twelve weeks after post-test 1 and without further access to the course to 
assess retention of the knowledge acquired.  
The EVIDENCE study was reviewed and approved by the ethics committee at Ghent 
University Hospital. 
 
Outline of the thesis 
Although the main focus of this thesis is the EVIDENCE study, it simultaneously aims to 
provide the reader with the broader context in which the EVIDENCE project is to be situated. 
To meet this goal, it has been divided into three main parts.  
Part one, Evidence-based prevention of healthcare-associated infection, aims to acquaint the 
reader with the background and core concepts of the EVIDENCE-project. 
Part two, Intensive care nurses’ knowledge of infection prevention guidelines, reports on the 
development of the multiple choice questionnaires and summarises the results of the needs 
analysis.  
Part three, E-learning, introduces the reader to this resource chosen to develop the 
EVIDENCE Crash Course and reveals the study results related to the testing of the course’s 
value in increasing and sustaining knowledge among healthcare professionals. 
The outline of these three parts is specified in their respective introduction sections.  
 
Publications included in the thesis 
Labeau S, Vandijck D, Blot S. Implementation strategies for the prevention of healthcare-
associated infection. In:  Vincent J-L, ed. Yearbook of Intensive Care and Emergency Medicine 
2010. Berlin: Springer; 2010: 244-256 
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2011;39(7):1800-1818.  
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         PART ONE 
 
 
EVIDENCE-BASED PREVENTION OF 
HEALTHCARE-ASSOCIATED INFECTION 
 
 
 
 
 
 
 
 
 
 
 
“It may seem a strange principle to enunciate 
as the very first requirement in a hospital that 
it should do the sick no harm.” 
   
Florence Nightingale (1820 - 1910)  
Notes on Hospitals, 1863 
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Introduction 
 
The first part of this thesis aims to create a framework that acquaints the reader with the 
broader context of the EVIDENCE-project. The reader is invited to explore the main concepts 
within the project throughout four chapters, that aspire to provide an adequate background 
for the interpretation of the study results, presented in parts two and three. 
 
As the EVIDENCE-project focuses on healthcare-associated infection, the first chapter is 
dedicated to this staggering problem. Besides a description of the incidence and the adverse 
outcomes associated with their development, the need for initiatives aiming at their 
prevention is stressed.  
Evidence-based recommendations are commonly bundled into guidelines, in order to 
optimally assist healthcare professionals in daily clinical decision making. The second chapter 
briefly introduces the concept of evidence-based guidelines, and lists a number of 
authoritative organisations that have been involved in the development and publication of 
evidence-based guidelines in the field of preventing healthcare-associated infection. 
Chapter three focuses on the determination of the evidence base of such guidelines. In this 
thesis, two evaluation strategies are presented: grading the evidence of interventions using 
the Grades of Recommendation, Assessment, Development, and Evaluation System 
(GRADE), and performing a systematic review and meta-analysis of randomised controlled 
trials, respectively. 
As adherence to guidelines among clinicians has been reported to be limited, a fourth and 
last chapter of this part is dedicated to the barriers and facilitators that respectively hamper 
or enhance compliance with recommendations.  
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1. Healthcare-associated Infections 
 
1.1. Definitions 
Healthcare-associated infection (HAI) is conveniently defined as an infection occurring in a 
patient in a hospital or other healthcare facility in whom the infection was not present or 
incubating on admission to that hospital/facility.44, 45 The Centers for Disease Control and 
Prevention (CDC) define HAI more specifically as a localized or systemic condition resulting 
from an adverse reaction to the presence of (an) infectious agent(s) or its (their) toxin(s), for 
which there must be no evidence that the infection was present or incubating at the time of 
facility admission.46  
In most cases, these definitions imply that the infection becomes manifest 48 hours (i.e., the 
typical incubation period for bacterial infections) or more after admission. Incubation 
periods, however, vary with the type of pathogen involved, and to some extent also with the 
patient’s underlying condition. Therefore, for each infection an individual assessment must 
be conducted to evaluate whether it is to be linked to the hospitalisation as such.47 
Nosocomial infections are a subset of healthcare-associated infections. Also known as 
hospital-acquired infections, they refer to infections patients acquire in hospital settings. 
Since 2008, the CDC uses the generic term health care-associated infection instead of 
nosocomial.46 
In the intensive care unit (ICU), the Big Four infection types that account for more than 80% 
of all HAIs are ventilator-associated pneumonia (VAP), central venous catheter-related 
bloodstream infection (CVC-RI), surgical site infection (SSI) and catheter-related urinary tract 
infection (CAUTI).48 
VAP is defined as pneumonia developing more than 48 to 72 hours after initiation of 
mechanical ventilation.10, 49-51  
In the context of this thesis, CVC-RI refers to any type of infection that has developed 
secondary to the presence of any central venous catheter. This could include but is not 
limited to, localized tissue infection at the catheter site, catheter-related bloodstream 
infection, metastatic infection, or colonization. 
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Surgical site infections are infections that develop in patients who underwent surgery. The 
following classification has been proposed by the Centers of Disease Control and 
Prevention:52 superficial incisional SSI, involving the skin and the subcutaneous tissue; deep 
incisional SSI, involving deep soft tissue layers, such as the fascial and muscle layers, of the 
incision; and organ/space SSI, involving any part of the anatomy, other than the incised body 
wall layers, that was opened or manipulated during the operation. Thereby, the specific 
organ or space involved is included as part of the definition to further identify the location of 
the infection.  
Catheter-associated urinary tract infection refers to the presence of microorganisms that 
have invaded the bladder of a patient with an indwelling catheter.  
For extensive information and detailed definitions we refer to the CDC/NHSN surveillance 
definition of healthcare-associated infection and criteria for specific types of infections in the 
acute care settings.46  
 
1.2. Epidemiological data 
Affecting 5% to 10% of hospitalized patients in acute care hospitals, nosocomial infections 
are the most common type of complication hospitalised patients in Europe and the United 
States have to face.1, 47 In developing countries, the problem is even more important with up 
to 50% of hospitalised patients affected.45  
The ICU is the “hot zone” of nosocomial infections.53 Critically ill patients often suffer 
immune depression induced by their condition or their medication, may have significant 
comorbidity, and mostly require multiple invasive devices that bypass natural host defences. 
It is therefore not surprising that HAIs affect up to 33% of ICU patients.1, 53, 54  
In 2002, it was estimated that in the United States 1 737 125 nosocomial infections occurred. 
Of these, 561 667 were due to urinary tract infections, 290 485 to SSI, 250 205 to 
pneumonia, 248 678 to bloodstream infections, and 386 090 to other causes. The estimated 
annual deaths due to HAI amounted to 98 987.55  
The more recently and world-wide conducted Extended Prevalence of Infection in Intensive 
Care (EPIC II) study was a one-day prospective point prevalence investigation that took place 
in March 2007 and gathered extensive data of 14 414 patients in 1265 participating ICUs 
from 75 countries. This major initiative revealed that 7087 of 13 796 patients analysed (51%) 
 14 
were considered infected on the study day. Infections were demonstrated to be common in 
ICU patients, and risk of infection to increase with duration of ICU stay. It should however be 
acknowledged that, unfortunately, the EPIC II study suffered from methodological 
limitations, which impeded clear-cut distinction between community-associated and 
healthcare-associated infections.56 
In 2008, Vrijens and colleagues47 conducted a prevalence study of nosocomial infections in 
Belgian acute hospital settings. They found that the crude prevalence rate of patients 
infected was 6.2% (95% CI 5.9% - 6.5%), and the prevalence of infections 7.1% (95% CI 6.7% - 
7.4%). Overall, the most prevalent infections were shown to be UTI (23.9%), lower 
respiratory tract infection (20.1%), SSI (14.6%) and bloodstream infections (BSI; 13.6%). In 
the ICU, the prevalence rate of patients infected added up to 25.3% and the prevalence of 
infections to 31.3%. Unsurprisingly, the most frequently diagnosed infections were lower 
respiratory tract infections (15.9%), BSI (6.20%), SSI (2.69%) and UTI (2.22%).47  
Additional epidemiological data on specific infection types are reported in the respective 
introduction sections of the papers included in Part Two of this thesis. 
 
1.3. Impact  
The impact of HAIs in terms of excess morbidity, mortality and expenditures is known to be 
detrimental.57-59 A study of 1 355 347 admissions in 55 US hospitals from 2001 to 2006 
estimated that each nosocomial infection increased medical costs by $12 197.60 According to 
a publication from the United Kingdom, the average increased medical cost for each central 
venous catheter infection was £6200,61 and in a Belgian study dated 2005, hospital-acquired 
bacteraemia was estimated to increase medical costs by an average of €12 853. 
More recently, Vrijens and colleagues estimated excess mortality, length of stay and costs 
attributable to HAIs in acute care hospitals in Belgium.62 A matched cohort design with the 
six following matching factors was used: hospital, diagnosis-related group, age, ward, 
Charlson score,63 and estimated length of stay prior to infection.62 This study revealed an 
excess mortality of 2.8% and an excess length of hospital stay of 7.3 days. The related public 
healthcare cost calculated was €290 million.62  
In US hospitals, it is estimated that the approximately 2 million HAIs occurring each year are 
associated with nearly 100,000 deaths.1 
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1.4. Prevention  
Due to the detrimental impact of HAIs, their prevention has been acknowledged a priority on 
a worldwide scale. Only quite recently though, HAIs are no longer accepted as an inevitable 
outcome of admission to the hospital. Today, a culture of zero tolerance and personal 
clinician accountability toward these infections are globally promoted.2-6  
This turnaround largely owes to the growing focus on improving patient safety over the past 
few years, particularly promoted in the US by the Institute of Medicine (IOM) and the 
Institute of Healthcare Improvement (IHI). The IHI made the institution of practices to 
prevent HAIs (specifically SSI, CVC-RI and VAP) three of the six planks of their 100,000 Lives 
Campaign (2004 – 2006), and kept this focus in their subsequent 5 Million Lives Campaign 
(2006 – 2008).6, 64  
Moreover, public reporting of infection rates in the US has been implemented as a means of 
informing the public and encouraging preventive efforts, with legislation requiring some 
type of reporting in the majority of states.65 Although transparency and public education 
have met with resistance, they now have the support of major national medical 
organizations.66 As a further initiative to promote quality, the American Centers for 
Medicare and Medicaid Services have proposed the installation of financial implications such 
as policies that decline payment in the event of preventable hospital-acquired conditions.2, 4, 
66 Following the example set in the US, the prevention of healthcare-associated infection has 
become a priority in most healthcare settings worldwide.  
Although not all HAIs are preventable, many can be avoided. A systematic review of 30 
reports published between January 1990 and October 2002 found that a minimum reduction 
effect of 10% and up to a maximum effect of 70% could be obtained, depending on the 
setting, study design, baseline infection rates and type of infection.67 The authors concluded 
by considering at least 20% of all nosocomial infections as probably preventable.67  
Another, more recent, estimation of the preventable proportion of HAI by Umscheid and 
colleagues considers up to 65%-70% of cases of central line-associated bloodstream 
infections and CAUTI, and 55% of cases of VAP and SSI to be avoidable.7  
 
Successful HAI prevention requires healthcare workers to follow the most recent evidence-
based recommendations.7 Moreover, and as illustrated by the examples below in the field of 
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preventing CVC-RI, a multidisciplinary approach has been shown to yield excellent results in 
reducing HAI rates.68-73 
Among the most appealing examples of successful HAI prevention, are a series of very fine 
studies using a well-defined set of multifaceted preventive strategies to reduce CVC-RI rates 
in the ICU, taken from the CDC guidelines17 for preventing catheter-associated infection.69, 70, 
74 This set, which has been shown to be utmost effective, consisted of the following five 
multidisciplinary interventions: (1) education of the local staff; (2) creation of a catheter 
insertion cart; (3) daily assessment of the need for the catheter to remain in situ; (4) 
implementation of  a checklist to ensure adherence to evidence-based CVC-RI prevention 
guidelines; and (5) empowerment of nurses to stop catheter insertion if breaches in the 
procedure are detected.  
Applying this set of interventions in a surgical ICU, Berenholtz and colleagues report a 
decrease of the rate of CVC-related bloodstream infections over a five-year time period from 
11.3 to zero per 1000 catheter days. The authors estimate that the interventions may have 
prevented 43 CVC-related bloodstream infections, eight deaths, and $1 945 922 in additional 
costs per year.69 
Using the same five strategies, Pronovost et al. report their study results obtained from 103 
intensive care units, including 1981 ICU-months of data and 375 757 catheter-days.70, 74 They 
describe a decrease in the median rate of catheter-related bloodstream infection per 1000 
catheter-days from 2.7 at baseline to zero at three months after implementation of the 
study intervention (p<0.002), and a decrease in the mean rate per 1000 catheter-days from 
7.7 at baseline to 1.4 at 16 to 18 months of follow-up (p<0.002). The regression model 
demonstrated a significant decrease in infection rates from baseline, with incidence-rate 
ratios that continuously decreased from 0.62 (95% CI 0.47 - 0.81) at zero to three months 
after implementation of the intervention to 0.34 (95% CI 0.23 - 0.50) at 16 to 18 months.70, 74  
 
These and other reports37, 38, 41, 42, 71, 75-79 on the successful implementation of initiatives to 
reduce HAI rates clearly indicate that prevention works, and that intensive and sustained 
multidisciplinary efforts are truly worthwhile. 
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2. Evidence-based Guidelines 
 Based on the book chapter:  Labeau S, Vandijck D, Blot S. Implementation strategies for the 
prevention of healthcare-associated infection. In:  Vincent J-L, ed. Yearbook of Intensive Care and 
Emergency Medicine 2010. Berlin: Springer; 2010: 244-256. 
 
2.1. Definition 
Evidence-based guidelines are guidelines which are founded on a critical appraisal of the 
available scientific evidence, clarifying which interventions are of proved benefit, and 
documenting the quality of the supporting data. They alert clinicians to interventions which 
are not supported by good science, reinforce the importance of critical appraisal, and advise 
against ineffective and dangerous strategies.80 
 
With the rise of the concept of evidence-based medicine since the early 1990s, worldwide, 
various ambitious programs for guideline development have been invested in. 
Simultaneously, however, numerous more modest and local guideline development 
initiatives also arose. The subsequent proliferation of recommendations and concerns about 
their quality and uniformity have led to the foundation of public resources for evidence-
based clinical practice guidelines, such as the United States’ National Guideline 
Clearinghouse, and to international collaborations, such as The Guidelines International 
Network, that released the International Guideline Library, a searchable database which now 
contains more than 2000 guideline resources.81  
 
In the field of preventing HAIs, various authoritative organisations and research groups have 
issued evidence-based guidelines, which they made readily available for healthcare workers 
to consult. These organisations include, among others, the US Centers for Disease Control 
and Prevention (CDC),14-20 the American Thoracic Society,10 the Association of Medical 
Microbiology and Infectious Diseases Canada,11 the Canadian Critical Care Trials Group of the 
Canadian Critical Care Society,12 the UK National Institute for Health and Clinical Excellence,8, 
13 and the UK Department of Health.9 Guidelines pertain to the prevention of VAP,10, 12, 18, 82-
87 CVC-RI,15, 17, 88 SSI,13, 20, 89 UTI19, 90-93 or to the prevention of HAIs in general.8 
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Beside the guidelines issued by separate organisations or research groups, joint initiatives in 
developing and publishing evidence-based HAI prevention guidelines were taken.94, 95 Such 
joint efforts of the Society for Healthcare Epidemiology of America and the Infectious 
Diseases Society of America Standards and Practice Guidelines Committee have led to the 
publication of a compendium of recommendations for HAI prevention. This compendium 
differs from most previously published guidelines in that it is typically implementation-
focused.1, 3 
 
2.2. Guideline implementation 
In recent years, there is a growing awareness of the fact that published guidelines are not 
self-implementing. Unsolicited distribution of guidelines as such has been proven not to 
change clinicians’ practice.21 Active and sustained implementation efforts in the healthcare 
setting are required before guidelines can be expected to actually influence clinicians’ 
behavior.26, 96 Transferring research findings into healthcare professionals’ daily practice is a 
slow and laborious process97, 98 that may be facilitated and supported by the findings of 
implementation research.  
Implementation research is defined as the scientific study of methods to promote the 
uptake of research findings, and hence to reduce inappropriate care. It includes the study of 
influences on healthcare professionals' behavior and interventions to enable a more 
effective use of implementation-related research findings.99 Implementation research 
requires a multidisciplinary collaboration between healthcare professionals.100, 101 
Guideline implementation is the phase in the guideline lifecycle in which strategies, systems 
and tools are created to operationalize the knowledge and recommendations set forth by 
the guideline developers.102 Guideline implementation is thus the final step in translating the 
scientific basis into clinical practice.  
 
2.2.1. Implementation strategies 
An implementation intervention or implementation tool is a single method or technique to 
assist a proposed change. In the literature, these interventions are also referred to as 
uptake, adoption, or change interventions. An implementation strategy or implementation 
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program is defined as an integrated set (bundle, package) of implementation 
interventions.103  
The following classification of strategies for guideline implementation has been proposed.6 
1. Clinician education (e.g. workshops, (computerized self-study tutorials, …)  
2. Patient education (e.g. pamphlets, classes, …) 
3. Audit and feedback (e. g. benchmarking, quality reports, …) 
4. Clinician reminder systems (e. g. in charts or computer-based, …) 
5. Organizational change (e. g. increased staffing, multidisciplinary teams, …) 
6. Financial or regulatory incentives for patients or clinicians 
The current insights in implementation interventions and strategies have greatly been based 
on implementation research that was conducted since the early 1990’s.104-106 During the 
course of years, the research focus clearly moved from evaluating the effect of isolated 
interventions to determining the impact of bundle approaches.1 Today, it is generally 
acknowledged that using only one type of implementation intervention is not likely to 
generate successful results, and that implementation efforts should use a combination of 
strategies tailored to the setting.36, 98, 107 
The 1990’s 
As early as in 1994, when the rise of evidence-based medicine was still on-going, Haines and 
Jones denounced the unacceptable delays in the implementation of research findings.108 
They promoted a number of approaches which they considered to be effective in speeding 
up implementation, including the influence of opinion leaders and the use of computer-
based decision support systems. Typical of the optimistic expectancies towards the 
implementation-promoting capabilities of evidence-based guidelines in that period, 
guidelines as such are mentioned among the implementation interventions that are 
considered to be potentially successful. The authors concluded that methods for improving 
the implementation of research findings required further investigation and greater resources 
devoted to them.108 
An early review on implementation strategies was conducted by Wensing in 1998.109 It 
covered a systematic literature study involving the period from January 1980 until June 1994 
using MEDLINE in association with a manual search of 21 medical journals. By selecting 
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randomised controlled trials and controlled before-after studies, 61 studies covering 86 
intervention groups that could be compared with a control group without the intervention, 
were included. The review aimed to identify the effects of different single and multifaceted 
interventions to implement guidelines or innovations in general practice by first comparing 
different single interventions with no intervention, and then comparing different 
multifaceted interventions with no intervention. Given the wide range of outcome 
measures, it was impossible for the author to identify a standardized outcome measure that 
could be compared across all studies. The predominant finding of the review thus was that 
there was a considerable variation in effectiveness among the different interventions 
included. The combination of information transfer and learning through social influence or 
management support was shown to be possibly effective, and so were reminders and 
feedback. Information transfer is probably always needed at some point in the process of 
implementing change, but more interventions appeared to be usually needed to achieve real 
changes in the practice routines of clinicians. Other interventions were also shown to have a 
potential beneficial effect, but the author reported to be unable to pronounce upon their 
effectiveness as further investigation remained required. The results of this analysis are to 
be treated with caution, especially because of the rather poor methodological quality of the 
studies included.109 
On 5 and 6 October 1999, a group of implementation experts from Europe and the United 
States was convened at Leeds Castle, England, to identify the best ways to encourage and 
undertake the implementation of best practices. The subsequent meeting summary 
expresses the experts’ common belief that the approach towards implementing a guideline 
should be multifaceted.96 They suggest that the implementation process can be facilitated by 
recruiting the help of local opinion leaders, involvement of all stakeholders, broad 
dissemination of the objectives, and local consensus conferences. Reluctant converts or 
larger groups could be reached by means of academic detailing, while computer-aided 
decision support systems, reminders, and audit and feedback were considered to be useful 
in supporting clinicians’ implementation efforts.96 
The 2000’s 
In 2001, the available systematic reviews of interventions that potentially influence 
healthcare professionals’ behavior change were investigated and discussed by Grimshaw 
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and colleagues.43 The authors identified 41 reviews, covering a broad variety of interventions 
and behaviors. The quality of the included manuscripts showed, again, to be variable, and 
some methodological flaws were noticed. In general, passive implementation approaches 
such as passive dissemination, were found to be ineffective and unlikely to change behavior, 
while active approaches showed to be more likely to be effective, but only under certain 
circumstances. The latter are, nevertheless, also likely to be more costly. Among the active 
approaches, educational outreach and reminders are described as promising interventions, 
and multifaceted strategies targeting different barriers to change are considered to be more 
effective than single interventions.43  
In 2004, a systematic review focussing on the effectiveness and costs of different guideline 
development, dissemination and implementation strategies included a total of 235 studies, 
which described 309 comparisons.110 Of these, 73% evaluated multifaceted strategies. 
Overall, the majority of comparisons reporting dichotomous process data observed 
improvements in care. However, considerable variation in the observed effects, both within 
and across interventions, was reported. Frequently assessed single interventions were 
reminders, dissemination of educational materials, and audit and feedback. No relationship 
was found between the number of interventions included in bundle strategies and the 
strategies’ effect. As a conclusion, the authors found an imperfect evidence base to support 
decisions about which guideline dissemination and implementation strategies are likely to be 
efficient under different circumstances. They state that further research is required to 
develop a validated theoretical framework on behavior and behavior change in order to 
make an informed choice of interventions and implementation strategies in the presence of 
different barriers and effect modifiers.110 
Current insights 
A 2008 synthesis of systematic review findings by Prior and colleagues concerning the 
effectiveness of guideline implementation strategies covered the period from 1987 to 2007, 
thus reflecting more recent insights.107 Here, 33 reviews concerning 714 primary studies 
involving 22 512 clinicians in various healthcare settings were analysed. Implementation 
strategies were found to be wide-ranging, rarely comparable, and to have variable 
outcomes. The effectiveness of educational strategies, generally labelled as continuing 
medical education, is suggested to be controversial while traditional educational strategies, 
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typically including passive information dissemination, showed to be constantly ineffective. 
Interactive educational strategies such as workshops and practical sessions coupled with 
evaluation processes were persistently reported as effective, with improvement effects 
ranging from 1% to 39%. For educational outreach a relative improvement up to 68% in 
process or compliance was reported, while audit and feedback were associated with a range 
from no effect over a 17% decline to a 63% improvement. Multifaceted intervention 
strategies consistently resulted in significant improvements in guideline compliance and 
behavioral change, with a reported effect of improvement ranging up to 60%. Multifaceted 
interventions showed to have greater evidence of effectiveness than single intervention 
strategies. Similar to the 2004 findings by Grimshaw et al.110 there was no evidence of any 
relationship between the number of components of a strategy and the strategy’s 
effectiveness, neither was there any evidence for the effect of combined strategies. The 
value of mass media strategies remained inconclusive. Clinicians’ behavior seems to be 
influenced by the construction and content of the guideline, with complex guidelines being 
inversely related to compliance. Trustworthiness of the developing organization and/or 
reference group showed to improve compliance, and so did the levels of evidence upon 
which guidelines were based. The use of reminders and clinical support systems 
demonstrated to be associated with considerable practice enhancements, while the effect of 
financial incentives was inconclusive. There was no consistent evidence that guideline 
adherence could be promoted by involving local opinion leaders.107  
This review’s overall findings are consistent with these of another 2008 systematic review on 
guideline implementation strategies in allied health professions36 and reflect the general 
consensus that today no clear evidence is available to support a specific set of guideline 
implementation interventions that might be most effective and efficient in the field of 
healthcare.  
 
2.2.2. Implementation of infection prevention guidelines  
The lack of certainty about the most effective strategies for guideline implementation also 
pertains to the field of guidelines for preventing and controlling infection. Until today, only 
few resources are available that provide healthcare professionals with clear guidance 
regarding effective implementation interventions and strategies specifically focused on this 
field.1  
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Interventional studies 
Numerous studies using a broad range of strategies and reporting varying results have been 
published related to the implementation of evidence-based guidelines for preventing 
infection. 
In the field of preventing infections associated with the use of central venous catheters, the 
studies by Berenholtz and colleagues69 en by Pronovost and colleagues70, 74 have been 
discussed previously in this thesis to illustrate the successes obtained through multifaceted 
implementation programmes.  
To implement evidence-based guidelines for preventing VAP in a surgical ICU, an electronic 
dashboard, serving as a screen saver on every desktop computer, was used.111 The left side 
of the screen indicated patient demographics and provided access to the medical records, 
while evidence-based preventive measures were indicated at the right hand side of the 
screen. Colour indicators green, red and yellow were used to mark the degrees of measures 
in compliance. Over a one year period, mean compliance with the recommendations 
improved from 39% to 89% (p<0.001), and VAP rates decreased from a mean (standard 
deviation) of 15.2 (7.0) to 9.3 (4.9) per 1000 ventilator days after introduction of the 
dashboard (p=0.01).111 
Next to numerous success stories, a number of studies were published that demonstrate a 
failure to implement evidence on infection prevention and control into daily practice. 
Examples of such less successful implementation reports are provided by Morse et al., where 
the single use of a poster-based education programme to improve the recording of date and 
time of insertion of peripheral venous catheters was shown to have little effect,112 and by De 
Miguel-Yanes et al., who report on a failure to implement evidence-based clinical guidelines 
for sepsis at the emergency department.113 
Although single studies may be suggestive and inspiring, they do not provide the healthcare 
worker with a global view of which (set of) implementation intervention(s) may be most 
beneficial.   
Systematic review 
Recently, more bundled information was provided by the Stanford-UCSF (University of 
California San Francisco) Evidence-based Practice Center, that reviewed the literature on 
effective implementation of measures to promote adherence to guidelines for the 
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prevention of VAP, SSI, CVC-RI and CAUTI.6 The authors aimed to identify (1) the 
implementation strategies that effectively increase adherence to evidence-based preventive 
interventions for healthcare-associated infections; (2) the critical components of effective 
quality improvement strategies; and (3) the limitations of the current research in this specific 
area. Sixty-four studies met the inclusion criteria: 28 studies addressed the prevention of SSI, 
19 of CVC-RI, 12 of VAP, and 10 studies focused on CAUTI prevention. Three additional 
studies targeted prevention of multiple HAIs. The strategies that demonstrated to be 
effective in implementing evidence-based guidelines for the prevention of the respective 
HAIs are summarized below. 
SSI  
The limited data suggests that educational interventions combined with audit and feedback 
may be effective at improving adherence to evidence-based recommendations for SSI 
prevention, specifically appropriate antibiotic prophylaxis. Clinician reminders may also be 
effective, especially when incorporated into a computerized physician order entry system. 
No conclusion could be reached regarding the effectiveness of educational interventions 
alone. The effect of using audit and feedback is not clear. 
CVC-RI 
Active educational interventions showed to reduce the incidence of CVC-RI. These 
interventions used demonstrations and self-study tutorials to improve adherence to 
evidence-based prevention guidelines during line insertion. The use of a checklist during the 
insertion procedure, and empowerment of nurses to stop catheter insertion whenever a 
violation of the procedure was noticed, resulted in marked reductions in infection rates.  
VAP 
Active educational interventions with the use of a self-study module for ICU staff, including 
web-based and video tutorials, appear to be a promising strategy for reducing VAP rates. No 
conclusion could be reached on the effectiveness of audit and feedback or other 
implementation strategies on VAP rates.  
CAUTI 
Printed or computer-based reminders to clinicians appear to be effective in reducing 
unnecessary catheter usage. A key element of these studies was the use of an automatic 
stop order, mandating discontinuation of the catheter after a specific time period (48 to 72 
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hours) unless the physician countermands the order. The effect of other implementation 
strategies on either infection rate or process measures could not be determined. 
In all included studies, information concerning potential adverse effects of the 
implementation strategies was extremely scarce, and so was high quality data concerning 
cost-benefit assessments. The reviewers’ conclusion is twofold: (1) preliminary data suggests 
that a number of implementation strategies are worthy of future investigation, and possibly 
wider implementation, and (2) higher quality studies of implementation strategies to 
implement preventive evidence-based recommendations are urgently needed. Due to the 
poor quality of included studies and the limited number of controlled trials, the authors 
were unable to perform any quantitative analyses, thus being unable to make any estimate 
of the effect size expected when implementing these strategies, nor any firm 
recommendation.6 
A rather new and innovative implementation strategy is the so-called bundled approach,64 
which was introduced by the IHI’s two subsequent major campaigns for the promotion of 
patient safety, i.e. the 100,000 Lives Campaign (2004 – 2006) and 5 Million Lives Campaign 
(2006 – 2008).64 A care bundle is defined as a small set of evidence-based practices, usually 
three to five, that individually have been proven to improve patient outcomes, and that are 
expected to result in a better outcome when implemented together than when 
implemented separately.114, 115 All recommendations included in a bundle should be 
respected by all healthcare workers, at all times, and for all eligible patients. Therefore, 
bundles are often referred to as a ‘all or nothing’-strategy. The first care bundles created by 
the IHI were the ventilator bundle and the central line bundle, focussing on the prevention 
of complications in mechanically ventilated patients and of CVC-RI, respectively. In the time 
to follow, various bundles for a plethora of conditions have been developed worldwide.2, 85, 
115-128  
Fulbrook and Mooney129 describe a seven-step process to develop a care bundle. The first 
and second step are the identification of a care theme, and a cluster of generally recognized 
practices or interventions within that theme, respectively. The third step consists of 
performing comprehensive and systematic literature searches in each of these areas. This 
review should not be limited to the search of scientific electronic databases but should also 
include the ‘grey’ literature, such as research abstracts and meeting proceedings. The fourth 
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and fifth step comprise an extraction and the reading and categorizing of the quality of 
evidence, respectively. Identification and clarification of the solidity of the evidence base is 
recognized to be the most challenging step in the bundle development process. In step six, 
all interventions lacking a solid evidence base are to be discarded. Finally, an appropriate 
clinical protocol can be drafted on the basis of the analysed research evidence. It is 
elementary that this protocol clearly outlines that it relates to a grouping of components, 
which should be practiced together at any time and by all healthcare professionals 
concerned.129 Inherent to the bundle concept is that bundle becomes obsolete when new or 
stronger evidence becomes available. Therefore, periodical systematic reviews of the related 
literature and timely updates of the bundle components are required. 
Various prospective studies have identified a positive relationship between patient 
outcomes in term of HAI prevention and bundle compliance.70, 74, 115, 119 Reviews 
investigating HAI prevention bundle effectiveness also yielded overall positive 
conclusions,130-133 but due to the limitations of the observational designs used in the studies 
retrieved, a definitive causal relationship between bundle use and reduction of infection 
rates cannot be stated today.131  However, the evidence to date is strongly indicative of a 
positive association.131 
 
2.2.3. Evaluating the implementation 
Evaluating an implementation consists of assessing whether or not the efforts have been 
effective when measured against the objective. A good evaluation comprises both the 
process and the outcome of the strategies used.  
A process evaluation consists of an examination of the approaches used to achieve the 
objective. While this process evaluation is important, it is a ‘surrogate’ endpoint only and the 
evaluation of outcomes should definitely not be forgotten.134 Evaluating the outcome is 
more difficult than evaluating the process, and requires a fair degree of planning. It also 
requires a budget and assigned personnel to carry out the task.134 
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2.2.4. Sustainability of implementations 
While initial implementation efforts have quite extensively been studied, less research has 
been dedicated to the sustainability of such innovations.135, 136  
A prerequisite to studying sustainability is a clear understanding of the concept. According to 
Bowman et al.136 sustaining improvements refers to holding the gains made during the 
implementation phase of a project that typically provides a generous supply of support for 
the intervention in terms of personnel and other resources, for a variably defined period 
after the funding has ceased and project personnel have been withdrawn. As such, a 
program or intervention’s impact may be considered sustained if desired health benefits 
remain at or above the level achieved during implementation and this increase can be 
attributed to continuation of the program.137 A program or intervention may be considered 
to be sustained at a given point in time if, after initial implementation support has been 
withdrawn, core elements are maintained and adequate capacity for continuation of these 
elements is maintained.137 This conceptualization implies the necessity of defining a 
timeframe adequately beyond an initial implementation effort in order to provide 
meaningful evidence.  
Shediac-Rizkallah and Bone138 propose the following categories of operational indicators to 
monitor sustainability over time: (1) maintenance of health benefits achieved through an 
initial program, (2) level of institutionalization of a program within an organization and (3) 
measures of capacity building in the recipient community.  
Wiltsey Stirman et al. conducted an extensive review of the English language literature, 
published or in press by July 2011, to determine the methods used to study sustainability of 
implementation efforts, the types of outcomes measured and reported, factors identified as 
potential influences on the sustained use of new practices, programs, or intervention, and 
findings from studies reporting long-term implementation outcomes.137 A total of 460 
published articles were identified, of which 125 met the inclusion criteria and were selected 
for the review. Although of considerable interest, a comprehensive report of all findings 
within this review is beyond the scope of this thesis. Below, only the results related to long-
term implementation outcomes and their potentially influencing factors retrieved from 
medical, public health/health promotion, and mental health studies are briefly reported. 
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As a noteworthy general finding, partial sustainability appeared to be more common than 
continuation of the entire program or intervention, even if full implementation was initially 
obtained. In general, not all aspects of the originally implemented program were maintained 
over time, with only very few studies elaborating on the nature of the adaptations made, the 
reasons for changes, or the process by which decisions to discontinue elements of the 
original program were made. It is well known indeed that studying sustainability of 
implementation efforts may be hindered by the fact that interventions as originally designed 
often need adaptation when used in specific settings or contexts that substantially differ 
from those in which they were developed. Today, however, few procedures or benchmarks 
are available to identify the extent to which interventions were continued as 
implemented.137 Multilevel measurement of sustainability, based on sound 
conceptualization, would allow for greater methodological rigor and interpretability of 
findings.139 This finding also stresses the importance of the recommendation by Bowman 
and colleagues136 that implementation scientists should keep the longer view in mind when 
designing interventions, including those that potentially will be exported to other contexts. 
The review identified a wide range of outcomes.137 Few studies based on independent 
observation validation reported high rates of continuation at the site or setting level. Those 
reporting on full sustainability at the provider level identified less than half of the observed 
providers sustaining the implemented interventions at a high level of skill, intensity, or 
fidelity. Seventy-five studies related changes in implementation or recipient-level outcomes 
after initial implementation efforts or funding had ended, of which 56 reported on the 
intervention or program implementation. Of the latter, 19 described lower levels of 
implementation following the initial implementation efforts,  17 reported an increase, and 3 
mentioned no change. Varying changes in rates across different program components were 
identified in 17 studies.  
In 22 studies, changes in outcomes were evaluated, 5 of which reporting a decrease in 
desired outcomes, 10 an increase, and 1 reported no change. The remaining five studies 
reported multiple outcomes or indicators with varying extents of durability. 
The authors identified four categories of factors that have a potential influence on the 
achievement of long-term implementation: (1) influences related to the innovation included 
the fit of the innovation for the local context, its ability to be modified according to local 
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needs, its effectiveness or benefit, and its ability to maintain fidelity or integrity; (2) 
influences related to the organizational context comprised culture, climate, leadership, 
specific characteristics of the setting such as structure and policies, and system or policy 
change; (3) influences related to the (internal and external) capacity were workforce, 
funding, resources, champions, and the involvement and / or support of stakeholders and 
the community; (4) influences related to the processes and interactions, finally, included 
engagement/relationship building, shared decision making among stakeholders, adaptation, 
integration of rules or policies, evaluation and feedback, training and education, 
collaboration/partnership, navigating competing demands, on-going support, and planning. 
When aiming to achieve long-term effects from implementation efforts, the findings of this 
review137 could be a helpful source of information. Importantly, however, it should be noted 
that relatively few of the studies included were assessed as comprehensive or 
methodologically rigorous. Mostly, no operational definition of sustainability was provided, 
and in less than 50% a published definition or model of the concept was used. These 
limitations as well as the variety of results reported did not allow the authors to generalize 
their findings.  
 
2.2.5. Cost considerations 
Studies and reviews concerning the effectiveness of implementation interventions and 
strategies are numerous, but economic evaluations of guideline implementation strategies 
are scarce. Developing and implementing guidelines, however, can be quite costly. 
Sometimes, implementation costs are even likely to prevail over the potential benefits, and 
organizations should consider that the implementation of less costly -but also less effective- 
implementation strategies might be more efficient in their setting.140 
The economic aspects of 63 out of 235 studies on guideline implementation110 were 
commented by Vale and colleagues.140 Of these, only 3 studies provided evidence that their 
guideline was effective and efficient; 38 reported treatment costs only, 12 implementation 
and treatment costs, 11 implementation costs only, and 2 reported on guideline 
development, implementation and treatment costs. None of the studies provided complete 
information on costs. The type of economic evaluation was rarely mentioned, and if it was, it 
was sometimes unclear. Seldom all relevant costs and benefits were included. Overall, 
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studies were of poor methodological quality, did not report an economic rationale for the 
choice of implementation strategies considered, nor did they cover all potentially relevant 
stages of guideline implementation. The multifaceted nature of various implementation 
strategies in the primary studies, the broad variety of strategies addressed and the weak 
methodology of most evaluations included made it impossible for the reviewers to generate 
a structured and uniform report of outcomes.140 
An earlier mentioned review by Prior and colleagues, summarizing the evidence of 
effectiveness of clinical guideline implementation strategies in terms of improved clinical 
processes, also took into account the effectiveness in terms of cost-benefits.107 Also in this 
report the authors remark that, although increased cost-efficiency is a frequently cited 
reason for implementing clinical guidelines, only few systematic reviews report primary 
studies that investigated financial outcomes. For most guideline implementation strategies 
in these reviews, significant cost reductions in clinical practice were reported, but it was not 
known whether the benefits were offset by the costs of the implementation strategies. This 
lack of economic evaluation is referred to as a major detractor from the widespread uptake 
of guidelines, particularly as it has been suggested that, due to the provision of services 
advocated as best practice, healthcare costs may increase.107 
 
2.2.6. Methodological considerations 
All systematic reviews discussed in the above sections are limited in the generalization of 
their findings due to some considerable methodological weaknesses of the publications 
included. A striking but valid illustration of this problem is provided through the bold 
statement by Bowman and colleagues that “… methods used in evaluating the success of 
implemented QI [quality improvement] interventions and strategies are 'messy' at best 
…”.136 To reach the goals of implementation science, strong methods are needed indeed to 
develop a solid knowledge base.  
In some cases, implementation science can rely upon rigorous tools and methods used in 
efficacy and effectiveness research. For example, an examination of the impact of 
implementation features on fidelity can be assessed by means of randomized controlled 
trials. In other cases, the adequate assessment of major nuances in implementation might 
need reconsideration of established methods. As such, achieving adequate sample sizes and 
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maximizing power may present challenges when small settings are involved. Finally, new 
tools and measures may be needed to address the questions of specific relevance to 
implementation science.141  
Depending on the specific research focus, a wide range of research methodologies can be 
employed. Randomised controlled (multi-center) trials are often required to evaluate the 
(cost-)effectiveness of specific strategies and programmes, while qualitative and 
observational research have their value in identifying problems in creating change and 
generating hypotheses about the determinants of and the conditions for change. Economic 
analyses are needed to assess the efficiency of implementation efforts. Psychometric 
studies, in turn, are required to determine the value of indicators and criteria for evaluating 
the success of implementation. Follow-up studies and continuous monitoring of successes 
and failures obtained are needed as well.100 
Some general recommendations that might contribute to a more methodological rigour of 
implementation research include: 
-  the use of a clear and established conceptual framework;142 
-  the selection of study designs tailored to the specific research question; 
- the use of mixed methods: mixed methods designs focus on collecting, analysing and 
merging both quantitative and qualitative data. The central premise is that the use of these 
approaches in combination provides a better understanding of research issues than either 
approach alone;143 
- the integration of a sustainability assessment to determine long-term effects of the 
implementation, including both formative and outcome evaluation.137 
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3. Determining the Evidence Base of Recommendations and Strategies 
 
A characteristic of evidence-based guidelines is that they document the quality of the 
supporting data. They do so by assigning to each recommendation a certain grade, that 
reflects the strength and the soundness of the body of evidence by which it is supported.  
The supporting evidence is indeed not equally strong for all available recommendations. 
Sometimes, it is very clear that a specific preventive strategy is absolutely superior to others; 
at other times, nevertheless, the current state of the science has not succeeded yet in 
determining which of different strategies is most (cost-)effective.  
The strength of a recommendation is thus determined by the body of evidence by which it is 
supported. Below, some basic information is provided concerning two ways by which the 
strength of the supporting body of evidence of individual interventions can be determined: 
(1) by systematically grading the evidence of separate published strategies and (2) by 
conducting a systematic review and meta-analysis. 
 
3.1. Grading the evidence of interventions 
 Based on the article:  Aitken LM, Williams G, Harvey M, Blot S, Kleinpell R, Labeau S, Marshall 
A, Ray-Barruel G, Moloney-Harmon PA, Robson W, Johnson AP, Lan PN, Ahrens T. Nursing 
considerations to complement the Surviving Sepsis Campaign guidelines. Crit Care Med. 
2011;39(7):1800-1818. 
 
In the course of the last three decades, a plethora of systems to grade the evidence base of 
published interventions has been developed,144 the first of which was issued in 1979 by the 
Canadian Task Force on the Periodic Health Examination.145 Since then, various alternative 
approaches have been proposed.145 All aim to inform clinicians about the strength of the 
evidence of published interventions, and to assist healthcare workers in daily clinical 
decision-making by rephrasing the results of the grading process into recommendations. 
Below, the results of such grading process is illustrated by an initiative that aimed to 
determine which nursing considerations would most effectively complement the 
recommendations for physicians outlined in the Surviving Sepsis Campaign.146 Thereto, the 
evidence base of eligible interventions and strategies was assessed by an international group 
using a modified Delphi method and the Grades of Recommendation, Assessment, 
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Development, and Evaluation System (GRADE). With the GRADE system, the quality of 
evidence is rated from high (A) to very low (D), and the strength of recommendations is 
determined: GRADE 1 indicates clear benefit and GRADE 2 indicates less confidence in the 
benefits of the intervention. 
  
Table 1 demonstrates the GRADE criteria utilised in the review process. 
 
Table 1: The GRADE criteria147, 148  
Strength of Evidence  Quality of Evidence  
1 – Strong  A – high, e.g. well conducted RCT  
2 – Weak  B – Moderate, e.g. downgraded RCT or upgraded observational studies  
 C – Low, e.g. well done observational studies  
 D – Very low, e.g. case series or expert opinion  
Factors influencing strength of evidence  
Methodological quality – poor planning and implementation increasing likelihood of bias is likely to decrease rating  
Importance of outcome – highly desirable outcomes are likely to increase rating  
Magnitude of treatment effect – RR > 2 with no plausible confounders is likely to increase rating  
Precision of estimate of treatment effect – highly precise results are likely to increase rating  
Inconsistency of results – multiple studies with inconsistent results is likely to decrease rating  
Directness of evidence – indirect evidence (e.g. different populations) is likely to decrease rating  
Risks associated with therapy – significant known risks or burden of therapy are likely to decrease rating  
Costs – significant costs associated with therapy are likely to decrease rating  
RCT: randomized control trial; RR: relative risk  
 
As part of the various nursing considerations and strategies relevant for the prevention and 
treatment of sepsis, interventions in the field of preventing HAIs were reviewed and graded. 
An overview of the resulting recommendations, with their respective grades of evidence and 
rationale, is listed below. 
 
Education  
1. We recommend interactive, multifaceted, longitudinal educational programs and 
educational outreach to enhance guideline implementation. Traditional education 
approaches, such as incorporated passive education and information dissemination 
through conferences, web sites and didactic lectures, are often not effective (GRADE 1A).  
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2. We recommend educational initiatives to reduce healthcare-associated infection rates 
(GRADE 1C). 
Rationale. Education is generally considered as a first step to increase awareness of a 
problem and as crucial for processes of change. A systematic review found that interactive, 
multifaceted, longitudinal educational programs and educational outreach enhance 
guideline implementation.107 More specifically, a systematic review that investigated the 
effect of education on the reduction in infection rates concluded that the implementation of 
educational interventions may considerably reduce healthcare associated infections.149 
 
Accountability 
We suggest the promotion of a culture of patient safety and individual accountability 
(GRADE 2D). 
Rationale. Recent trends have seen a transition from accepting healthcare-associated 
infection as an inevitable outcome of admission to the Intensive Care Unit (ICU)54 towards 
personal accountability and a goal of zero tolerance in relation to hospital-acquired 
infections.2, 3 A systematic review of 30 reports of nosocomial infection found that at least 
20% could be preventable.67 A major impediment to achieving zero tolerance towards 
hospital-acquired infection has been a lack of accountability of all levels of hospital staff.2 
This attitude is shifting, with recognition that hospital management, as well as every 
healthcare worker, is responsible and accountable for ensuring patient safety including 
infection prevention and control.2, 3 Educating and empowering nurses to ensure infection 
control guidelines are followed by all staff has the potential to positively impact on hospital-
acquired infections.69, 74 
 
Surveillance of nosocomial infections 
We recommend a continuous surveillance program for the detection of nosocomial 
infection (GRADE 1B). 
Rationale. Local surveillance systems (eventually integrated in a national surveillance 
program) allow monitoring of nosocomial infection data and are therefore essential to guide 
and evaluate interventions to reduce infection rates. Surveillance systems combined with 
appropriate feedback contribute to reduced nosocomial infection risk.150-155 
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Hand hygiene 
1. We recommend hand antisepsis, irrespective of the use of gloves, between caring for 
different patients or between different care activities for the same patient, immediately 
before and after each episode of direct patient contact, and after any activity or contact 
that potentially results in hands becoming contaminated (GRADE 1B). 
2. We recommend hand antisepsis by means of an alcohol-based hand rub (GRADE 1A). 
3. We recommend hand washing with soap and water when hands are visibly soiled 
(GRADE 1A). 
4. We recommend the use of gloves when contact with blood or other potentially 
infectious materials, secretions, mucous membranes and non-intact skin could occur 
(GRADE 1D). 
Rationale. Adequate hand antisepsis has proven to result in reduced infection rates.9, 95 The 
use of alcohol-based hand rub is particularly effective; in contrast with hand washing, it kills 
susceptible bacteria more rapidly and to a greater extent, is less time consuming, and skin 
health is better preserved when moisturizers are added. Hand disinfection after glove 
removal is necessary because gloves may have imperceptible defects or may be torn during 
use, resulting in contamination of hands. Hand washing is necessary when hands are visibly 
dirty because alcohol-based hand rub is ineffective in the presence of organic material. 
However, after hand washing, the use of alcohol-based hand rub remains mandatory.9, 95 
As a rule of thumb, a first step towards adequate hand hygiene consists of avoiding 
direct contamination of hands. The use of non-sterile, well-fitting gloves is recommended 
whenever the risk of contamination exists. Gloves must be changed between separate tasks 
on one patient (when going from a dirty/contaminated to a clean body site) and in between 
different patients. 9, 95, 156  
Site-specific considerations 
Most healthcare associated infections in the ICU are related to the use of therapeutic 
devices. These include VAP, CVC-RI, SSI, and CAUTI.157, 158 Recommendations for their 
prevention are outlined below.  
Prevention of respiratory infections 
The development of pneumonia in patients mechanically ventilated with an artificial airway 
may affect 10–48% of patients.159-161 VAP is associated with a higher mortality rate, and 
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significantly longer ICU length of stay and hospital costs.158, 160-162 However, VAP is often 
preventable, and application of practices such as education strategies72, 163 and ventilator 
bundles130, 164 have contributed to a reduction in VAP incidence. Strategies to prevent VAP 
should be considered in all patients with severe sepsis.87  
1. We recommend head-of-bed elevation 30–45° for all critically ill and mechanically 
ventilated patients (GRADE 1B). Special attention should be given to manoeuvres in 
which it is difficult to achieve a 30° head-of-bed elevation, such as during bed bath or 
changing sheets. In such circumstances we recommend backrest elevation of at least 10° 
should be maintained.  
Rationale. Aspiration of upper airway secretions is a common event even in normal healthy 
adults.165 Semi-recumbent position in mechanically ventilated patients has been associated 
with lower levels of aspiration into the lower airways166-168 and lower VAP incidence than the 
supine position.169-171 In patients receiving enteral nutrition, head-of-bed elevation is 
especially effective in reducing the risk of VAP.169 However, the feasibility of maintaining 
head-of-bed elevation in daily practice has been questioned by some authors.172, 173 Van 
Nieuwenhoven et al.173 achieved average head-of-bed elevation of only 28° despite a target 
of 45°, while Song et al.172 achieved head-of-bed elevation >30° in 43.4% of patients.  
2. We recommend the use of an endotracheal tube with subglottic secretion drainage in 
patients expected to require mechanical ventilation for more than 72 hours (GRADE 1A).  
Rationale. Impaired gag reflex leads to pooling of secretions in the posterior part of the 
oropharynx,174 with microaspiration of subglottic secretions leading to VAP. Subglottic 
secretion drainage is accomplished through use of a specially designed endotracheal or 
tracheotomy tube with a separate dorsal lumen that opens directly above the endotracheal 
tube cuff. Subglottic secretions drainage appears to be effective in preventing VAP (relative 
risk [RR] 0.51, 95% confidence interval [95% CI] 0.37–0.71) in patients expected to be 
mechanically ventilated for more than 72 hours.175  
3. We suggest the use of a silver-coated endotracheal tube be considered (GRADE 2A).  
Rationale. In multicenter randomized controlled trials, a silver-coated endotracheal tube was 
demonstrated to reduce bacterial airway colonization as well as VAP in patients intubated 24 
hours or more.176, 177 More studies that confirm the current findings are required.  
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4. We suggest the use of an endotracheal tube with a polyurethane cuff (GRADE 2B). 
Rationale. In a single center randomized controlled trial, an endotracheal tube with a 
polyurethane cuff was shown to significantly reduce early onset post-operative pneumonia 
in cardiosurgical patients.178 More studies that confirm this result are required. 
5. We recommend endotracheal cuff pressure be maintained at least 20 cm H2O, but not 
more than 30 cm H2O (GRADE 1C).  
Rationale. Inadequate cuff pressure is a risk factor for microaspiration of oropharyngeal 
secretions and subsequent pneumonia. One observational study among intubated patients 
not receiving antibiotic therapy showed that a persistent intracuff pressure below 20 cm H2O 
was an independent predictor of VAP (RR 4.2, 95% CI 1.1–15.9).179 Cuff pressure should be 
maintained at the lowest pressure above 20 cm H2O that prevents cuff leak.  
6. We suggest heat and moisture exchangers (HME) should be changed between patients, 
every 5–7 days, or as clinically indicated (GRADE 2C). 
Rationale. Humidification of inspired air to prevent mucosal injury may be achieved by using 
a heated humidifier, a heated humidifier with a heated-wire circuit, or passively using a 
HME. There are insufficient data to demonstrate a benefit in VAP reduction for any 
humidification device.180 No benefit in infection rates or functionality of ventilator circuits 
has been demonstrated when HMEs are changed every day compared to 5–7 days.181, 182 
7. We recommend ventilator circuits should not be changed routinely, except between 
patients (GRADE 1B). 
Rationale. There is no evidence that routine ventilator circuit changes can reduce the 
incidence of VAP.159, 183 New ventilator circuits should be used for each patient, and circuit 
changes performed only if the circuit becomes visibly soiled or damaged.87 
8. We recommend the aspiration of endotracheal secretions in response to clinical signs, 
i.e. visible or audible signs of respiratory secretions, respiratory deterioration or other 
changes in the patient’s condition that may be due to respiratory secretions, in intubated 
patients (GRADE 1C). 
Rationale. Critically ill patients mechanically ventilated via a tracheal tube frequently require 
removal of tracheobronchial and upper airway secretions due to increased mucus 
production and a decreased ability to clear secretions.184, 185 Secretion removal may reduce 
infectious, respiratory and tube patency complications.186-188 
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Suctioning should only be performed when necessary, using the lowest possible suction 
pressure, take no longer than 15 seconds, use continuous rather than intermittent 
suctioning; the suction catheter should occlude less than half the lumen of the endotracheal 
tube and be inserted no further than the carina; hyperoxygenation should be provided 
before and after suctioning, and saline lavage should be avoided.187-189 
The optimum frequency of endotracheal suctioning has not been clearly determined, but 
should be in response to clinical signs.188 There is insufficient evidence to recommend the 
benefits of either an open or closed suctioning system.189 
9. We recommend regular mouth care and oral cavity assessment be provided to all 
critically ill and intubated patients (GRADE 1C). 
Rationale. Colonization of the oropharynx by pathogens is a potential risk factor for the 
development of VAP.190-192 Critical illness contributes to changes in the oral flora, and an 
increase in gram-negative flora that includes more virulent organisms may occur.193, 194 
Providing regular oral care, incorporating oral cavity assessment, is an important part of 
providing comfort to the critically ill patient195 and is also demonstrated to contribute to a 
decrease in VAP.195-198 Assessment should include the condition of the teeth, gums, tongue, 
mucus membranes and lips, and barriers to mouth care delivery.195 The use of a designated 
oral care protocol, in association with an education program for nurses in its importance in 
preventing VAP, can increase compliance and assessment of mouth care.42  
10. We recommend the use of chlorhexidine-based antiseptic for oral care in intubated 
patients (GRADE 1A). 
Rationale. Chlorhexidine is widely used and investigated in the oral care of intubated 
patients.199-202 Chlorhexidine effectively decontaminates the oropharynx203, 204 and its use in 
oral care has been proven to decrease dental plaque205 and incidence of respiratory 
infections,206 and substantially decrease the incidence of VAP.207-209 The optimal 
concentration of chlorhexidine solution (0.12%, 0.2% or 2%) remains undetermined. The 
optimum frequency for oral care with chlorhexidine has not been demonstrated. In general, 
a frequency of 3–4 times daily is proposed.199, 210, 211 The benefit of tooth brushing in 
critically ill patients as a component of oral care protocols has demonstrated efficacy but 
additional research is indicated.197, 198 Tap water is not recommended for oral care in the 
critically ill.195 
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Prevention of catheter-related bloodstream infections (CR-BSI) 
1. We recommend the implementation of a central line care bundle including staff 
education, creation of a catheter insertion cart, implementation of a checklist to ensure 
adherence to evidence based guidelines, empowering nurses to stop catheter insertion 
procedures when a guideline violation is observed, and daily assessment of possible 
catheter removal (GRADE 1B). 
Rationale. A bundle approach to central venous catheter (CVC) insertion and care69, 74, 118, 212 
has proven to be effective in substantially reducing the rate of CR-BSI. Nurses play a key role 
in preventing CR-BSI infection through the activities outlined above.  
2. We recommend the use of maximal sterile barriers during CVC insertion (GRADE 1A). 
Rationale. During the CVC insertion procedure, all healthcare personnel involved must wear 
a mask, cap, sterile gown, and sterile gloves and the patient is to be covered with a large 
sterile drape.88, 213-215 Use of maximal sterile barrier precautions during CVC insertion have 
led to reduced infection rates.214, 216, 217 
3. We recommend the use of a chlorhexidine-based antiseptic for skin preparation before 
insertion and subsequent catheter care (GRADE 1A). 
Rationale. As the risk of CR-BSI increases with the density of microorganisms at and around 
the insertion site,9 site antisepsis is crucial in the prevention of infection. Aqueous 
chlorhexidine (2%) solution has consistently been found to be superior to both 10% 
povidone iodine and 70% alcohol for preventing CR-BSI.218-220 
4. We suggest the replacement of administration sets every 96 hours (GRADE 2A), except 
when used for the administration of blood, blood products or lipids, in which case sets 
must be changed within 24 hours (GRADE 1A). 
Rationale. A Cochrane systematic review found no increase in the risk for CR-BSI when the 
interval for administration set replacement was increased from 72 hours to 96 hours.221 
When a fluid that enhances microbial growth is infused (lipid emulsions, blood products) 
more frequent changes of administration sets are indicated because these products have 
been identified as independent risk factors for CR-BSI in both adults and neonates.222-227 
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5. We recommend the use of minocyclin-rifampin impregnated catheters (GRADE 1B). 
Rationale. Studies have repeatedly demonstrated a significant reduction in CR-BSI with the 
use of impregnated CVCs in comparison with standard catheters;228-231 this reduction in 
infection rates has been greatest with minocycline-rifampin coated CVCs when compared to 
other impregnated CVCs.232 Minocycline-rifampin impregnated CVCs are approved for use in 
the pediatric population by the Food and Drug Administration (USA); however, studies have 
not been conducted in children.  
 
Prevention of surgical site infections (SSI) 
1. We recommend that antimicrobial prophylaxis be administered within one hour before 
incision to maximize tissue concentration. Two hours are allowed for the administration 
of vancomycin and fluoroquinolones (GRADE 1A). 
Rationale. In 2003, the Surgical Infection Prevention Guideline Writers Workgroup meeting 
reviewed the various guidelines for antimicrobial prophylaxis in surgery.233 On the basis of 
published evidence, the workgroup concluded that infusion of the first antimicrobial dose 
should begin within 60 minutes before incision, and when a fluoroquinolone or vancomycin 
is indicated the infusion should begin within 120 minutes before incision to prevent 
antibiotic-associated reactions.89, 233 
2. We recommend that only hair that will interfere with the operation be removed, and 
that, if hair removal is necessary, it should be removed by using electric clippers (GRADE 
1B). 
Rationale. Although several authors have reported pre-operative hair removal is associated 
with increased SSI rates,20, 234-236 a Cochrane systematic review compared a variety of hair 
removal methods (depilatory cream, razors, clippers) versus no hair removal and reported 
no difference in SSI rates among patients who had hair removal prior to surgery and those 
who did not.236 The same review found that shaving led to statistically significantly more SSIs 
compared with clipping or depilatory cream.236 The increased infection risk associated with 
the technique of shaving is attributed to the formation of microscopic cuts in the skin that 
later act as foci for bacteria.20 Although the use of depilatories has been associated with a 
lower SSI risk than shaving or clipping237, 238 they can produce hypersensitivity reactions.238  
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3. We recommend that blood glucose levels be controlled during the immediate post-
operative period for patients undergoing cardiac surgery: controlled blood glucose level 
(lower than 200 mg/dL) on post-operative day 1 and post-operative day 2, with 
procedure day being post-operative day 0 (GRADE 1C). 
Rationale. Increased glucose levels (>200 mg/dL) in the immediate post-operative period 
(≤48hrs) are associated with increased SSI risk.239, 240 One study found that patients with 
blood glucose levels >300 mg/dL within 48hrs of surgery had over three times the likelihood 
of a wound infection.241 Regular monitoring of glucose levels and timely administration of 
insulin and hyperglycemic agents is a direct nursing responsibility, therefore nursing 
education should stress the importance of glucose control in preventing SSI.  
4. We recommend the identification and treatment of infections remote to the surgical site 
before elective surgery (GRADE 1B). 
Rationale. Concurrent remote site infections are considered to increase SSI risk.242-244 
Therefore, whenever possible, all infections remote to the surgical site should be identified 
and treated before elective operation, and elective operations on patients with remote site 
infections should be postponed until the infection has resolved.20  
Prevention of urinary tract infections (UTI) 
1. We recommend that all attempts should be made to limit the duration of urinary 
catheterization (GRADE 1C). 
Rationale. The urinary tract is the most prevalent source of nosocomial infection and there 
are several recommendations to prevent or reduce the incidence of UTI.245 Duration of 
catheterization is the most important risk factor for developing UTI.245 Post-operative 
urinary catheterization >2 days is associated with an increased likelihood of UTI and 30-day 
mortality, as well as a decreased likelihood of discharge to home.246 Nurses should advocate 
for prompt removal of catheters247 and discourage long-term catheterization, if possible.  
2. We recommend that a sterile, continuously closed drainage system be maintained 
(GRADE 1A). 
Rationale. Closed urinary drainage systems are pivotal in preventing UTI.9, 247 The risk of 
infection reduces from 97% using open systems to 8–15% when sterile closed systems are 
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used.248-250 Errors in maintaining sterile closed drainage and opening the closed drainage 
system have been well documented to predispose patients to infection.248, 250-253  
3. We recommend regular perineal hygiene measures (GRADE 1C). 
Rationale. Most episodes of UTI are caused by the patient’s own flora.245 Daily cleansing of 
the urethral meatus using soap and water or perineal cleanser is recommended.247, 254 
 
4. We suggest the maintenance of unobstructed urine flow (GRADE 2C). 
Rationale. Reflux of urine is associated with infection; therefore, drainage bags should be 
positioned below the level of the bladder at all times to prevent urine back-flow and 
unobstructed urine flow should be maintained.9, 255, 256 
  
3.2. A systematic review and meta-analysis of randomised controlled trials 
 Based on the article:  Labeau SO, Van de Vyver K, Brusselaers N, Vogelaers D, Blot SI. 
Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-
analysis. Lancet Infect Dis. 2011;11(11):845-854. 
 
In case separate randomised controlled trials yield inconclusive evidence, a meta-analysis 
can help to limit uncertainty. Uncertainty is undeniably an important issue when entering 
the field of providing optimal oral care to intubated patients, regardless whether the 
outcome is patient comfort, oral health, prevention of VAP, or prevention of system 
diseases.199 The lack of evidence pertains to various aspects of oral care, such as the best 
method, the best frequency, the best product and its best concentration.199, 257  
 
Gaps in the evidence base of interventions hamper nursing practice.258, 259 Aiming to 
contribute to determining best practice for oral care in intubated patients, we conducted a 
meta-analysis hypothesising that oral care with chlorhexidine or povidone-iodine reduces 
the occurrence of VAP in mechanically ventilated adults compared with absence of oral care 
or oral care with a placebo, saline 0.9%, or other active product. 
Introduction 
Ventilator-associated pneumonia is defined as pneumonia in people who have a device to 
continuously assist or control respiration through a tracheostomy or by endotracheal 
intubation within 48 h before the onset of infection, inclusive of the weaning period.46 
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Affecting 10–30% of mechanically ventilated patients, this type of pneumonia is one of the 
most frequent nosocomial infections in intensive care units.49, 158 Depending on the casemix, 
disease severity, microorganisms involved, and adequacy of anti-infective management, the 
attributable mortality (mortality in exposed patients in excess to mortality in matched 
unexposed patients) can exceed 50%.260 Moreover, ventilator-associated pneumonia is an 
important cause of morbidity, increased use of health-care resources, and excess cost.158 As 
such, prevention of this disease is a priority in quality improvement programmes in intensive 
care units85, 261 and plenty of efforts have been taken to elucidate the effect of distinct 
preventive measures.164, 262, 263 
 
The most important mechanism for development of ventilator-associated pneumonia is 
aspiration of colonised oropharyngeal secretions into the lower respiratory tract.264 Oral 
bacterial colonisation results from accumulation of debris in the oral cavity. Adequate 
salivary flow is an important factor for maintenance of oral health through its antimicrobial, 
lubricating, and buffering properties. In intubated patients, however, a constantly open 
mouth and the use of drugs such as antihypertensives, anticholinergics, antipsychotics, and 
diuretics predispose for xerostomia and subsequent reduction in salivary immune factors. 
Additionally, an endotracheal tube can hamper thorough inspection of the oral cavity and 
limit access for oral care. 199, 211 Reduction of the number of oral microorganisms might hold 
a potential for prevention of ventilator-associated pneumonia. 205, 265 Both chlorhexidine and 
povidone-iodine have been proposed as powerful antiseptic drugs against oral bacteria, but 
studies aiming to determine the most effective product, its optimum concentration, and 
frequency of use have yielded inconclusive results. We did a systematic review and 
subsequent meta-analysis postulating that oral care with chlorhexidine or povidone-iodine 
reduced the occurrence of ventilator-associated pneumonia in mechanically ventilated 
adults compared with absence of oral care or oral care with a placebo, saline 0.9%, or 
another active product. 
 
Methods 
Search strategy 
Our systemic search for relevant publications included the electronic databases PubMed, 
CINAHL, Web of Science, and The Cochrane Central Register of Controlled Trials (CENTRAL). 
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We searched combinations of the keywords “oral care”, “oral health”, “oral hygiene”, “oral 
decontamination”, “antiseptics”, “intubation”, “(mechanical) ventilation”, “ventilator-
associated pneumonia”, “prevention”, “reduction”, “pneumonia”, “respiratory (tract) 
infection”, “chlorhexidine”, “iodine”, “betadine”, “povidone”, and “nosocomial pneumonia”. 
We included articles in English, French, or Dutch published from January, 1975 to February, 
2011. We identified unpublished studies in conference abstracts or in registers of clinical 
trials (ClinicalTrials.gov and Current Controlled trials). We also consulted bibliographies of 
relevant articles, science citation index, and Google Scholar. 
Study selection 
We narrowed the list of publications obtained to studies meeting our predetermined 
inclusion criteria. Thereby, we included only randomised controlled trials of mechanically 
ventilated adult patients receiving oral care with chlorhexidine or povidone-iodine. We 
excluded studies in which antibiotics were used as experimental intervention for oral 
decontamination. We included standard oral care, use of a placebo, or another product for 
oral care as control interventions. We retained only studies reporting rates of ventilator-
associated pneumonia as outcome. Two investigators (Nele Brusselaers and Katrien Van de 
Vyver) did a first broad selection based on study title, under close supervision of the 
principal investigator (Stijn Blot) who is a content expert. To allow further narrowing, four 
independent reviewers (Katrien Van de Vyver, Stijn Blot, Sonia Labeau, Nele Brusselaers) 
screened the selected abstracts, each masked to the results of the others’ selection. Mostly, 
all reviewers decided unanimously. In one case of disagreement, assessment of eligibility 
was done by mutual consideration. 
Data extraction 
Categories of extracted data included author and year of publication, settings and study 
populations, inclusion and exclusion criteria, definitions and diagnosis of ventilator-
associated pneumonia, intervention in the study and the control group, and prevalence of 
the disease. The concentration of the antiseptic used and the application method were also 
extracted from the studies if available. Prevalence was registered as the proportion of 
patients with ventilator-associated pneumonia to the total number of patients, in both study 
and control groups. When important data were missing, the author was contacted. 
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Secondary outcome variables were extracted for the systematic review, but not included in 
the meta-analysis. 
Quality assessment 
The quality of the included randomised trials was assessed by two reviewers (Nele 
Brusselaers and Katrien Van de Vyver) with a validated checklist of the Dutch Cochrane 
Centre (Addendum 4, Dutch version, English version not available), and subsequently 
appraised by another reviewer (Sonia Labeau).266 This checklist consists of three major parts: 
(a) assessment of the validity; (b) assessment of the study results; and (c) assessment of the 
applicability (in the Dutch healthcare system).  
Criteria for validity assessment included the use of (blinded) randomisation and masking of 
patient, practitioner, or assessor. Additionally, the comparability of the groups at baseline, 
loss-to-follow-up, intention-to-treat analysis, and comparability of treatment were 
evaluated. Table 2a provides an overview of the validity indicators of each study according to 
the checklist. Table 2b relates to the assessment of the study results. The part of the 
checklist concerning the applicability (in the Dutch healthcare system) was not used as this 
did not yield additional useful information concerning the methodological quality of the 
studies included. 
An additional quality check included assessment of the sample size, definition of inclusion 
and exclusion criteria, and clear definition of outcomes (Table 3).  
Statistical analysis 
We did a random-effects meta-analysis using Review Manager 5.0 (Cochrane Collaboration, 
2008) following the Mantel-Haenszel model to obtain relative risks (RR) and 95% CIs. We 
assessed clinical heterogeneity by comparing protocol, populations, and methodology of the 
studies included. We assessed statistical heterogeneity using the I² statistic that measures 
the degree of inconsistency across studies; it results in a 0–100% range quantifying the 
proportion of variation in the effect, which is due to inter-study variation. We predefined 
heterogeneity (I²≤25% for low, 25%<I²<50% for moderate, and I²≥50% for high). We 
constructed a funnel plot to assess publication bias and did sensitivity analysis by different 
subgroup analyses. A p value of less than 0.05 was used to denote statistical significance. 
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Results 
Our broad search strategy yielded 1720 abstracts (873 in PubMed, 502 in Web of Science, 78 
in CINAHL, and 267 in CENTRAL). After elimination of identical publications and studies that 
did not meet inclusion criteria, 13205, 206, 209, 265, 267-275 studies were selected. Scanning of 
reference lists yielded one additional study.276 As a result, 14 studies published in English 
between January, 1996 and February, 2011 consisting of 2481 patients were included in the 
systematic review (Figure 1). Construction of funnel plot did not show publication bias 
(Figure 2). 
Sample sizes varied considerably (Table 3). With regard to interventions, Seguin and 
colleagues267 randomly assigned patients in the intervention group to receive oral care with 
either povidone-iodine or saline. For the present meta-analysis, the patients treated with 
povidone-iodine were considered the intervention group, and were compared with the joint 
saline and standard regimen groups (controls). Also, a study group combining the use of 
chlorhexidine and colistin (Koeman and colleagues)271 was excluded from the present 
analysis. Scannapieco and colleagues275 randomly assigned their study patients to (1) a 
control group with placebo administration twice daily; (2) an experimental group with 0.12% 
chlorhexidine once daily and placebo application once daily; and (3) an additional 
experimental group with 0.12% chlorhexidine administration twice daily. For the present 
analysis, both groups in which patients were given chlorhexidine 0.12% were considered as 
experimental groups.  
Interventions varied considerably between studies. Teeth were brushed before application 
of antiseptics,209, 268, 276 oral rinse with 15 mL chlorhexidine was applied with a sponge swab 
for 30 s,206, 270 chlorhexidine gel was given after rinse of the mouth and oropharyngeal 
aspiration,205, 269 chlorhexidine was used as a spray or swab, 265 or multiple interventions 
were combined.209  Koeman and colleagues271 applied chlorhexidine paste 2 cm bilaterally in 
the mouth after removal of remnants of the previous dose with a gauze moistened with 
saline 0.9%. In the study by Panchabhai and colleagues,274 application of chlorhexidine 0.12% 
was preceded by oral and pharyngeal suction of pooled secretions, and by swabbing of the 
oral cavity, teeth, palate, buccal spaces, posterior pharyngeal wall, and hypopharynx with 
normal saline solution. Nurses trained in the study protocol gave 15 mL chlorhexidine 0.12% 
after mechanical cleaning of the mouth.273 Chlorhexidine was also 
  
Table 2a: Validity assessment of the studies included 
Author (year) Randomised 
 
 
Y/N/NA 
Consealed 
randomisation 
 
Y/N/NA 
Patients 
blinded 
 
Y/N/NA 
Practitioner 
blinded 
 
Y/N/NA 
Assessor 
blinded 
 
Y/N/NA 
Groups 
comparable 
at baseline 
Y/NC/NNC/NA 
Follow-
up 
 
Y/N/NA 
Analysed in 
group of 
randomisation 
Y/N/NA 
Groups 
equally 
treated 
Y/N/NA 
Inter- 
mediate 
assessment 
S/D/I 
De Riso et al. 
(1996)17 Y N Y Y Y Y Y Y Y S 
Fourrier et al. 
(2000)9 Y N N N Y Y Y Y Y S 
Houston et al. 
(2002)19 Y NA N N NA Y Y Y NA S 
Chua et al. 
(2004)25 Y Y N Y Y Y Y Y Y S 
Grap et al. 
(2004)10 Y N NA NA N Y N** Y Y D 
Macnaughton et 
al. (2004)20 Y N Y Y Y Y Y NA NA S 
Fourrier et al. 
(2005)18 Y N Y Y Y Y Y Y Y S 
Bopp et al. 
(2006)16 Y NA N N NA NNC Y y NA I 
Koeman et al. 
(2006)3 Y N Y Y Y Y Y Y Y S 
Seguin et al. 
(2006)15 Y N Y N N Y Y Y Y S 
Tantipong et al. 
(2008)21 Y NA NA NA NA Y Y Y Y S 
Scannapieco et 
al. (2009)24 Y Y Y Y Y Y Y Y Y S 
Panchabhai et al. 
(2009)23 Y Y N N Y Y Y Y Y S 
Bellissimo-
Roderigues et al. 
(2009)22 
Y Y Y Y Y Y Y Y Y S 
Y: Yes; N: No; NA: Information Not Available; NC: No, but corrected for in analysis; NNC: No and not corrected for in analysis; S: Sufficiently valid and applicable; D: Doubtful; 
I: Insufficiently valid and applicable; **: No, but selective loss-to-follow-up sufficiently excluded
  
Table 2b: Results assessment of the studies included 
 
Author (year) Outcome* Follow-up    p(I) 
Event 
p(C) 
Event 
ARR NNT RR RRR 
De Riso et al. 
(1996)17 
  Group Event No event Total       
VAP/no VAP ICU discharge or death 
Intervention 3 167 170 
0.0176 0.05 -0.032 31.25 0.352 0.648 
  Control 9 17 180 
Fourrier et al. 
(2000)9 
  Group Event No event Total       
VAP/no VAP ICU discharge 
Intervention 5 25 30 
0.167 0.6 -0.433 2.31 0.278 0.722 
  Control 18 12 30 
Houston et al. 
(2002)19 
  Group Event No event Total       
VAP/no VAP 
10 days post-operative, 
extubation, tracheostomy, 
VAP diagnosis, or death 
Intervention 4 266 270 
0.015 0.031 -0.016 62.5 0.484 0.516 
  Control 9 282 291 
Chua et al. 
(2004)25 
  Group Event No event Total       
VAP/no VAP extubation, death, VAP diagnosis 
Intervention 6 16 22 
0.273 0.4 -0.127 7.874 0.682 0.318 
  Control 8 12 20 
Grap et al. 
(2004)10 
  Group Event No event Total       
VAP/no VAP extubation or 72 hours after inclusion 
Intervention 4 3 7 
0.571 0.6 -0.029 34.483 0.951 0.049 
  Control 3 2 5 
Macnaughton 
et al. (2004)20 
  Group Event No event Total       
VAP/no VAP extubation 
Intervention 32 59 91 
0.352 0.318 0.034 29.41 1.107 0.107 
  Control 28 60 88 
Fourrier et al. 
(2005)18 
  Group Event No event Total       
VAP/no VAP 28 days, ICU discharge, or death 
Intervention 13 101 114 
0.114 0.105 0.009 111.1 1.086 0.086 
  Control 12 102 114 
Bopp et al. 
(2006)16 
  Group Event No event Total       
VAP/no VAP ICU discharge 
Intervention 0 2 2 
0 0.33 0 / / / 
  Control 1 2 3 
  
Koeman et al. 
(2006)3 
  Group Event No event Total       
VAP/no VAP 
extubation, death, VAP 
diagnosis, or withdrawal 
consent 
Intervention 13 114 127 
0.102 0.177 -0.075 13.33 0.576 0.424 
  Control 23 107 130 
Seguin et al. 
(2006)15 
  Group Event No event Total       
VAP/no VAP ICU discharge, or death 
Intervention 3 33 36 
0.083 0.419 0.336 2.976 0.198 0.802 
  Control 13 18 31 
Tantipong et al. 
(2008)21 
  Group Event No event Total       
VAP/no VAP extubation 
Intervention 5 97 102 
0.049 0.114 0.065 15.38 0.43 0.57 
  Control 12 93 105 
Scannapieco et 
al. (2009)24 
  Group Event No event Total       
VAP/no VAP 21 days, extubation, ICU discharge, or death  
Intervention 14 102 116 
0.121 0.203 -0.082 12.19 0.596 0.404 
  Control 12 47 59 
Panchabhai et 
al. (2009)23 
  Group Event No event Total       
VAP/no VAP ICU discharge or death 
Intervention 14 74 88 
0.159 0.181 -0.022 45.45 0.878 0.122 
  Control 15 68 83 
Bellissimo-
Roderigues et 
al. (2009)22 
  Group Event No event Total       
VAP/no VAP 48 hours after ICU discharge  
Intervention 16 48 64 
0.25 0.246 0.004 250 0.016 0.984 
  Control 17 52 69 
*: VAP incidence, expressed as the number of VAPs which developed in the intervention and control groups was the primary outcome of the meta-analysis. Other outcome 
measure, as mentioned by some of the authors, were not taken into account  
p(I) Event: chance of event in Intervention group 
p(C) Event: chance of event in Control group 
ARR: Absolute Risk Reduction 
NNT: Number Needed to Treat 
RR: Relative Risk 
RRR: Relative Risk Reduction 
VAP: Ventilator-Associated Pneumonia 
ICU: Intensive Care Unit
  
Table 3: Study characteristics of subpopulations included 
Author (year)  
 
Inclusion Exclusion Diagnose VAP Intervention Control Blinded 
Y(es)/N(o) 
De Riso et al. 
(1996)17 
Cardiothoracic 
(open heart 
surgery) 
CABG, valve 
surgery, septal 
surgery, cardiac 
tumor excision, or 
combinations 
Intraoperative death, 
preoperative infection or 
intubation, pregnancy, 
heart and lung transplant 
recipients, 
hypersensitivity to CHX 
New or progressing 
pulmonary infiltrate, 
fever, leukocytosis, and 
purulent tracheobronchial 
secretions 
CHX 0.12% 15ml oral 
rinse 2x/d, start pre-
operatively and 
continue 
postoperatively until 
discharge from ICU or 
death (n=173) 
 
Placebo (n=180) Y 
Fourrier et al. 
(2000)9 
 
Medico-
surgical ICU 
Age >18 years, 
medical condition 
suggesting ICU 
stay ≥ 5 days, 
mechanically 
ventilated by 
orotracheal or 
nasotracheal 
intubation or 
tracheostomy 
 
Edentulous patients Temperature>38°C or 
<36°C, infiltrates on chest 
radiographs, leukocytosis 
(>10.10³/mm³) or 
leukopenia (>3.10³/mm³), 
positive culture from 
tracheal aspirate and/or 
positive culture of BAL 
CHX 0.2% gel 3x/d 
during ICU stay 
(n=30) 
Standard oral care: 
mouth rinsing with 
bicarbonate 
isotonic serum, 
oropharyngeal 
sterile application 
4x/d (n=30) 
Y 
Houston et al. 
(2002)19 
Cardiothoracic 
(open heart 
surgery) 
Patients after 
CABG and/or valve 
surgery requiring 
cardiopulmonary 
bypass 
Intraoperative death, 
pregnancy, preoperative 
documented respiratory 
infection 
New or progressing 
pulmonary infiltrate, 
fever, leukocytosis, 
positive microbial culture 
results 
CHX 0.12% 15ml oral 
rinse 2x/d, start pre-
operatively until 10 
days postoperative or 
until extubation, 
tracheostomy, death, 
or diagnosis 
pneumonia (n=270) 
 
Listerine® 
(phenolic mixture) 
15 ml oral rinse 
2x/d (n=291) 
N 
Chua et al. 
(2004)25 
Medical, 
surgical, 
neurological, 
neurosurgical 
& central ICU 
Mechanically 
ventilated adults 
(> 18 years), seen 
within 24 hours of 
intubation 
Nosocomial pneumonia, 
hyperthyroidism, 
hypersensitivity to 
povidone-iodine 
As defined by Centers of 
Disease Control and 
Prevention1 
PVP-I 1% 3x/d + teeth 
cleaning 1x/d (n=22) 
Placebo + teeth 
cleaning 1x/d 
(n=20) 
Y 
  
Grap et al. 
(2004)10 
Surgical 
trauma ICU, 
neuroscience 
ICU, 
emergency 
department 
 
Age > 18 years, 
endotracheally 
intubated & 
mechanically 
ventilated 
Edentulous patients Clinical Pulmonary 
Infection Score > 6 
CHX 0.12% 2ml single 
application (n=7) 
Standard oral care 
(n=5) 
Y 
Macnaughton 
et al. (2004)20 
Mixed 
surgical-
medical ICU 
Patients requiring 
ventilatory 
support for at 
least 48 hours 
Treatment for infections 
at admission of ICU, 
hypersensitivity to CHX 
Leukocytosis, fever > 38°C, 
deterioration in 
oxygenation/chest signs, 
new consolidation on 
chest radiograph, 
significant bacterial 
growth on BAL, CPIS > 6 
 
CHX 0.2% 2x/d (n=91) Placebo (n=88) Y 
Fourrier et al. 
(2005)18 
ICUs Age>18 years, 
medical condition 
suggesting ICU 
stay ≥ 5 days, 
mechanically 
ventilated by oro- 
or nasotracheal 
intubation 
Patients with 
tracheostomy, or 
hospitalised for > 48 
hours before ICU 
admission, edentulous 
patients, facial trauma, 
postsurgical and 
requiring specific 
oropharyngeal care, 
allergy to CHX 
 
Temperature>38°C or 
<36°C, new infiltrates on 
chest radiographs, 
leukocytosis 
(>10.10³/mm³) or 
leukopenia (>3.10³/mm³), 
positive quantitative 
culture from tracheal 
aspirate and/or BAL 
CHX 0.2% gel 3x/d 
until day 28; 
toothbrushing was 
not allowed (n=114) 
Placebo (n=114) Y 
Bopp et al. 
(2006)16 
Critical care 
unit 
Orally or nasally 
intubated patients 
Patients on 
metronidazole, allergy to 
CHX, sensitivity to 
alcohol, risk for infective 
endocarditis, history or 
presence of various 
comorbidities; and /or 
admitted to hospital with 
pneumonia and 
subsequently intubated 
VAP was diagnosed by a 
physician, criteria are not 
specified 
CHX 0.12% 2x/d until 
extubation, 
toothbrushing with 
CHX (n=2) 
Standard oral care 
2x/d with foam 
swab, hydrogen 
peroxide and oral 
lubricant (n=3) 
N 
  
Koeman et al. 
(2006)3 
Mixed and 
surgical ICUs 
Age > 18 years, 
requiring 
mechanical 
ventilation for ≥ 
48 hours 
Pre-admission 
immunocompromised 
status, pregnancy, 
physical condition not 
allowing oral application 
of study medication 
New, persistant or 
progressive infiltrate on 
chest radiograph + at least 
3 of 4 criteria: fever > 38°C 
or < 35.5°C, leukocytosis 
(>10.10³/mm³) or 
leukopenia (>3.10³/mm³), 
purulent aspect of 
tracheal aspirate, positive 
semiquantitative culture 
from tracheal aspirate 
 
CHX 2% paste 4x/d 
until diagnosis VAP, 
death, extubation, or 
withdrawal of 
consent (n=127) 
Placebo (n=130) Y 
Seguin et al. 
(2006)15 
Surgical ICU Adult patients > 
18 years, severe 
closed head 
trauma, expected 
to need 
mechanical 
ventilation for > 2 
days 
Admitted to ICU > 12 
hours after initial trauma 
with facial, thoracic, 
abdominal, or spinal 
injuries, reaction to 
iodine, respiratory 
disease, infiltrates on 
chest radiograph, need 
for curative antibiotics 
New, pulmonary infiltrate 
on chest radiograph + 2 of 
the following: fever > 38°C 
or < 36°C, purulent 
endotracheal aspirate, 
leukocytosis 
(>10.10³/mm³) or 
leukopenia (>3.10³/mm³), 
bacterologic culture 
growth BAL 
Povidone-iodine 10% 
6x/d (n=36) 
Standard care 
without instillation 
but with aspiration 
of secretions 6x/d 
(31) 
OR  
nasopharynx 
and oropharynx 
rinsing with 60 mL 
of saline solution 
6x/d (n=31) 
 
N 
Tantipong et 
al. (2008)21 
ICU Adult patients > 
18 years, 
mechanically 
ventilated 
Pneumonia, allergy to 
CHX 
New, persistant or 
progressive infiltrate on 
chest radiograph + at least 
3 of 4 criteria: fever > 38°C 
or < 35.5°C, leukocytosis 
(>10.10³/mm³) or 
leukopenia (>3.10³/mm³), 
purulent tracheal aspirate, 
positive semiquantitative 
culture from tracheal 
aspirate 
 
CHX 2% 15 ml 
solution 4x/d with 
toothbrushing 
(n=102) 
Saline, with the 
same oral care 
procedure (n=105) 
N 
  
Scannapieco 
et al. (2009)24 
Trauma ICU Adult patients > 
18 years, 
intubated and 
mechanically 
ventilated within 
48 hours of 
admission 
Witnessed aspiration; 
confirmed diagnosis of 
post-obstructive 
pneumonia; known 
hypersensitivity to CHX; 
absence of consent; 
diagnosed 
thrombocytopenia 
(platelet count less than 
40 and/or a INR above 2, 
or other coagulopathy); 
do not intubate order; 
pregnancy; legal 
incarceration; transfer 
from another ICU; oral 
mucositis; 
immunosuppression 
(either-HIV or drug 
induced; and re-
admission to the ICU 
 
Upon suspicion of 
pneumonia, lung 
secretions 
analysis by Blind 
Quantitative 
Bronchoalveolar Lavage 
(bqBAL) using a mini-BAL 
technique with 
>104CFU/ml of a target 
PRP in bqBAL fluid or a 
positive pleural fluid 
culture in the absence of 
previous pleural 
instrumentation 
considered as positive 
evidence for diagnosis of 
pneumonia. 
CHX 0.12% 1x/day 
plus placebo (n=58) 
OR 
CHX 0.12% 2x/day 
(n=58) 
Placebo 2x/day 
(n=59) 
Y (double-
blind) 
Panchabhai 
et al. (2009)23 
Mixed ICU All patients 
admitted to the 
ICU during the 8-
month study 
period 
Pregnancy; pneumonia 
on hospital admission; 
patients in whom oral 
care was contraindicated 
or with history of allergy 
to CHX 
Nosocomial pneumonia 
was defined by 2 
independent, blinded 
reviewers: development 
of new persistent alveolar 
infiltrates on chest 
radiograph; >38°C; 
leukocytosis (>12.10³ 
WBCs/µL), and purulent 
sputum developing >48 
hours after ICU admission  
with worsening of 
hypoxemia on arterial 
blood gas analysis. All 
parameters were essential 
for the diagnosis. 
10 ml CHX 0.2% 
2x/day  (n=88) 
10 ml 0.01% 
potassium 
permanganate 
2x/day  (n=83) 
N 
  
Semiquantitative cultures 
obtained by the protected 
nonbronchoscopic 
mini-BAL technique were 
considered positive with 
>10³ CFU/ml. A positive 
culture was not essential 
for the diagnosis of 
pneumonia. 
 
Bellissimo-
Roderigues et 
al. (2009)22 
Mixed ICU All patients 
admitted to the 
ICU with a  
prospective length 
of stay > 48 hours, 
regardless of 
whether they 
received 
mechanical 
ventilation. 
 
Previous CHX 
hypersensitivity; 
pregnancy; formal 
indication for CHX use, or 
prescription of another 
oral topical medication. 
As defined by Centers of 
Disease Control and 
Prevention1 
CHX 0.12% 15ml after 
mechanical cleaning 
3x/day (n=64) 
Placebo 15ml after 
mechanical 
cleaning 3x/day 
(n=69) 
Y (double-
blind) 
CHX = chlorhexidine 
ICU = Intensive Care Unit 
PVP-I = povidone-iodine 
CABG = Coronary Artery Bypass Grafting 
VAP = Ventilator-Associated Pneumonia 
BAL = BronchoAlveolar Lavage 
CFU = Colony Forming Units 
PRP = potential respiratory bacterial pathogen 
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applied with a rinse-saturated oral foam applicator.275 Seguin and colleagues267 rinsed the 
nasopharynx and oropharynx with 20 mL povidone-iodine 10% reconstituted in a 60 mL 
solution with sterile water, followed by aspiration of oropharyngeal secretions. Chua and 
colleagues276 rinsed the oropharyngeal area with cotton pledgets soaked in 15–20 mL sterile 
water, then swabbed the entire oropharyngeal mucosa and part of the endotracheal tube 
with cotton pledgets soaked in povidone-iodine 1%. Chlorhexidine was used at 
concentrations of 0.12%,206, 265, 268, 270, 273, 275 0.2%,205, 269, 272, 274and 2%,271 and povidone-
iodine at 1%276 and 10%.267 Frequency of antiseptic application varied from once265, 275 or 
twice a day,206, 268, 270, 272, 274, 275 over three205, 269, 273, 276 and four209, 271 to six times a day.267  
 
 
Figure 1: Summary of literature search and study selection; VAP = ventilator-associated pneumonia 
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Figure 2: Funnel plot of the included studies 
 
Chlorhexidine was applied as oral rinse, foam, gel, or paste and povidone-iodine as oral rinse 
only. Duration of oral care varied greatly between studies and was not always reported.  
In the chlorhexidine studies, patients in the control group were given a placebo (n=640),206, 
269, 271-273, 275 standard oral care (n=38),205, 265, 268 saline 0.9% (n=105),209 potassium 
permanganate 0.01% (n=82),274 or the phenolic oral rinse Listerine (Johnson & Johnson 
Limited; n=291; Table 3).270 In the povidone-iodine studies, patients in the control group 
were given a placebo (n=20),276 saline,267 or ‘standard’ oral care (n=62).267 The definition of 
standard oral care varied noticeably between trials.  
Age older than 18 years was specified as inclusion criterion in eight studies (Table 3).205, 209, 
265, 267, 269, 271, 275, 276 All others206, 268, 270, 272-274 also included adults only but did not specify the 
lower age limit for inclusion. Exclusion criteria varied widely. With regard to diagnostic 
criteria, Grap and colleagues265 used the Clinical Pulmonary Infection Score (CPIS) for 
definition of ventilator-associated pneumonia. The other studies applied the US Centers for 
Disease Control and Prevention (CDC) definitions for nosocomial pneumonia206, 270, 273, 276 or 
similar definitions.205, 209, 267, 269, 271, 272 Bopp and colleagues268 reported no diagnostic criteria. 
Nosocomial pneumonia was defined by two independent, masked reviewers in the study by 
Panchabhai and colleagues.274 Scannapieco and colleagues275 based their diagnosis on 
microbiological assessment of lung secretions. 
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Two studies206, 270 done in cardiothoracic intensive-care units reported antibiotic 
administration perioperatively and until 48 h postoperatively. Stress ulcer prophylaxis,206, 274 
semirecumbent body position with head of bed elevation of 30°,209, 267, 271, 274 daily 
assessment for readiness for extubation,274 deep vein thromboprophylaxis, 274 and regular 
emptying of condensate from ventilator tubing274 were also reported. Although, even if not 
mentioned, these are components of standard care and, as such, were probably applied as 
part of routine practice. In a medico-surgical intensive-care unit, Fourrier and colleagues205 
reported prevalences of ventilator-associated pneumonia of 17% (five of 30 patients) in the 
interventional group and 60% (18 of 30 patients) in the control group, accounting for 10.7 
and 32.3 episodes of ventilator-associated pneumonia per 1000 ventilator-days, respectively 
(p<0.05; relative risk [RR] reduction 53%). In the study by Koeman and colleagues271 52 
patients were diagnosed with ventilator-associated pneumonia (13 [10%] of 127 patients in 
the chlorhexidine group and 23 [18%] of 130 in the control group; the remaining 16 [13%] 
patients were given a combination of chlorhexidine 2% and colistin 2% as part of an 
intervention group. This group was not included in our study. Tantipong and colleagues209 
reported five (4.9%) of 102 patients with the disease in the chlorhexidine group and 12 
(11.4%) of 105 patients in the control group (RR 0.43, 95% CI 0.16–1.17; p=0.08) with a mean 
number of seven cases per 1000 ventilator-days in the intervention group and 21 per 1000 
ventilator-days in the control group (p=0.04). In the povidone-iodine study by Seguin and 
colleagues267 a significant decrease (p=0.001) in the rate of pneumonia in surgical patients 
was shown in the intervention group (three [8%] of 36 patients [95% CI 0–17] versus 12 
[39%] of 31 patients [95% CI 22–56] in the control group [p=0.003] and 13 [42%] of 31 
patients [95% CI 25–59] in the saline and the standard regimen groups [p=0.001]).267 In the 
povidone-iodine study by Chua and colleagues276 in a mixed intensive-care unit, the rates of 
pneumonia did not differ between both groups (p=0.58).  
 
We did a meta-analysis of all 14 retrieved studies205, 206, 209, 265, 267-276 to assess the pooled 
effect of oral care with topical chlorhexidine or povidone-iodine on the occurrence of 
ventilator-associated pneumonia. This analysis showed an important reduction of the 
disease (p=0.004; Figure 3), with a moderate statistical heterogeneity. Subgroup analysis 
based on type of antiseptic showed a significant reduction in cases of ventilator-associated 
pneumonia in the chlorhexidine studies, but the effect resulting from povidone-iodine 
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remains unclear (Figure 3). The povidone-iodine subanalysis was based on fewer studies, and 
also showed a larger heterogeneity and broader CIs (Figure 3).  
To determine the most effective chlorhexidine concentration, subgroup analyses included 
chlorhexidine 2%,209, 271 0.2%205, 269, 272, 274 and 0.12%.206, 265, 268, 270, 273, 275 Chlorhexidine 2% 
was to be associated with a significant risk reduction with a low heterogeneity (Figure 4). 
This protective effect of chlorhexidine was less strong at lower concentrations, with an RR of 
0.79 for chlorhexidine 0.2% and 0.73 for chlorhexidine 0.12%, and with broad 95% CIs 
enclosing RR 1 (nil effect; Figure 4). Results from the studies assessing the use of 
chlorhexidine 0.12%, however, showed true homogeneity.  
Given their specific profile in terms of infection control, the use of chlorhexidine in all 
concentrations was compared between cardiosurgical, 206, 270 mixed, 205, 209, 265, 268, 269, 271-274 
and surgical or trauma intensive-care unit populations.267, 275 This analysis showed a 
significant risk reduction associated with the intervention in cardiosurgical patients (Figure 
5). The two cardiosurgical studies206, 270 were homogeneous. In both groups of non-
cardiosurgical patients, the risk reduction was not significant (Figure 5). Subanalyses 
considering blinded205, 206, 265, 269, 271-273, 275, 276 studies showed a RR of 0.73 (95% CI 0.54– 
1.00) and those considering non-blinded209, 267, 268, 270, 274 studies a RR of 0.50 (95% CI 0.29–
0.87; data not shown). 
 
Discussion 
This meta-analysis of 14 randomised trials provides strong evidence that oral care with 
chlorhexidine or povidone-iodine effectively reduces rates of ventilator-associated 
pneumonia when compared with oral care without these antiseptics. This effect was most 
prominent for chlorhexidine 2%. For chlorhexidine 0.12%, which is currently the 
recommended dosage by the CDC for cardiosurgical patients,18 the risk reduction was not 
significant. With regard to povidone-iodine application, only two rather small studies with 
higher statistical heterogeneity could be assessed. Although the evidence was not 
statistically convincing, the risk reduction associated with povidone-iodine use was 
substantial. As such, povidone-iodine might become a worthy alternative for chlorhexidine, 
which is currently regarded as the gold standard,277 without the disadvantage of brown-
staining teeth in chronic use.278 Larger and standardised comparative studies are necessary 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Overall effect of oral antiseptic use on the prevalence of ventilator-associated pneumonia, and subanalysis of chlorhexidine versus povidone-iodine use; 
 M-H=Mantel-Haenszel test 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Subanalysis of 2%, 0.2%, and 0.12% chlorhexidine concentrations 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Subanalysis following type of intensive-care unit
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to obtain more conclusive results for the use of povidone-iodine in oral care. The strengths 
of this analysis include the comprehensive search for relevant randomised trials, four-fold 
screening, assessment of methodological quality, and use of the random-effects model. This 
study is limited, however, by the clinical and statistical heterogeneity between the trials 
included. Although this lack of homogeneity was clinically perceived as substantial, 
statistically it was moderate in the overall meta-analysis (I²=38%), and no evidence of 
heterogeneity (I²=0%) was reported in the subanalyses of studies on cardiosurgical patients 
(Figure 5), and those assessing chlorhexidine at concentrations of 0.12% and 2% (Figure 4).  
Heterogeneity is an inherent problem in systematic reviews and meta-analyses.279 It results 
from variation in sample sizes, baseline characteristics of the populations, study protocols 
and definitions used, diagnostic criteria, and study outcomes (positive or negative).  
 
Furthermore, substantial clinical heterogeneity can be expected with regard to associated 
prevention measures. In the selected studies, information about prevention of ventilator-
associated pneumonia—other than oral care—was rather scarce or absent. Besides, 
heterogeneity was also identified within studies, since different frequencies of care or 
combinations of interventions were applied.268, 269  Although various subgroup analyses were 
done to elucidate the heterogeneity, insufficient data were available to analyse the effect of 
frequency of antiseptic application, its form, or whether teeth were brushed in combination 
with the intervention. Although it can be assumed that combination of different 
interventions for oral care might act synergetically, further research is needed to identify 
their specific attributable benefit on the prevention of the disease. 
 
During our literature search, we identified other studies198, 280-282 assessing the effect of 
chlorhexidine on occurrence of ventilator-associated pneumonia. These studies, however, 
did not meet our inclusion criteria, or the provided data were incomplete. Because we were 
unable to obtain the necessary data, these studies could not be included. Although effects 
are unlikely to be less explicit in blinded studies, our subanalysis of these trials still showed a 
27% risk reduction, which proved to be very close to statistical significance.  
 
Cardiosurgical patients benefited considerably from topical antiseptic use. In both studies 
including this category of patients,206, 270 the intervention consisted of application of 
chlorhexidine 0.12%. Cardiosurgical patients have nevertheless a specific profile in terms of 
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infection control, which hampers comparison with critically ill patients in general. Most 
often, cardiac surgery is an elective procedure. As such, cardiosurgical patients are usually in 
better physical condition than are general patients in intensive-care units. Those requiring 
valve surgery are moreover submitted to a thorough preoperative dental and oral control, 
and to tooth extraction if required. Also, cardiosurgical patients are intubated in the 
operating theatre under optimum and controlled conditions, whereas critically ill patients 
are more often emergently intubated, in less optimum circumstances.  
 
Considering all the above, it is not surprising that the beneficial effects from oral care on 
occurrence of ventilator-associated pneumonia in cardiosurgical patients (RR 0.41) largely 
exceed those in mixed intensive-care-unit patients (RR 0.77). Finally, cardiosurgical patients 
generally have less confounders and experience a shorter period of mechanical ventilation 
than do medical or trauma patients. Thereby, oral antiseptics could be assumed to be more 
successful in the prevention of early onset compared with late onset ventilator-associated 
pneumonia, occurring 5 days or more after endotracheal intubation. Due to a lack of 
available data, however, the present review remains inconclusive on this issue. 
Our meta-analysis is the first to include studies assessing povidone-iodine. Moreover, it 
includes five studies that have not been included in any previous meta-analysis. 
 
Previous meta-analyses assessing the effect of oral antiseptics on rates of ventilator-
associated pneumonia207, 208, 283, 284 had different scopes. Chan and colleagues207 assessed, 
besides antiseptics, the effect of oral antibiotics on rates of ventilator-associated 
pneumonia. Chlebicki and Safdar,208 Kola and Gastmeier,284 and Pineda and colleagues284 
focused on oral care with chlorhexidine only.  
 
In conclusion, this meta-analysis provides strong evidence of the beneficial effect of oral 
antiseptics in the prevention of ventilator-associated pneumonia, especially in cardiosurgical 
patients and with use of 2% chlorhexidine. 
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4. Clinicians’ Adherence to Guidelines 
 Based on the book chapter: Labeau S, Vandijck D, Blot S. Implementation strategies for the 
prevention of healthcare-associated infection. In: Vincent J-L, ed. Yearbook of Intensive Care and 
Emergency Medicine 2010. Berlin: Springer; 2010: 244-256. 
 
4.1. Do healthcare workers adhere to evidence-based guidelines? 
Since the beginning of their successful rise, guidelines were considered to be the perfect tool 
for closing the gap between what clinicians do and what scientific evidence supports. Soon, 
however, it became clear that, once developed, guidelines are far from being self-
implementing.21 Overall, assessments of healthcare workers’ compliance with guidelines 
demonstrate limited adherence rates.27, 29, 31, 33, 77, 285-288 Also in the field of infection 
prevention, compliance with the recommendations seems to be restricted, as illustrated by 
the examples listed below.23, 34, 289, 290 
For many years, hand hygiene is commonly known to be the cornerstone of infection 
prevention. Although the evidence-based recommendations for performing good hand 
hygiene are crystal-clear, wide-spread and readily available, compliance still remains a key 
problem with reported compliance rates of 40%.290 
Rello and colleagues investigated physicians’ adherence to evidence-based guidelines for the 
prevention of VAP by means of a questionnaire and found an overall self-reported non-
adherence rate of 37%.34 Ricart et al. used the same questionnaire in a sample of ICU nurses 
and found the non-adherence rate to be 22.3%.23 Moreover, as self-reports on behavior are 
known to be coloured by social desirability, it can be presumed that the actual non-
adherence rates are even higher.  
Rickard et al. conducted a survey of unit policies regarding adherence to the CDC guidelines 
for preventing intravascular catheter-related infections in 14 Australian ICUs.14, 289 They 
found a wide diversity of practices and the absence of consistent adherence to the 
guidelines. Studies by Rubinson and colleagues24, 291 also investigated adherence to the CDC 
guidelines for the prevention of infections associated with the use of central venous 
catheters, but focussing on internists in the United States. Strikingly, they identified the 
adherence rate with full maximal barrier precautions for catheter insertion to be 28.2% only. 
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Castella et al.25 observed the application of procedures recommended for the prevention of 
SSI in the general surgery departments and the operating rooms of 49 hospitals in Italy. Their 
results highlighted a wide range of practices that could be improved with corrective 
interventions, among them the noticeable finding that in 60% of operations, hair removal 
was performed the day before the operation, and in 75% of operations by razor shaving.25 
Noteworthy, Gammon et al.287 conducted a review of the evidence for suboptimal 
compliance of healthcare practitioners to standard/universal infection control precautions, 
assessing reports published between 1994 to 2006. Thirty-seven studies were included in the 
review: 24 were related to measuring healthcare workers’ compliance and 13 evaluated the 
impact of an intervention on adherence rates. Compliance with infection control precautions 
was found to be internationally suboptimal. Wide variations in the adherence to specific 
aspects of standard/universal precautions were reported to prevail, and healthcare workers 
appear to be selective in their application of recommendations.287  
 
4.2. Barriers and facilitators for adherence 
About clinicians’ reasons for non-adherence, numerous reports and theories are available. 
There is a general consensus that potential barriers and facilitators are the major players 
involved. Information on these barriers and facilitators can be obtained in various ways, 
including interviews, surveys, focus groups, Delphi methods, observation, auditing records of 
routinely collected data, and analysis of documents.31 Identifying and understanding the 
barriers and opportunities related to the adherence of evidence-based recommendations is 
a crucial first step in guideline implementation.100 When designing an effective guideline 
implementation framework, local barriers and facilitators always need to be targeted, and 
the insights of different theories of behavior change integrated.98, 100  
Behavior change theory can indeed provide a framework in which effective guideline 
implementation strategies can be integrated in order to help clinician adherence to 
evidence-based guidelines.98 Grol has studied the different approaches to altering clinical 
practice, and linked them to different theories of change: (1) educational theories explain 
change by the desire to learn and to be professionally competent, while, in (2) epidemiologic 
theories, humans are considered rational beings who are expected to weigh the available 
evidence and come to a reasonable conclusion. According to (3) marketing theories, 
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behavior change is promoted by exposure to attractive marketing packages.  (4) Behaviorist 
theories in turn suggest that change is influenced by numerous external factors which are 
applied before, during, or after the targeted change, while (5) social influence theories 
highlight the importance of the social group and peers. In (6) organizational theories, 
altering the system of care is suggested to enhance change. (7) Coercive theories, finally, 
propose to use pressure and control to achieve change, such as regulations and 
legislation.292  
Cabana et al. developed a framework that goes beyond merely identifying barriers to 
guideline adherence, but also sets out these barriers in relation to behavior change (Figure 
6).35 Their model has been widely used in numerous quality improvement programs, and 
today still is a useful and inspiring outline to tackle non-adherence in the healthcare setting.  
 
Figure 6: Model adapted from Cabana et al.35 
4.2.1. Facilitators 
Four groups of factors have been identified that enhance behavioral change and facilitate 
the uptake and long-term use of clinical guidelines: (1) features of the guidelines, which 
comprise the scientific basis for the guideline and its sources, and the way in which the 
guideline is presented. A clear, logical and attractive presentation should facilitate guideline 
acceptance and uptake. Also, guidelines that are written with high behavioral specificity and 
in ‘‘plain English’’ have a greater chance to be implemented than vague, hard-to-read 
information; (2) features of the target group, thus necessitating the implementer to 
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thoroughly understand the target group’s level of knowledge, skills, attitudes, working 
practices and personalities; (3) features of the social context and the setting, which refer to 
the expectations and behaviors of care providers, the actual operating culture, the working 
routines, and the views of opinion leaders; and (4) features of the organizational context, 
including the financial, organizational and structural aspects of implementation, such as the 
availability of staff and equipment, and legal and regulatory issues.100 
4.2.2. Barriers 
Barriers impede the implementation of change. Cabana et al. conducted an extensive 
systematic review of the literature from January 1966 to January 1998 to identify barriers to 
guideline adherence.35 Out of 76 articles, 120 surveys evaluating 293 potential barriers to 
physician guideline adherence were reviewed. All barriers abstracted were grouped into 
common themes, and then further organized into groups based on whether they affected 
physician knowledge, attitude, or behavior, thus setting out a framework for barrier-
oriented behavior change. An adaption of this framework was outlined in Figure 6.35 
Lack of access to hand washing sinks, insufficient time, skin irritation, ignorance about the 
problem, and individual preferences or habits were reported as common barriers to 
adherence to hand hygiene guidelines, while low staffing and high patient acuity could 
contribute to making compliance even more difficult.290 Importantly, the lack of a universally 
accepted standard for measuring compliance was recognized as an additional major barrier. 
Disagreement with the interpretation of clinical trials (35%), unavailability of resources 
(31.3%) and costs (16.9%) were the most common self-reported reasons for non-adherence 
with evidence-based recommendations for VAP prevention among a sample of physicians 
who were surveyed by Rello et al.,34 while a sample of ICU nurses who were surveyed using 
the same questionnaire considered patient-related barriers to be significantly more 
important.23  
A lack of knowledge is commonly recognized as an elemental barrier to adherence.35, 36 
Indeed, knowledge of the recommendations is doubtlessly and logically a conditio sine qua 
non for compliance. Strikingly, however, it is missing from the lists of ICU clinicians’ self-
reported barriers for adhering to guidelines for the prevention of nosocomial infection.23-26, 
34, 289 
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Conclusion of part one 
 
Nosocomial infection, and the Big Four in particular,48 account for a considerable burden on 
patients and society as they are associated with increased morbidity and mortality rates, 
prolonged hospital and ICU stay, and with excess costs and expenditures.57-59 
Recent trends have seen a transition from accepting healthcare-associated infection as an 
inevitable outcome of admission to the healthcare facility54 towards personal accountability 
and a goal of zero tolerance in relation to hospital-acquired infections.2, 3 Luckily, a 
considerable proportion of HAIs are preventable if the most recent evidence-based 
prevention recommendations are followed. 7, 67 Evidence-based infection prevention has 
therefore become of utmost importance in healthcare settings worldwide, and a 
responsibility of each and every healthcare professional.1 
 
Evidence-based guidelines for the prevention of infections are widely available for 
healthcare workers to consult, but have been shown not to be self-implementing.21 This is 
illustrated by the overall low levels of adherence to guidelines reported among healthcare 
workers.27, 29, 31, 33, 77, 285-288 Sustained implementation efforts, based on a combination of 
multifaceted and multidisciplinary strategies with proven efficacy and efficiency, tailored to 
the local needs and culture, are needed to direct clinicians’ daily care routines toward 
compliance with published recommendations.107  
 
Both facilitators and barriers influence the level of success of guideline implementation 
strategies.100 In the field of infection prevention, both factors have been investigated, most 
often by means of surveys with a self-reporting design, and comprehensively published.23, 34, 
289, 290  Among the plethora of self-reported hindrances for compliance, a lack of adequate 
knowledge of the guidelines’ contents has, however, not been included.  
 
The latter finding has led to the onset of the EVIDENCE-project. The first step of the project 
thus consisted of an assessment of the knowledge about evidence-based infection 
prevention guidelines among ICU nurses. The results of this needs analysis are reported in 
the following, second part of this thesis.  
 
  
PART TWO 
 
 
INTENSIVE CARE NURSES’ KNOWLEDGE 
OF INFECTION PREVENTION GUIDELINES 
 
 
 
 
 
 
 
 
 
 
 
 
 
“To be conscious that you are ignorant is a 
great step to knowledge.”  
 
Benjamin Disraeli (1804 - 1881) 
Sybil, 1845  
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Introduction 
As mentioned above, a lack of knowledge of guideline contents has never been mentioned 
among ICU clinicians’ self-reported barriers for compliance with evidence-based 
recommendations for the prevention of healthcare-associated infection.23-26, 34, 289 In 2006, 
we conducted a literature search aiming to detect reliable and validated instruments that 
could be used for evaluating healthcare workers’ knowledge on this topic. No such 
instruments, however, were identified, thereby revealing a gap in the field of research 
dedicated to this particular area.  
  
Convinced of the importance of adequate knowledge levels as a first and primordial 
condition for any further initiative for quality improvement, we aimed to help filling this gap 
by dedicating a special interest to the assessment of ICU nurses’ knowledge about evidence-
based guidelines for the prevention of healthcare-associated infections. As no tools were 
readily available, we started our project by developing multiple choice knowledge tests 
concerning the prevention of the Big Four. These questionnaires were taken through the 
process of validation and reliability testing.293-295 Subsequently, they were used to assess 
knowledge levels of ICU nurses, with two among them on a European scale.295-297  
 
Part two of this thesis relates on the process of developing multiple choice knowledge tests 
concerning the prevention of VAP, CVC-RI and SSI, and of the methods used for their 
validation and reliability testing. It moreover reports how on the local and European surveys 
conducted using these questionnaires. 
 
Chapter one is dedicated to the development of and survey results obtained with the 
questionnaire regarding the prevention of VAP. The second chapter concentrates on the 
development and survey results related to the questionnaire concerning the prevention of 
CVC-RI. The third and last chapter reports on the development of the questionnaire 
concerning the prevention of SSI, and, again, on the results of the related survey.
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1. Knowledge about evidence-based guidelines for the prevention of  
ventilator-associated pneumonia 
 
1.1. Development of an evaluation questionnaire 
 Based on the article:  Labeau S, Vandijck D, Claes B, Van Aken P, Blot S. Critical care nurses' 
knowledge of evidence-based guidelines for preventing ventilator-associated pneumonia: An 
evaluation questionnaire. Am J Crit Care. 2007;16(4):371-377. 
 
Introduction 
Ventilator-associated pneumonia (VAP) is defined as a pneumonia developing more than 48 
to 72 hours after initiation of mechanical ventilation.10, 49-51 With an incidence of 8% to 
68%,298, 299 VAP is the most common hospital-acquired infection among patients who require 
ventilatory support.72, 299, 300 Moreover, VAP is associated with high morbidity and mortality 
rates, increased duration of ventilatory support and hospitalization, and increased use of 
healthcare resources.58, 158, 301-303 
 
Prevention of VAP focuses on reduction of exposure to mechanical ventilation by preferring 
non-mechanical ventilation when possible and minimizing duration when mechanical 
ventilation is necessary,304, 305 on avoiding microaspiration of subglottic secretions, 
preventing oropharyngeal colonization with exogenous pathogens, and preventing 
contamination of ventilator equipment.12, 264, 298 Evidence-based guidelines for the 
prevention of VAP have been developed10, 12, 306 and have been promoted by programs and 
campaigns of authoritative organisations.307, 308 Nevertheless, non-adherence to these 
guidelines has been reported.23, 34, 298, 309 Also, the results of assessments of nurses’ 
knowledge of evidence-based practice in general310-312 have been disappointing. Recently, 
lack of knowledge was indicated as a barrier for non-adherence to evidence-based 
practice.311 Although knowledge does not ensure adherence, misconceptions about effective 
prevention strategies can be important in decision-making. The reduction in the rates of 
hospital-acquired infection69, 313 that occurred after educational programs on strategies to 
prevent infection provide indirect evidence for the value of knowledge.  
 
Our objective was to develop a reliable and valid questionnaire to determine critical care 
nurses’ knowledge of evidence-based guidelines for preventing VAP. 
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Methods 
Selection of Interventions and Design of the Questionnaire 
The selection of interventions or strategies to prevent VAP was based on a recently 
published review12 of evidence-based guidelines. In a search for relevant randomized, 
controlled trials and systematic reviews that involved adults that were treated with 
mechanical ventilation and that were published before April 2003, Dodek et al.12 looked for  
physical, body positioning and pharmacologic interventions that might influence the 
development of VAP. Independently and in duplicate, these authors scored the validity of 
trials; the effect size and confidence intervals; the homogeneity of results and safety; 
feasibility, and economic issues.  On the basis of this review12, a total of 10 interventions or 
strategies with relevance for nursing practice were selected: (1) use of oral endotracheal 
tubes, (2) frequency of ventilator circuit changes, (3) use of a heat and moisture exchanger, 
(4) frequency of humidifier changes, (5) use of a closed suction system, (6) frequency of 
change in suction system, (7) drainage of subglottic secretions, (8) use of kinetic beds, (9) 
use of semi-recumbent positioning, (10) chest physiotherapy.  
 
A multiple choice question with four response alternatives or options (the correct 
answer/response and 3 distractors or alternatives that are not the answer) was developed 
for each item on the list314 (Table 4). For each test item, the response alternatives included 
the phrase ‘I do not know’ to avoid gambling by the respondents and 2 interventions with 
investigated preventive value. In their evidence-based clinical practice guideline for the 
prevention of VAP, Dodek et al.12 advise consideration of 2 interventions, drainage of 
subglottic secretions and use of kinetic beds, but make no recommendation for use of these 
2 because of cost concerns. Therefore, questions on these 2 interventions were designed to 
assess knowledge about the impact on the interventions on the risk for VAP. For two other 
interventions, closed suction system and frequency of ventilator circuit changes, the 
recommendations of Dodek et al.12 are based on economic considerations.  
 
Expert validation 
The selected preventive interventions and questionnaire were presented to a panel of eight 
experts for face and content validation.315 Experts had at least three years of experience in 
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an intensive care unit (ICU), a master’s degree in nursing sciences (or medicosocial sciences), 
and a particular interest in ICU-acquired infections.  
To achieve face validity, the experts were asked if all questions were clearly worded and 
would not be misinterpreted. For content validity, the experts evaluated the nursing 
relevance of the ten selected strategies by using a scale of 1 to 3, where 1 =  not relevant, 2 = 
relevant but not necessary, and 3 = absolutely necessary. Additionally, the experts were 
asked if questions about any other preventive interventions should be added to the 
questionnaire.  
The remarks of the panel were collected and discussed and were used to revise the 
questionnaire. After the revision, the experts examined the questionnaire again; they 
unanimously declared agreement with its content and clarity. 
 
Assessment of the Questionnaire 
Revising tests on the basis of test scores is an essential part of improving instruction.314 
Therefore, the items on the questionnaire were analysed to determine their level of 
difficulty and discrimination, and the quality of the 4 response alternatives or options for 
each question was evaluated.314, 316, 317 
 
a) Difficulty level 
The difficulty level of an item or question is defined as the proportion of respondents who 
answer the question correctly.314, 316, 317 Possible values range from 0.0 to 1.0. Items that are 
answered correctly by more than 90% of the respondents (value >0.9) are considered too 
easy; items answered correctly by less than 10% of the respondents (value <0.1) are 
considered too difficult. 
 
b) Item discrimination 
A discrimination index indicates the extent to which items on the questionnaire discriminate 
between high scorers and low scorers. The following formula was used to divide 
respondents into high scorers and low scorers, with 27% of respondents in each group:  
 
number of correct answers in the high-scorer group – number of correct answers in low-scorer group 
total number of correct answers in both groups 
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Values of 0.35 and higher are (very) good; values from 0.25 to 0.35 are satisfying/good; 
values 0.15 to 0.25 are mediocre/satisfying; and values less than 0.15 are bad/mediocre. 
 
 
c) Quality of the Response Alternatives 
The quality of a response alternative is defined by calculating the proportion of respondents  
who choose  the alternative. Values range from 0.0 to 1.0. Response alternatives with a 
value of 0.0 are not attractive, and those with a value of 1.0 might be too attractive. 
 
Population Surveyed 
The questionnaire was distributed and collected during the annual congress of the Flemish 
Society of Critical Care Nurses (Ghent, November 25, 2005). Of the 855 registered 
participants, 638 completed the questionnaire (response rate: 74.6%). The responses were 
collected anonymously. The questionnaire also included questions on general characteristics 
of the respondents: sex, years of ICU experience, number of ICU beds in the hospital where 
the respondent worked, and whether the respondent had a special degree in emergency and 
intensive care.  
 
Results 
Expert Validation  
The experts reported that some items needed to be slightly rephrased to be clear. According 
to the experts, question 10 (chest physiotherapy) was irrelevant for nurses. Therefore, this 
question was omitted; the final questionnaire consisted of 9 items on interventions to 
prevent VAP.  
 
Item Analysis 
Overall values for item difficulty and discrimination were very good to satisfying (Table 4). 
For question 9 (patient positioning), however, the values were borderline, indicating that 
respondents had a good knowledge of this intervention. Nevertheless, question 9 was kept 
in the questionnaire because of the enormous impact of patient positioning on the 
prevention of VAP and the major relevance of this question for ICU nurses. Also, because  
the questionnaire is a criterion-referenced test, an item that is valuable for the content does 
not necessarily have to be excluded because the item is too easy.318 
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Table 4: Questionnaire and item analysis’ results 
 DIF Q ID 
1. Oral vs. nasal route for endotracheal intubation 0.2  0.60 
A* Oral intubation is recommended  0.2  
B Nasal intubation is recommended  0.1  
C Both routes of intubation can be recommended  0.6  
D I do not know  0.1  
2. Frequency of ventilator circuits changes 0.5  0.35 
A It is recommended to change circuits every 48 hrs (or when clinically indicated)  0.2  
B It is recommended to change circuits every week (or when clinically indicated)  0.3  
C* It is recommended to change circuits for every new patient (or when clinically indicated)  0.5  
D I do not know  0.0  
3. Type of airway humidifier 0.5  0.30 
A Heated humidifiers are recommended  0.2  
B* Heat and moisture exchangers are recommended  0.5  
C Both types of humidifiers can be recommended  0.1  
D I do not know  0.2  
4. Frequency of humidifier changes 0.1  0.55 
A It is recommended to change humidifiers every 48 hrs (or when clinically indicated)  0.6  
B It is recommended to change humidifiers every 72 hrs (or when clinically indicated)  0.1  
C* It is recommended to change humidifiers every week (or when clinically indicated)  0.1  
D I do not know  0.2  
5. Open vs. closed suction systems 0.2  0.40 
A Open suction systems are recommended  0.0  
B* Closed suction systems are recommended  0.2  
C Both systems can be recommended  0.7  
D I do not know  0.1  
6. Frequency of change in suction systems 0.2  0.65 
A Daily changes are recommended (or when clinically indicated)  0.5  
B Weekly changes are recommended (or when clinically indicated)  0.2  
C* It is recommended to change systems for every new patient (or when clinically indicated)  0.2  
D I do not know  0.1  
7. Endotracheal tubes with extra lumen for drainage of subglottic secretions 0.6  0.30 
A* These endotracheal tubes reduce the risk for VAP  0.6  
B These endotracheal tubes increase the risk for VAP  0.0  
C These endotracheal tubes do not influence the risk for VAP  0.1  
D I do not know  0.3  
8. Kinetic vs. standard beds 0.5  0.50 
A Kinetic beds increase the risk for VAP  0.0  
B* Kinetic beds reduce the risk for VAP  0.5  
C The use of kinetic beds does not influence the risk for VAP  0.2  
D I do not know  0.3  
9. Patient positioning 0.9  0.10 
A Supine positioning is recommended  0.0  
B* Semi-recumbent positioning is recommended  0.9  
C The position of the patient does not influence the risk for VAP  0.1  
D I do not know  0.0  
10. Chest physiotherapy**    
A Chest physiotherapy reduces the risk for VAP    
B Chest physiotherapy does not reduce the risk for VAP    
C The influence of chest physiotherapy on the risk for VAP is unknown    
D I do not know    
* correct answer 
** question omitted after experts’ validation 
DIF: Item difficulty 
Q: Quality of the option 
ID: Item discrimination 
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In the analysis of the quality of the response alternatives, some had values of 0.0, suggesting 
that reformulation should be considered. Nevertheless, this finding may also indicate that 
inclusion of the standard response alternative “I do not know” restrained respondents from 
gambling. Additionally, because the response alternatives were restricted to interventions 
with an investigated preventive value, our formulation possibilities were limited. Of note, 
the score for the question 9 (patient positioning) option “Supine positioning is 
recommended” was 0.0, although this intervention is often used in daily practice. Therefore, 
despite its low score, this option was not changed for the final version of the questionnaire. 
The quality of the response alternatives also indicated the extent of existing misconceptions 
about the preventive value of certain interventions. The responses to the final questionnaire 
indicated that nurses thought that both the oral and nasal routes for intubation were 
recommended (value 0.6); however, the oral route (value 0.2) is recommended in the 
guidelines. Respondents also thought that a change of humidifiers every 48 hours (or when 
clinically indicated) was recommended (value 0.6), whereas guidelines recommend weekly 
changes (or when clinically indicated) (value 0.1). The respondents thought that both open 
and closed suction systems were recommended (value 0.7), but only  closed suction systems 
(value 0.2) are recommended in the guidelines. For frequency of change of suction systems, 
nurses thought that daily changes (or when clinically indicated) were recommended (value 
0.5), whereas the guidelines recommend changes for every new patient who needs 
mechanical ventilation (or when clinically indicated) (value 0.2).  
For all four of these items, respondents are convinced that an intervention without 
evidence-based preventive value is preferred over the evidence-based intervention. 
Mapping out this kind of widely spread misconceptions is important for better focussing 
education of critical care nurses. 
 
Characteristics of the Sample 
Most of the 638 respondents were women (n = 472, 74%; Table 5). A total of 274  
respondents (43%) had more than 10 years of ICU experience, and 274 worked in units with 
more than 15 beds. Most respondents (n = 437, 68%) had a special degree in intensive care  
and emergency nursing.  
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Table 5: General characteristics of the population surveyed (n=638) 
n = 638 
ICU experience < 1 year 1-5 years 6-10 years > 10 years 
 n = 153 (24%) n = 111 (17.0%) n = 100 (16%) n = 274 (43%) 
ICU beds < 8 beds 8 – 15 beds 15 beds missing 
 n = 104 (16%) n = 177 (28%) n = 274 (43%) n = 83  
Degree  holding degree no degree 
 n = 201 (32%) n = 437 (68%) 
Gender male female 
 n = 166 (26%) n = 472 (74%) 
 
Discussion and limitations 
We developed a reliable questionnaire for evaluating critical care nurses’ knowledge on 
evidence-based guidelines for preventing VAP. Face and content validity were achieved. As a 
result of experts’ validation, the original 10-item questionnaire was adapted and reduced to 
nine items.  
In the United States, some of the interventions mentioned in the questionnaire, such as 
frequency of ventilator circuit changes and frequency of humidifier changes, are 
implemented by respiratory care practioners. In Belgium, where this study was conducted, 
and in the rest of Europe, these 2 interventions are implemented by critical care nurses. We 
are convinced that all the interventions mentioned in the questionnaire are relevant for 
critical care nurses because nurses have a major role in monitoring patients’ care to 
determine if best practices are followed. Additional interventions or strategies that are 
directly under the control of nurses in both the United States as in Europe, such as 
chlorhexidine mouth rinse, were not included in our questionnaire because the questions 
address only evidence-based interventions from the review by Dodek et al.12 
Item analysis of the questionnaire was based on the responses of 638 nurses who attended 
the annual congress of the Flemish Society of Critical Care Nurses. This convenience 
sampling may have led to selection bias and may have created a barrier to extrapolating our 
results. Nevertheless, our sample represents 21% of all Flemish critical care nurses. 
Moreover, this bias should be limited because the federal government in Belgium requires 
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all critical care nurses who have a special degree in intensive care and emergency nursing to 
attend at least 16 hours a year of continuing education to maintain the degree.  
Finally, guidelines can change over time. Adaptation and re-evaluation of the questionnaire 
will be needed each time new evidence-based interventions for preventing VAP are 
discovered. 
 
Conclusion 
A reliable questionnaire was developed to assess critical care nurses’ knowledge on 
evidence-based interventions for preventing VAP. Face and content validity were achieved. 
The results of surveys with this questionnaire can be used to focus educational programs on 
VAP. The questionnaire also can be used before and after educational programs to assess 
the effect of the programs on nurses’ knowledge of interventions to prevent VAP. 
 
1.2. Flemish ICU nurses’ knowledge of evidence-based VAP prevention 
 Based on the article:  Labeau S, Blot SI, Vandijck DM, Van Aken P, Claes B. Evidence-based 
guidelines for the prevention of ventilator-associated pneumonia. Results of a knowledge test among 
intensive care nurses. Intensive Care Med. 2007;33(8):1463-1467. 
 
Introduction 
Ventilator-associated pneumonia (VAP) leads to a considerable excess in morbidity and 
mortality, and to a significant economic burden.58, 158 Prevention of VAP primarily focusses 
on avoiding microaspiration of subglottic secretions, preventing oropharyngeal colonization 
with exogenous pathogens and contamination of ventilator equipment. Although research 
efforts have been undertaken to determine the value of numerous preventive measures, 
interpretation of the results is not always obvious.319 There may be flaws in the study design 
and results from different studies may not be concordant. The positive effect of preventive 
measures may decrease with length of time at risk. So has continuous aspiration of 
subglottic secretions a favourable effect on the incidence of early onset VAP, but the effects 
on late onset VAP are less convincing.192, 320-322 Also, preventive measures may be effective 
but too expensive for general implementation.12, 323, 324 In response to the complexity of the 
issue, studies of expert panels have resulted in evidence-based guidelines.12, 325 
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Surveys evaluating compliance of practices with the recommendations have been 
published.23, 34, 298, 309 Yet, to our knowledge, surveys evaluating knowledge of guidelines for 
VAP prevention by means of a knowledge test have not been performed. While knowledge 
does not insure adherence, a lack of knowledge may be a barrier to adherence. This study 
aimed to determine intensive care nurses’ knowledge of evidence-based recommendations12 
for VAP prevention. 
 
Materials and methods 
A multiple-choice questionnaire (Table 6) was developed,293 following the evidence-based 
VAP prevention guidelines by Dodek et al.12 Selection of its items was limited to strategies 
with a major importance for nursing practice and adapted to an expert validation panel’s 
comments.293 
 
Demographic data gathered were gender, years of experience in an intensive care unit (ICU), 
number of critical beds in the hospital where respondents are put to work, and whether they 
hold a degree in emergency and intensive care. This degree can be achieved after the basic 
three year nursing education (Bachelor degree) and is acknowledged as a Bachelor-after-
Bachelor degree. Although it is not obligatory to hold this degree to work in a Flemish ICU, it 
is strongly promoted by hospital directors since ICU licenses depend on a minimum number 
of nurses employed, holding this special degree (50%). 
 
The questionnaire was distributed during the annual congress of the Flemish Society for 
Critical Care Nurses (Ghent, November 25, 2005) and presented plenary by a Board member. 
The contextual framework was explained and some time was provided to fill in the 
demographic data. Then, each question was read aloud while projected in the congress hall. 
Thirty seconds were left between two questions. Finally, the questionnaires were collected 
immediately after this procedure. 
 
Continuous variables are described as median (interquartile range). Chi-square test, Mann-
Whitney U test and Kruskal-Wallis test were used as appropriate. Relationships between 
total scores and demographic data were assessed using linear regression analysis. Variables 
with p>0.15 were stepwise removed from the regression model. Statistical analysis was 
performed using SPSS for Windows 12.0.0 (SPSS, Chicago, IL, US). 
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Table 6: Nurses’ answers on the nine items of the questionnaire  
Item  % of 
answers 
1. Oral vs. nasal route for endotracheal intubation  
 Oral intubation is recommended 18.7* 
 Nasal intubation is recommended 11.1 
 Both routes of intubation can be recommended 59.6 
 I do not know 10.7 
2. Frequency of ventilator circuits changes  
 It is recommended to change circuits every 48 hrs (or when clinically indicated) 19.4 
 It is recommended to change circuits every week (or when clinically indicated) 27.4 
 It is recommended to change circuits for every new patient (or when clinically indicated) 48.6* 
 I do not know 4.5 
3. Type of airway humidifier  
 Heated humidifiers are recommended 17.2 
 Heat and moisture exchangers are recommended 54.7* 
 Both types of humidifiers can be recommended 12.5 
 I do not know 15.5 
4. Frequency of humidifier changes  
 It is recommended to change humidifiers every 48 hrs (or when clinically indicated) 58.8 
 It is recommended to change humidifiers every 72 hrs (or when clinically indicated) 11.4 
 It is recommended to change humidifiers every week (or when clinically indicated) 13.3* 
 I do not know 16.5 
5. Open vs. closed suction systems   
 Open suction systems are recommended 3.3 
 Closed suction systems are recommended 16.9* 
 Both systems can be recommended 69.3 
 I do not know 10.5 
6. Frequency of change in suction systems  
 Daily changes are recommended (or when clinically indicated) 45.1 
 Weekly changes are recommended (or when clinically indicated) 22.3 
 It is recommended to change systems for every new patient (or when clinically indicated) 19.6* 
 I do not know 13.0 
7. Endotracheal tubes with extra lumen for drainage of subglottic secretions  
 These endotracheal tubes reduce the risk for VAP 60.3* 
 These endotracheal tubes increase the risk for VAP 3.6 
 These endotracheal tubes do not influence the risk for VAP 8.2 
 I do not know 27.9 
8. Kinetic vs. standard beds  
 Kinetic beds increase the risk for VAP 1.3 
 Kinetic beds reduce the risk for VAP 48.7* 
 The use of kinetic beds does not influence the risk for VAP 19.3 
 I do not know 30.7 
9. Patient positioning  
 Supine positioning is recommended 0.8 
 Semi-recumbent positioning is recommended 90.3* 
 The position of the patient does not influence the risk for VAP 5.5 
 I do not know 3.4 
*Correct answer; VAP: ventilator-associated pneumonia 
 
Results 
Of the 855 registered participants of the congress, 638 completed the questionnaire (74.6%). 
Most respondents were female (n=472; 74.0%). About 1/4 (n=153; 24.0%) had <1 year of ICU 
experience, 111 (17.4%) 1 to 5 years, 100 (15.7%) 6 to 10 years, and 274 (43.0%) >10 years. A 
majority (n=274; 42.9%) worked in a hospital with >15 ICU beds, 177 (27.7%) with 8 to 15 
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beds and 104 (16.3%) with <8 beds. A degree in emergency and critical care was held by 68% 
(n=437). Nurses from 91 ICUs attended the congress. 
The questionnaire and nurses’ answers are shown in Table 6. Average scores according to 
respondents’ characteristics are demonstrated in Table 7. The average score was 3.7 on 9 
questions (41.2%). No substantial differences were found between males and females, nor 
did the number of beds affect the results. Nurses with <1 year experience performed worse 
than nurses with >1 year experience. Nurses holding the degree had significantly better 
scores than those not holding it. Linear regression analysis identified years of experience 
(per class increase) and degree as independently associated with better knowledge (Table 8). 
 
Table 7: Average scores on nine questions according to respondents’ characteristics 
Characteristic Mean (%) Median (interquartile range) p 
Total cohort 3.71 (41.2) 4 (3 – 5) - 
Gender   0.545 
Female 3.69 (41.0) 4 (3 – 5)  
Male 3.77 (41.9) 4 (3 – 5)  
Number of ICU beds   0.401 
<8 beds 3.72 (41.3) 4 (2 – 5)  
8 – 15 beds 3.97 (44.1) 4 (3 – 5)  
>15 beds 3.93 (43.7) 4 (3 – 5)  
Years of ICU experience   <0.001 
<1 year 2.85 (31.7) 3 (2 – 4)  
1 – 5 year 3.70 (41.1) 4 (3 – 5)  
6 – 10 years 4.16 (46.2) 4 (3 – 5)  
>10 years 4.03 (44.8) 4 (3 – 5)  
Special title in emergency and intensive care   <0.001 
Yes 3.94 (43.7) 4 (3 – 5)  
No 3.22 (35.8) 3 (2 – 4)  
 
 
Table 8: Adjusted relationships with the average knowledge 
 B ± standard error 95% confidence interval p 
ICU experience (per class increase)* 0.31 points** ± 0.05 0.20 – 0.41 <0.001 
Degree in emergency and critical care 0.32 points** ± 0.14 0.03 – 0.58 0.032 
*classes are <1 year, 1-5 years, 6-10 years, or >10years of ICU experience;  
**on a total of nine (one point per question);  
R²=0.1 
 
Discussion 
We evaluated Flemish nurses’ knowledge of VAP guidelines. Overall the results were poor.  
Our results can be compared with four previously published reports.23, 34, 298, 309 Rello et al. 
distributed a questionnaire in 22 countries to indicate whether practices were according to a 
recent review article, thus identifying barriers to physicians’ adherence to guidelines.34 The 
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study by Heyland et al. described the use of strategies for VAP prevention prior to 
publication of the Canadian Critical Care Trials Group’s guidelines.298  In the survey by Sierra 
et al., practices on prevention and diagnosis of VAP were explored among physicians in 28 
Spanish ICUs.309 The study by Ricart et al. focusses on nursing adherence to VAP guidelines.23 
The utmost important difference between our study and those reporting care practices23, 34, 
298, 309 is that our questionnaire was designed to measure knowledge. Nevertheless, we 
assume that our results also reflect, at least to some extent, practice in Flemish ICUs. 
Sierra et al. found that in 75% of the ICUs ventilator circuits were changed every 72 hours or 
later.309 This is in accordance with our findings where nurses indicated to change circuits 
weekly or later in 76%. Fifty-five% of our respondents identified heat and moisture 
exchangers as the recommended type of airway humidification. In the studies by Heyland et 
al., Ricart et al., and Sierra et al., respectively 80%, 84%, and 96% of the respondents used 
heat and moisture exchangers.23, 298, 309  
It is recommended to change airway humidification systems weekly or when clinically 
indicated.12 Only 12% of our respondents were aware of this recommendation, suggesting 
that, in daily practice, humidification systems are changed too frequently. Also in the studies 
by Rello et al. and Ricart et al., heat and moisture exchangers were changed on a daily basis 
in 59% and 75% respectively.23 
In our survey only 17% recognized closed systems as recommended. In Canada closed 
suction systems are used in 88% of the ICUs, while in Spain open tracheal suctioning was 
reported in 96% of the ICUs.23, 34, 298, 309 In Flanders, closed suction systems are not 
commonly used, results of our survey thus reflecting nurses’ unfamiliarity with those 
systems. 
Sixty% knew that draining subglottic secretions decreases the risk for pneumonia. The 
beneficial effect of kinetic beds was recognized by about half of the nurses. However, for 
these two issues, respectively 28% and 31% of nurses reported not to know the answer, this 
suggesting that these strategies are seldom used in Flemish ICUs. Finally, in our survey semi-
recumbent positioning was well acknowledged to prevent VAP. 
Generally, more experienced nurses had a higher knowledge level than those with <1 year 
experience. The knowledge level among nurses holding a special degree was also higher 
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(Table 7). After adjustment for years of ICU experience, the advantage of the special degree 
remained significant (Table 8). 
Our findings demonstrate that nurses’ awareness about VAP guidelines is low, and stress the 
need for thorough education based on current recommendations. One might question the 
importance of pure knowledge versus degree of application in practice. We believe that 
thorough understanding of the recommended strategies supports adherence and overcomes 
potential barriers as previously identified.23, 34 Additionally, increasing the average level of 
knowledge has been the first step in successful multifaceted educational programs.69, 264, 326 
Guidelines themselves only have a limited impact on changing behaviour. Within 
institutions, efforts must be taken to organize educational programs to fine-tune practice 
with guidelines. The favourable value of such programs has been demonstrated.327-329 
As all surveys, the present study suffers from selection bias. Individuals with a higher interest 
in the topic are more likely to participate. Moreover, the questionnaire was distributed at 
the annual congress of the Flemish Society for Critical Care Nurses. Nurses attending 
congresses might be more skilled or motivated. However, this bias is limited by the fact that 
the federal government requests at least 16 hours of education yearly, to maintain the 
degree. 
Additionally does knowledge of recommendations not necessarily reflect practice. Nurses 
may change ventilator circuits for every new patient, not knowing this is a guideline. 
Moreover, no weights were linked to the different strategies’ relative importance. For 
example, supine positioning can be considered as a higher risk for VAP than changes of heat 
and moisture exchangers per 48 hours. In this way, the higher scores achieved for patient 
positioning and subglottic secretions drainage are in favour of the study population. 
This study is a preliminary investigation in a strict geographical region. Its results cannot be 
extrapolated. A multi-country study should be conducted to draw more general conclusions. 
Despite the geographical restriction, our major strength is the large sample size. We 
collected 638 questionnaires. The number of Flemish ICU nurses being approximately 3000, 
our sample covers >20% of potential respondents. 
In conclusion, Flemish nurses’ knowledge of VAP prevention guidelines is low. Their 
education should include supplementary support from current evidence-based guidelines. 
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1.3. European ICU nurses’ knowledge of evidence-based VAP prevention 
Based on the article: Labeau S, Vandijck D, Rello J, Adam S, Rosa A, Wenisch C, Bäckman C, 
Agbaht K, Csomos A, Seha M, Dimopoulos G, Vandewoude K, Blot S, for the EVIDENCE-study 
investigators. Evidence-based guidelines for the prevention of ventilator-associated pneumonia: 
results of a knowledge test among European intensive care nurses. J Hosp Infect. 2008;70(2):180-
185. 
 
Introduction 
Nosocomial infections concern 5% to 35% of patients admitted to the intensive care unit 
(ICU) and 50% to 60% of patients remaining in the ICU for more than five days.49, 301 This is 
associated with prolonged hospital stay, increased morbidity and mortality, and important 
additional costs for patient and society.54 Infection prevention is considered a priority in the 
ICU and an important indicator of quality of care. 
 
Structured multifaceted interventional programmes have a positive influence on nosocomial 
infection rates.69 The first step in such programmes is to provide education, in order to 
increase awareness of evidence-based infection control practice.69 Adult learning theory, 
focusing on learner involvement in the learning process, has substantially changed medical 
education over the past three decades, but its influence is not yet widespread in web-based 
teaching.330  
 
With the EVIDENCE-project, we aim to develop a website-based e-learning platform for ICU 
nurses on infection prevention (URL: www.vvizv.be/Pages/Evidence.php). As the first step in 
any educational endeavour is needs analysis,330 we started our study by assessing our target 
group’s knowledge of measures for infection prevention. We report the results here of a 
knowledge test on evidence-based VAP prevention guidelines among 3329 European ICU 
nurses. 
 
Methods 
For assessing nurses’ knowledge of measures for infection prevention, reliable and validated 
multiple-choice questionnaires were developed (Table 9).293, 294 The evidence-based 
guidelines by Dodek et al. were used as standard for developing a questionnaire on VAP 
prevention recommendations.12, 293  
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Table 9: Nurses’ answers on multiple choice questions 
Item  % of answers 
1. Oral vs. nasal route for endotracheal intubation  
 Oral intubation is recommended 54.7* 
 Nasal intubation is recommended   5.8 
 Both routes of intubation can be recommended 33.0 
 I do not know   6.5 
2. Frequency of ventilator circuits changes  
 It is recommended to change circuits every 48 hrs (or when clinically indicated) 19.4 
 It is recommended to change circuits every week (or when clinically indicated) 42.2 
 It is recommended to change circuits for every new patient (or when clinically indicated) 35.1* 
 I do not know   3.3 
3. Type of airway humidifier  
 Heated humidifiers are recommended 22.0 
 Heat and moisture exchangers are recommended 38.2* 
 Both types of humidifiers can be recommended 24.6 
 I do not know 15.2 
4. Frequency of humidifier changes  
 It is recommended to change humidifiers every 48 hrs (or when clinically indicated) 49.6 
 It is recommended to change humidifiers every 72 hrs (or when clinically indicated) 12.5 
 It is recommended to change humidifiers every week (or when clinically indicated) 21.4* 
 I do not know 16.7 
5. Open vs. closed suction systems   
 Open suction systems are recommended   9.1 
 Closed suction systems are recommended 45.7* 
 Both systems can be recommended 39.5 
 I do not know   5.6 
6. Frequency of change in suction systems  
 Daily changes are recommended (or when clinically indicated) 61.7 
 Weekly changes are recommended (or when clinically indicated) 13.5 
 It is recommended to change systems for every new patient (or when clinically indicated) 18.2* 
 I do not know   6.6 
7. Endotracheal tubes with extra lumen for drainage of subglottic secretions  
 These endotracheal tubes reduce the risk for VAP 50.6* 
 These endotracheal tubes increase the risk for VAP   5.9 
 These endotracheal tubes do not influence the risk for VAP 10.1 
 I do not know 33.4 
8. Kinetic vs. standard beds  
 Kinetic beds increase the risk for VAP   3.1 
 Kinetic beds reduce the risk for VAP 57.3* 
 The use of kinetic beds does not influence the risk for VAP 18.9 
 I do not know 20.7 
9. Patient positioning  
 Supine positioning is recommended   3.2 
 Semi-recumbent positioning is recommended 85.1* 
 The position of the patient does not influence the risk for VAP   6.5 
 I do not know   5.2 
To establish a European network, 31 potential were identified by searching the electronic 
database Pubmed for researchers with a particular interest in ICU infections. They were 
invited to act as a national representative beginning of October 2006. Representatives were 
engaged to distribute the questionnaire nationally among ICU nurses and to the completed 
copies via postal mail by 1 March 2007. Of 31 potential collaborators contacted, 26 agreed 
to cooperate and were mailed the questionnaire in mid-October 2006. They informed and 
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instructed local ICU nurses through responsible hospital staff. Monthly newsletters helped 
strengthen the network. 
Demographics included nationality, gender, ICU experience, number of ICU beds, and 
acquisition of a postgraduate degree in intensive care, provided by a higher education 
institution or similarly professionally accredited organisation. The questionnaire comprised 9 
questions; one point was given for each correct answer; a wrong answer did not affect the 
score negatively. A maximal score thus consisted of nine and a minimal score of zero points. 
For statistical analysis SPSS 13.0.0 for Windows was used (SPSS, Chicago, IL, US). Continuous 
variables are described as median (interquartile range). Chi-square, Mann-Whitney U-tests 
and Kruskal-Wallis tests were used as appropriate. Relationships between total scores and 
demographics were assessed by means of a linear regression analysis. Variables with p>0.15 
were stepwise removed from the regression model. 
 
Results 
Data were obtained from 22 out of 26 countries that had agreed to participate, 
corresponding with 3329 questionnaires (Table 10). As for the four remaining countries, 
communication was stopped by the potential collaborators and no questionnaires were 
returned. The global response rate was 69.1%. The questionnaire and the distribution of the 
nurses’ answers among its answering alternatives are shown in Table 9. Table 11 shows the 
nurses’ scores in relation to their characteristics.  
The average score was 4.06 on nine questions (45.1%). More experienced nurses performed 
significantly better than their less-experienced colleagues (p<0.001 for <1 year vs. >1 year; 
p<0.001 for <5 years vs. >5 years and p=0.001 for <10 years vs. >10 years ICU experience, 
respectively). Scores of nurses from larger ICUs were significantly lower than those of 
respondents from smaller units (p<0.001 for <8 beds vs. >8 beds; and p=0.048 for <15 beds 
vs. >15 beds, respectively).  
Linear regression analysis (R²=0.12) showed ICU experience (per class of increase: <1 year, 1-
5 years, 6-10 years, or >10 years of experience) to be independently associated with better 
test scores (p<0.001; B ± standard error 0.09 points ± 0.02; confidence interval 0.04 – 0.14). 
An increase in class of the number of ICU beds (<8 beds, 8-15 beds, or >15 beds) was 
associated with lower scores (p<0.001; B ± standard error -0.15 points ± 0.03; confidence 
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interval -0.02 – -0.09). No independent relationships between gender (p=0.51) or nationality 
(p=0.75) and test scores were identified. 
Table 10: Questionnaires received per country 
Country # questionnaires % 
Austria 204 6.1 
Belgium 686 20.6 
Czech Republic 15 0.5 
Denmark 31 0.9 
Finland 121 3.6 
Germany 138 4.1 
Greece 174 5.3 
Hungary 178 5.3 
Italy 140 4.2 
Latvia 82 2.5 
Lithuania 11 0.3 
Malta 43 1.3 
Netherlands 93 2.8 
Norway 16 0.5 
Portugal 484 14.5 
Slovakia 112 3.4 
Slovenia 120 3.6 
Spain 143 4.3 
Sweden 147 4.4 
Switzerland 178 5.3 
Turkey 197 5.9 
United Kingdom 15 0.5 
Total 3329 100.0 
 
Discussion 
Low scores were found on a knowledge test on evidence-based VAP prevention guidelines 
among European ICU nurses. Interpretation of this finding requires caution, however, as the 
standard for the test question answers was derived from a particular set of evidence-based 
recommendations.12 Marked differences are noted to exist between local and international 
guidelines and it is not entirely clear whether poor test scores reflect a lack of knowledge, 
deficiencies in training, differences in what is regarded as good practice, and/or a lack of 
consistent policy. If better scores are obtained after judging the participants against local 
guidelines, this would suggest that the problem is lack of consistent policy, rather than poor 
training. Indeed, there has been a rapid increase in the number of country-specific VAP 
guidelines, that vary in their overall recommendations, in Europe recently.164 Development 
of comprehensive pan-European guidelines would help rationalise conflicting proposals, 
provide a useful resource and limit guideline proliferation.164, 331  
 
 89 
Table 11: Average scores on nine questions according to respondents’ characteristics 
Characteristic n Mean (%) Median  
(interquartile range) 
p 
Total cohort 3329 4.06 (45.1) 4 (3 – 5) - 
Gender    0.533 
Female 2657 4.07 (45.2) 4 (3 – 5)  
Male 672 4.03 (44.7) 4 (3 – 5)  
Number of ICU beds    < 0.001 
<8 beds 1012 4.27 (47.4) 4 (3 – 5)  
8 – 15 beds 1331 4.07 (45.2) 4 (3 – 5)  
>15 beds 887 3.98 (44.2) 4 (3 – 5)  
Years of ICU experience    < 0.001 
<1 year 420 3.48 (38.6) 3 (2 – 5)  
1 – 5 year 969 4.09 (45.4) 4 (3 – 5)  
6 – 10 years 690 4.25 (47.2) 4 (3 – 5)  
>10 years 1242 4.14 (46.0) 4 (3 – 5)  
Qualification in intensive care* 2390   0.229 
Yes 1257 4.08 (45.3) 4 (3 – 5)  
No 1122 4.01 (44.5) 4 (3 – 5)  
* only taking in account these participating countries where such a degree can be obtained (Austria, Belgium, 
Czech Republic, Denmark, Germany, Greece, Hungary, Italy, the Netherlands, Norway, Slovakia, Slovenia, Spain, 
Sweden, Switzerland,  United Kingdom). The total number of respondents from these countries is 2390. 
Percentages (numbers) may not always add up to 100 (3329) due to missing values. 
 
Our questionnaire took no account of the costs related to recommendations. This may be an 
important issue in some of the emerging economies since several of the mentioned 
strategies (such as kinetic beds) are quite expensive. Nurses may simply not be aware of the 
possibilities because they are not available locally. 
 
Non-adherence to evidence-based recommendations for VAP prevention is reported to be 
common.23, 34, 174, 309, 332 Rello et al. reported an overall non-adherence rate of 37.0% among 
physicians.34 Ricart et al. found the overall non-adherence rate in a sample of ICU nurses to 
be 22.3%.23 In Spanish ICUs, common prevention and diagnostic procedures differed 
significantly from evidence-based recommendations.309 Recently, nurses self-reported lack 
of consistency and uniformity in VAP guideline implementation with only half of the 
respondents maintaining elevation of the head of the bed if not contraindicated.174 An 
Italian study, assessing ICU nurses’ knowledge and application of VAP prevention guidelines, 
found 17.9% applying none and only 22.6% self-reporting their knowledge of VAP prevention 
strategies to be satisfactory.332 Although knowledge of recommendations does not 
necessarily reflect practice, we recommend implementing multifaceted educational 
programmes on VAP prevention guidelines in European ICUs, and strongly promote nurses’ 
participation in order to create awareness of (local) evidence-based recommendations. 
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Differences between scores of nurses holding and not holding a specialised degree in 
intensive care was minimal. Nonetheless, throughout Europe, substantial differences exist in 
duration, level and content of the courses leading to this degree, and in the nature and level 
of the institutions providing them. These differences were not considered when performing 
statistical analysis. In individual countries, acquisition of a specialised qualification may be 
associated with a better knowledge of the questionnaire’s guidelines, as demonstrated in a 
sample of Flemish nurses.333 For specialised ICU courses, we strongly recommend including 
the most recent evidence-based guidelines for infection prevention in general, and for VAP 
prevention in particular. 
The major strength of our study is the sample size and the amount of participating countries. 
Our results may nevertheless suffer from selection bias. It is possible that respondents had a 
particular interest in infection prevention or were more motivated than nurses who did not 
participate in the study. If so, the scores of non-respondents might even be lower than those 
reported. Moreover, from some countries we collected a rather small number of 
questionnaires (e.g. Lithuania, United Kingdom; cf. Table 10). These results may be less 
representative than those from countries where a larger number of questionnaires were 
gathered. 
 
In conclusion, further research might help to explain European ICU nurses’ low scores on a 
knowledge test on VAP prevention guidelines. In the meantime, we recommend 
implementing multifaceted educational programmes comprising information on recent VAP 
prevention guidelines in the ICU, and promoting nurses’ participation to maximise 
awareness of infection control practices. 
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2. Knowledge about evidence-based guidelines for the prevention of  
central venous catheter-related infection 
 
2.1. Development of an evaluation questionnaire 
 Based on the article: Labeau  S, Vereecke A, Vandijck D, Claes B, Blot S. Critical care nurses' 
knowledge of evidence-based guidelines for preventing infections associated with central venous 
catheters: an evaluation questionnaire. Am J Crit Care. 2008;17(1):65-71. 
 
Introduction 
Central venous catheters (CVC) are life-sustaining devices in the care of critically ill patients 
but are associated with a risk for infections that can increase morbidity and mortality and 
the cost of care.14, 57, 334-336 Infections associated with intravascular catheters account for 
10% to 20% of all nosocomial infections.337 The mean rate of CVC-related bloodstream 
infections in the intensive care unit (ICU) is 5.3 per 1000 catheter days.14 From 10% to 70% 
of all CVC-related infections are preventable.67 Therefore, evidence-based guidelines have 
been published.14, 338, 339 
The guidelines for the prevention of intravascular catheter-related infections,14 published by 
the Centers for Disease Control and Prevention, provide recommendations for catheter care 
whose preventive value is supported by scientific research. Although the recommendations 
are evidence-based, non-adherence to them has been reported.24, 69, 340 This lack of 
adherence may be due to a lack of knowledge of the guidelines. Research37, 39, 41, 69, 341, 342 has 
indicated that education of healthcare workers, preferably as part of a multifaceted quality 
improvement program, can reduce the rate of CVC-related infection. 
The study reported here is part of a project of our research group to determine ICU nurses’ 
knowledge of evidence-based guidelines for preventing infections.293, 333 Our objective was 
to develop a reliable and valid questionnaire that can be used to assess critical care nurses’ 
knowledge of evidence-based guidelines for preventing CVC-related infection. 
 
Methods 
Selection of interventions and design of the questionnaire 
The interventions to prevent CVC-related infection were selected on the basis of the current 
guidelines14 of the US Centers for Disease Control and Prevention for the prevention of 
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intravascular catheter-related infections. These guidelines are supported by the results of 
rigorously selected clinical trials or systematic reviews and were prepared by a 
multidisciplinary working group of professionals in different fields of medicine and nursing. 
On the basis of these guidelines, 10 interventions or strategies related to central venous 
catheters and with relevance for nursing practice were selected: (1) frequency of CVC 
changes, (2) frequency of changes in CVCs over a guidewire, (3) frequency of changes in 
pressure transducers and tubing, (4) use of coated CVCs, (5) frequency of changes of 
catheter dressing, (6) use of gauze and polyurethane catheter dressings, (7) use of 2% 
aqueous chlorhexidine disinfecting the insertion site, (8) use of antibiotic ointment, (9) 
frequency of changes in administration sets when lipid emulsions were administered, (10) 
frequency of changes in administration sets when neither lipid emulsions nor blood products 
were administered. 
As in previous studies,293, 333 a multiple-choice questionnaire with four response alternatives 
or options (the correct answer/response and three distractors or alternatives that are not 
the answer) was developed for each item on the list (Table 12). For each test item, the 
response alternatives included the phrase “I do not know” to avoid gambling by the 
respondents. The two remaining response alternatives consisted of strategies whose 
preventive value has not been established in evidence-based studies. 
 
Expert validation 
A panel of 7 experts examined the 10 preventive interventions and the questionnaire for 
face and content validation.315 Of the experts, 6 had at least 10 years of experience in an 
ICU; 1, who has worked as a nursing hospital hygienist for several years, had three years of 
ICU experience. All 7 had at least a master’s degree in nursing sciences (or medical-social 
sciences), and were involved, at least locally, in research on ICU-acquired infections. 
Methods for expert validation and questionnaire assessment were similar as reported in the 
paper relating on the development of the VAP questionnaire (Part Two: 1.1. Development of 
an evaluation questionnaire). 
 
Population Surveyed 
The questionnaire was distributed and collected during the annual congress of the Flemish 
Society of Critical Care Nurses (Ghent, Belgium, November 24, 2006). Of the 855 registered 
 93 
participants, 762 completed the questionnaire (response rate: 89.1%). The responses were 
collected anonymously. The questionnaire also included questions on general characteristics 
of the respondents: sex, years of ICU experience, number of ICU beds in the hospital where 
the respondent worked, and whether the respondent had a special degree in emergency and 
intensive care. Such a degree can be achieved after the basic three-year nursing education 
(bachelor’s degree) and is acknowledged as a bachelor-after-bachelor degree. 
The study was approved by the ethics committee of Ghent University Hospital, Ghent, 
Belgium. 
 
Results 
Expert Validation 
For clarity, some items needed to be slightly rephrased. The experts considered all 10 items 
of the questionnaire relevant for nursing practice. Table 12 shows the final questionnaire. 
 
Characteristics of the Sample 
The majority of the 762 respondents were women (n = 581, 76%). A total of 353 respondents 
(46%) had more than 10 years of ICU experience, and 349 (46%) worked in units with more 
than 15 beds. A majority of the respondents (n = 557, 73%) had a special degree in intensive 
care and emergency nursing (Table 13). 
 
Item Analysis 
Values ranged from 0.1 to 0.9 for item difficulty and from 0.05 to 0.41 for item 
discrimination (Table 12). Values were very good to satisfying for 9 of the 10 questions. For 
question 9 (frequency of changes in administration sets when lipid emulsions were 
administered), however, the values were too low, indicating that respondents had a good 
knowledge of this intervention. Nevertheless, question 9 was kept in the questionnaire 
because of the relevance of the question for ICU nurses. Also, in a criterion-referenced test 
such as this questionnaire, items valuable for content are not necessarily excluded because 
they are too easy.318, 343 
The quality of the response alternatives was 0.0 for 9 of the 10 questions, suggesting a 
possible need for reformulation. However, another interpretation of this finding is that 
respondents refrained from gambling because of the response alternative “I do not know”.  
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Table 12: Questionnaire 
 DIF Q ID 
1. It is recommended to replace CVCs routinely …   0.20 
A Yes, every seven days  0.2  
B Yes, every three weeks  0.2  
C b No, only when indicated 0.6    
D I do not know  0.0  
2. It is recommended to replace CVCs over a guidewire …   0.17 
A Yes, every three days  0.0  
B Yes, every seven days  0.1  
C b No, only when indicated 0.7   
D I do not know  0.2  
3. It is recommended to replace pressure transducers and tubing routinely …   0.38 
A b Yes, every four days 0.4   
B Yes, every eight days  0.3  
C No, only when indicated  0.3  
D I do not know  0.1  
4. In settings with a high rate of catheter-related infections it is recommended to use a CVC 
coated or impregnated with an antiseptic agent …  
 0.34 
A b Yes, in patients whose CVC is expected to remain in place for more than five days 0.2   
B No, because the use of such catheters is not cost-effective  0.1  
C No, because the use of such catheters does not result in a significant decrease in the rate of catheter-related infections  0.4  
D I do not know  0.4  
5. It is recommended to change the dressing on the catheter insertion site …   0.23 
A On a daily basis  0.1  
B Every three days  0.3  
C b When indicated (soiled, loosened, …) and at least weekly 0.6   
D I do not know  0.0  
6. It is recommended to cover up the catheter insertion site with …   0.28 
A Polyurethane dressing (transparent, semipermeable)  0.7  
B Gauze dressing  0.1  
C b Both are recommended because the type of dressing does not affect the risk for catheter-related infections 0.2   
D I do not know  0.0  
7. It is recommended to disinfect the catheter insertion site with …   0.41 
A b 2% aqueous chlorhexidine 0.1   
B 0.5% alcoholic chlorhexidine  0.8  
C 10% povidone-iodine  0.1  
D I do not know  0.0  
8. It is recommended to apply an antibiotic ointment at the insertion site of a CVC …   0.23 
A Yes, because it decreases the risk for catheter-related infections  0.0  
B b No, because it causes antibiotic resistance 0.3   
C No, because it does not decrease the risk for catheter-related infections  0.6  
D I do not know  0.1  
9. When lipid emulsions are administered through a CVC it is recommended to replace the 
administration set …  
 0.05 
A b Within 24 hours 0.9   
B Every 72 hours  0.1  
C Every 96 hours  0.0  
D I do not know  0.0  
10. When neither lipid emulsions, nor blood products are administered through a CVC it is 
recommended to replace the administration set …  
  0.30 
A Every 24 hours  0.1  
B Every 48 hours  0.4  
C b Every 96 hours 0.5   
D I do not know  0.0  
* correct answer 
DIF: Item difficulty; Q: Quality of the option; ID: Item discrimination 
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Table 13: General characteristics of the population surveyed (n=762) 
n = 762 
ICU experience < 1 year 1-5 years 6-10 years > 10 years 
 n = 134 (18%) n = 150 (20%) n = 125 (16%) n = 353 (46%) 
ICU beds < 8 beds 8 – 15 beds 15 beds missing 
 n = 109 (14%) n = 213 (28%) n = 349 (46%) n = 91 (12%)  
Degree  holding degree no degree missing 
 n = 557 (73%) n = 202 (26.5%) n = 3 (0.5%) 
Gender male female 
 n = 181 (24%) n = 581 (76%) 
Additionally, possible formulations were limited because the response alternatives were 
restricted to interventions with an investigated preventive value. 
The responses to the final questionnaire indicated that nurses had numerous 
misconceptions about the care of CVCs. First, that they often responded that the use of 
coated CVCs does not result in significant decrease of catheter-related infections (value 0.4); 
however the guidelines14 recommend these catheters in settings with a high rate of 
catheter-related infections for patients whose CVC is expected to remain in place for more 
than five days. Second, the respondents chose the use of polyurethane dressings at the 
catheter site (value 0.7), whereas both gauze and polyurethane dressings are 
recommended14 (value 0.2). Finally, the nurses selected 0.5% alcoholic chlorhexidine 
solution (value 0.8) over the recommended 2% aqueous chlorhexidine solution14 (value 0.1). 
All respondents thought correctly that the use of an antibiotic ointment at the catheter 
insertion site is not recommended. Remarkably, most nurses thought use of such an 
ointment is not recommended because antibiotic ointments do not decrease the risk for 
catheter-related infections (value 0.6), whereas the correct reason is that the use of these 
ointments causes antibiotic resistance (value 0.3). 
For the first three items on the questionnaire (use of coated CVCs, type of catheter dressing 
and type of disinfection solution), respondents are convinced that an intervention without 
evidence-based preventive value is preferred over the evidence-based intervention. Nurses 
seem to have a misconception about the reason antibiotic ointments are not used at the 
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catheter site. Discovering this kind of widely spread misconception is important for focusing 
education of critical care nurses. 
 
Discussion and Limitations 
This questionnaire had both face and content validity. We did not determine construct 
validity, which indicates what construct a test actually measures and can be established 
using the known-groups technique. In this procedure, groups that are expected to differ on 
the critical attribute take the test, and group scores are compared.343 In order to establish 
construct validity for our questionnaire, the test should be presented to a group of other 
than critical care nurses. The scores of the non-critical care nurses should differ from those 
of a group of critical care nurses. Nevertheless, CVCs are not used exclusively in the ICU; they 
have become frequently used devices in many units. In Flanders, CVC care is included in the 
curriculum of the three basic years of nursing education. Thus, knowledge of CVC-care 
should have become common knowledge among nurses. Establishing construct validity 
could support or contradict this assumption. 
Use of the convenience sample of nurses attending the annual congress of the Flemish 
Society of Critical Care Nurses could lead to selection bias and create a barrier to 
extrapolating our results. Nevertheless, the 762 nurses in our sample account for 21% of all 
Flemish critical care nurses. Moreover, this bias can be limited because the federal 
government in Belgium obliges all critical care nurses who have a special degree in intensive 
care and emergency to attend at least 16 hours a year of continuing education in order to 
maintain this degree.  
Finally, guidelines are revised according to the latest research and adaptation, and re-
evaluation of the questionnaire will be necessary for the prevention of CVC-related infection. 
 
Conclusion 
The questionnaire developed to assess critical care nurses’ knowledge of evidence-based 
strategies for the prevention of CVC-related infection is reliable and has face and content 
validity. The questionnaire can be used before and after an educational program on 
prevention of such infections to determine the effectiveness of the program. Results of 
surveys in which the questionnaire is used can lead to better educational programs for 
critical care nurses in infections associated with use of CVCs. 
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2.2. European ICU nurses’ knowledge of evidence-based CVC-RI prevention 
 Based on the article: Labeau SO, Vandijck DM, Rello J, Adam S, Rosa A, Wenisch C, 
Bäckman C, Agbaht K, Csomos A, Seha M, Dimopoulos G, Vandewoude K, Blot S, for the EVIDENCE-
study investigators. Centers for Disease Control and Prevention guidelines for preventing central 
venous catheter-related infection: Results of a knowledge test among 3405 European intensive care 
nurses. Crit Care Med. 2009;37(1):320-323. 
 
Introduction 
Central venous catheters (CVCs) are life-sustaining devices, but carry a substantial infection 
risk.344 Catheter-related infections represent 10-20% of all nosocomial infections.344 The 
median rate of central line-associated bloodstream infection in ICUs of all types ranges from 
1.6 to 6.8 per 1000 catheter-days.345 Evidence-based prevention guidelines are available,14 
but as far as we know, clinicians’ knowledge of these recommendations has not been 
assessed by means of a validated test.  
This study is part of the EVIDENCE-project, that aims to develop an e-learning platform on 
infection prevention for ICU nurses (URL: www.vvizv.be/Pages/Evidence.php). As part of the 
needs analysis that precedes its development, European ICU nurses’ knowledge of evidence-
based guidelines for infection prevention is assessed using validated questionnaires.293, 294, 
333  
This paper reports the results of 3405 European ICU nurses on a knowledge test concerning 
the guidelines for preventing central venous catheter-related infection (CVC-RI) from the 
Centers for Disease Control and Prevention (CDC) 
 
Methods 
We conducted a survey, using a validated and reliable multiple-choice knowledge test,294 
based on the CDC central venous catheter-related infection prevention guidelines (Table 
14).14 To establish a European network, 31 potential collaborators were identified by 
searching the electronic database Pubmed for researchers with a particular interest in ICU 
infections. They were invited to act as a national representative beginning of October 2006. 
Representatives engaged to distribute the questionnaire nationally among ICU nurses, and 
to return the filled out copies via postal mail by March 1, 2007. Of 31 potential collaborators 
contacted, 26 agreed to cooperate and were mailed the questionnaire mid October 2006.  
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Table 14: Nurses’ answers on ten multiple choice questions 
Item % of answers 
1. It is recommended to replace CVCs routinely …  
A Yes, every seven days 24.6 
B Yes, every three weeks 16.0 
C * No, only when indicated 55.8 
D I do not know 3.6 
2. It is recommended to replace CVCs over a guidewire …  
A Yes, every three days 3.8 
B Yes, every seven days 7.4 
C * No, only when indicated 74.5 
D I do not know 14.3 
3. It is recommended to replace pressure transducers and tubing routinely …  
A * Yes, every four days 53.1 
B Yes, every eight days 15.8 
C No, only when indicated 22.5 
D I do not know 8.6 
4. In settings with a high rate of catheter-related infections it is recommended to use a CVC coated or 
impregnated with an antiseptic agent …  
A * Yes, in patients whose CVC is expected to remain in place for more than five days 30.9 
B No, because the use of such catheters is not cost-effective 7.0 
C No, because the use of such catheters does not result in a significant decrease in the rate of catheter-related infections 26.1 
D I do not know 36.0 
5. It is recommended to change the dressing on the catheter insertion site …  
A On a daily basis 31.7 
B Every three days 22.9 
C * When indicated (soiled, loosened, …) and at least weekly 43.4 
D I do not know 2.0 
6. It is recommended to cover up the catheter insertion site with …  
A Polyurethane dressing (transparent, semipermeable) 62.6 
B Gauze dressing 8.2 
C * Both are recommended because the type of dressing does not affect the risk for catheter-related infections 26.2 
D I do not know 3.1 
7. It is recommended to disinfect the catheter insertion site with …  
A * 2% aqueous chlorhexidine 13.9 
B 0.5% alcoholic chlorhexidine 42.5 
C 10% povidone-iodine 33.1 
D I do not know 10.5 
8. It is recommended to apply an antibiotic ointment at the insertion site of a CVC …  
A Yes, because it decreases the risk for catheter-related infections 5.8 
B * No, because it causes antibiotic resistance 29.6 
C No, because it does not decrease the risk for catheter-related infections 47.8 
D I do not know 16.8 
9. When lipid emulsions are administered through a CVC it is recommended to replace the 
administration set …  
A * Within 24 hours 90.0 
B Every 72 hours 5.9 
C Every 96 hours 0.9 
D I do not know 3.2 
10. When neither lipid emulsions, nor blood products are administered through a CVC it is 
recommended to replace the administration set …   
A Every 24 hours 28.6 
B Every 48 hours 38.5 
C * Every 96 hours 26.5 
D I do not know 6.4 
*: correct answer according to CDC guidelines;  
CVC: central venous catheter 
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They instructed local nurses through responsible hospital staff. Monthly newsletters 
strengthened the network. 
The questionnaire comprised ten questions; each correct answer was given one point; a 
wrong answer did not affect the score negatively. A maximal score thus consisted of ten 
points, a minimal score of zero points.  
Demographics included nationality, gender, ICU experience, number of ICU beds, and 
acquisition of a post-graduate degree in intensive care, provided by a higher education 
institution or similarly professionally accredited organisation.  
Statistical analysis was performed using SPSS for Windows 13.0.0 (SPSS, Chicago, IL, US). 
Continuous variables are described as median (interquartile range). Chi-square, Mann-
Whitney U and Kruskal-Wallis tests were used as appropriate. Relationships between total 
scores and demographics were assessed by linear regression analysis. Variables with p>0.15 
were stepwise removed from the regression model. 
The study was reviewed and approved by the Ethics Committee of Ghent University Hospital. 
 
Results 
Data were obtained by 22 of 26 countries that had agreed to cooperate. Belgium provided 
762 questionnaires (22.4%), Portugal 484 (14.2%), Austria 204 (6.0%), Turkey 197 (5.8%), 
Hungary 178 (5.2%), Switzerland 178 (5.2%), Greece 175 (5.1%), Sweden 147 (4.3%), Spain 
143 (4.2%), Italy 140 (4.1%), Germany 138 (4.1%), Finland 121 (3.5%), Slovenia 120 (3.5%), 
Slovakia 112 (3.3%), The Netherlands 93 (2.7%), Latvia 82 (2.4%), Malta 43 (1.3%), Denmark 
31 (0.9%), Norway 16 (0.5%), United Kingdom 15 (0.4%), Czech Republic 15 (0.4%), and 
Lithuania provided 11 questionnaires (0.3%). Overall, 3405 questionnaires (response rate 
70.9%) were collected. Table 14 shows the questionnaire and nurses’ answers. Table 15 
demonstrates the scores according to the demographics.  
The mean score was 4.44 on 10 questions. Experienced nurses performed significantly better 
than less experienced nurses (p<0.001 for <1 year vs. >1 year;  p<0.001 for <5 years vs. >5 
years; and p=0.002 for <10 years vs. >10 years ICU experience, respectively). Nurses from 
larger ICUs scored significantly lower than nurses from smaller units (p<0.001 for <8 vs. >8 
beds and for <15 vs. >15 beds, respectively).  
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Table 15: Answers according to respondents’ characteristics 
Characteristic Mean  Median (interquartile range) p 
Total cohort (n = 3405) 4.44 4 (3 – 5) - 
Gender    0.094 
    Female (n = 2741) 4.42 4 (3 – 5)  
    Male (n = 664) 4.52 5 (4 – 6)  
Number of ICU beds   < 0.001 
    <8 beds (n = 1003) 4.73 5 (4 – 6)  
    8 – 15 beds (n=1406) 4.39  4 (3 – 5)  
    >15 beds (n =972) 4.21  4 (3 – 5)  
Years of ICU experience   < 0.001 
    <1 year (n=392) 3.96 4 (3– 5)  
    1 – 5 year (n = 997) 4.42 4 (3 – 5)  
    6 – 10 years (n = 708) 4.52  5 (4 – 5)  
    >10 years (n = 1300) 4.55  5 (4 – 5)  
Qualification in intensive care    0.205* 
    Yes (n = 1380) 4.43 4 (3 – 5)  
    No (n = 1075) 4.44  4 (3 – 5)  
* only taking in account participating countries where such a degree can be obtained (Austria, Belgium, Czech 
Republic, Denmark, Germany, Greece, Hungary, Italy, the Netherlands, Norway, Slovakia, Slovenia, Spain, 
Sweden, Switzerland and the United Kingdom). The total number of respondents from these countries is 2467.  
Numbers may not always add up to 3405 due to missing values. 
 
Linear regression analysis (R²=0.028) showed ICU experience (per class of increase: <1, 1-5, 
6-10, or >10 years of experience) to be independently associated with better test scores 
(p<0.001; B ± standard error 0.150 points ± 0.025; 95% confidence interval (CI) 0.101–0.199). 
An increase in class of the number ICU beds (<8, 8-15, or >15 beds) was associated with 
lower scores (p<0.001; B ± standard error -0.272 points ± 0.034; 95% CI -0.399 – -0.204). 
 
Discussion 
The Institute for Healthcare Improvement (IHI) has issued a Central Line Bundle 346 to raise 
clinicians’ awareness of recommendations for central venous catheter-related infection 
prevention. Use of the bundle is promoted as part of the 5 Million Lives Campaign, aiming to 
improve American healthcare’s quality by protecting patients from five million incidents of 
medical harm between December 2006 and December 2008.347 Indeed, awareness is a 
conditio sine qua non for guideline implementation. We are convinced that thorough 
understanding of the recommended strategies is a first step in overcoming potential barriers 
to compliance, and a significant contribution to the improvement of patients’ safety.  
Although our questionnaire evaluated knowledge, we assume that our results, at least to a 
certain extent, also reflect nursing practice. Generally, a varied distribution of answers 
among the different response alternatives is shown. This accords with the findings of a 
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survey on practices involving catheter care, that reported a wide diversity of practice and a 
lack of consistent adherence to the CDC guidelines.289 
As care for the catheter insertion site typically is a nursing responsibility, it could be assumed 
that questions about this topic would mainly be answered correctly. This assumption proved 
to be wrong. Lobo et al.41 reported similar results with 40% of medical residents being 
unable to answer correctly on a question concerning skin preparation for CVC insertion. The 
fact that 33% of nurses think that it is recommended to disinfect the catheter insertion site 
with 10% povidone-iodine can result in a higher incidence of catheter-related infection, for 
in a randomised trial the use of 2% aqueous chlorhexidine was associated with lower 
incidence of local catheter-related infection and catheter-related bacteraemia than 10% 
povidone-iodine or 70% alcohol.348 Nevertheless, although the CDC guidelines recommend 
using 2% chlorhexidine, they also state that tincture of iodine, an iodophor, or 70% alcohol 
can be used as well.14 This lack of an unambiguous recommendation is not only reflected by 
the variety in response alternatives chosen by our respondents, but also by various 
investigators’ continued search for the most effective disinfection solution for catheter 
care.153 
Both sterile gauze and transparent, semi-permeable dressings can be recommended to 
cover the catheter site.14 Interestingly, a majority (62.6%) thinks that polyurethane dressings 
are recommended while 8.2% indicates gauze dressings as the recommended dressing type. 
It can be assumed that these answers reflect practice and nurses’ preferences: in a survey by 
Rickard et al.289 nurses reported a predominant use (93%) of semi-permeable transparent 
dressings, with utilisation of gauze dressings reported by only 7%. Transparent dressings 
have many advantages, but gauze dressings can be preferred if blood is oozing from the 
insertion site or in settings where the more expensive polyurethane dressings are 
unavailable.  
Nurses seem convinced of an excessive need to change devices: dressings at the catheter 
site as well as administration sets are replaced too frequently. It has nevertheless been 
demonstrated that frequent changes of these devices do not decrease the risk of catheter 
infection, while they increase the assistance cost.349-354 Moreover, frequent changes may 
have a negative impact on patients’ comfort. 
 102 
A large number (36.0%) of respondents do not know what is recommended concerning the 
use of coated central venous catheters. This unawareness presumably reflects an infrequent 
use of these devices, whose role in preventing infection is still being defined.355 Moreover, 
contrarily to the CDC guidelines that recommend the use of antimicrobial catheters under 
special circumstances, the German guidelines consider this as an unresolved issue.153 Indeed, 
and as a first limitation of our study, CDC recommendations may not always accord with the 
participating countries’ national guidelines. Nurses may have answered according to 
national/local rather than international guidelines. As a consequence, besides a lack of 
knowledge or deficiencies in training, the poor test scores may reflect differences in what is 
regarded as good practice, and/or a lack of consistent policy. Developing pan-European 
guidelines would help to rationalize conflicting recommendations. 
Further, and as with all surveys, our results may suffer from selection bias. Possibly, our 
respondents were more motivated or more interested in infection prevention than non-
responders. If so, the scores of non-responders might even be lower than those reported.  
Furthermore, from some countries a rather small number of questionnaires was collected 
(e.g. Lithuania, United Kingdom). Results from these countries may be less representative 
than those from countries where a larger number of questionnaires were gathered. Also, 
although the questionnaire has been validated before use, the phrasing of question five, 
concerning the frequency of change in catheter dressings, can induce to misunderstanding 
because the CDC guidelines recommend replacing gauze dressings every 2 days and 
transparent dressing at least every 7 days. Rephrasing this questions should be considered 
before further use of the survey tool.  Last, our questionnaire linked no weights to the 
different strategies’ relative importance, nor were any costs taken into account. 
The major strength of our study is the large sample size and the amount of participating 
countries.  
 
In conclusion, there is room for improving European ICU nurses’ knowledge of CVC-RI 
prevention guidelines. We recommend including supplementary support from current 
evidence-based guidelines in their educational curricula and continuing refresher programs.  
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3. Knowledge about evidence-based guidelines for the prevention of surgical  
site infection 
 Based on the article: Labeau S, Witdouck S, Vandijck D, Claes B, Rello J, Vandewoude K, Lizy  
C, Vogelaers D, Blot S, and on behalf of the Executive Board of the Flemish Society for Critical Care 
Nurses. Nurses’ knowledge of evidence-based guidelines for the prevention of surgical site infection. 
Worldviews Evid Based Nurs. 2010;7(1):16-24. 
 
Introduction 
Worldwide, healthcare-associated infection (HAI) constitutes a major public health problem. 
Prevalence rates of 5% to 9% and 5% to 10%,  respectively, are reported in European47 and 
American1 acute hospital settings. In developing countries, the risk of infection is 2 to 20 
times higher, with a proportion of patients infected that can exceed 25%.356 Serious 
complications caused by HAI include increased morbidity and mortality and substantial 
added costs.13 Complications can afflict all patients, but those requiring intensive care 
particularly are at risk.262  The significant physical, social, and psychological outcomes for the 
patients and their relatives have increased both government and public awareness of the 
risks associated with healthcare interventions, especially that of acquisition of new 
infections.9 In the United States, a number of states have enacted legislation to mandate 
public reporting of HAI, and additional states continue to propose similar legislation.  
Surgical site infections (SSI) account for one-fourth of all HAIs.20 Approximately 500,000 SSIs 
occur annually in the United States, resulting in 3.7 million excess hospital days and $1.6 
billion in extra hospital charges.357 In general surgery, the incidence varies between 2% to 3% 
and 12% to 15%, depending on the class of operation.25  
Nurses are in an excellent position to participate, or play a leading role in initiatives that aim 
to minimize the risk of SSI, and thus to enhance patient safety. The reliable implementation 
of peri-operative evidence-based guidelines for the prevention of SSI and SSI-related deaths 
was a goal of the Institute of Healthcare Improvement’s (IHI) 100,000 Lives and subsequent 
5 Million Lives Campaign (http://www.ihi.org). The IHI website reports many success stories 
in which nurses took the lead to realize extraordinary progress in quality of care and patient 
safety. Indeed, many SSIs are preventable,67 and evidence-based guidelines are readily 
available to guide healthcare professionals in daily practice.3, 13, 20 However, clinicians’ 
adherence to SSI guidelines is known to be suboptimal.25 Education of healthcare 
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professionals, preferably as part of a multifaceted quality program, has been shown to 
promote guideline implementation and HAI reduction.149  
To promote knowledge of evidence-based recommendations for infection prevention among 
intensive care unit (ICU) nurses, we conceived a European study, called EVIDENCE, that 
aimed to develop a website-based interactive e-learning module on infection prevention and 
infection control (URL: www.evidenceproject.org). As the first step in any educational 
endeavour is needs analysis,330 we started the project by assessing our target group’s 
knowledge of evidence-based measures for infection prevention. For this purpose, we 
developed a multiple choice knowledge test concerning the evidence-based measures for 
preventing ventilator-associated pneumonia and a second one concerning the prevention of 
central venous catheter-related infection.293, 294 Subsequently, we used these questionnaires 
to assess the knowledge of over 3300 European ICU nurses . The overall results of these 
tests were rather poor296, 297, 333 and indicated that substantial opportunities exist to 
optimize European ICU nurses’ knowledge of both topics. 
The current manuscript reports on the development and validation of a similar multiple 
choice questionnaire concerning the prevention of SSI, and the results of a survey using this 
questionnaire among a sample of 650 Flemish ICU nurses. 
 
Methods 
Design 
We conducted a cross-sectional questionnaire survey using a multiple choice knowledge 
test. The survey was preceded by experts’ assessment of face and content validity and 
reliability testing of the questionnaire. The study was approved by the Ethics Committee of 
Ghent University Hospital. 
 
Instrument Development 
We developed a multiple choice questionnaire (Table 16), based on the CDC SSI prevention 
guideline,20 with 4 response alternatives per question: one correct answer, two distractors, 
and the option “I do not know” to discourage guessing. The demographics gathered included 
gender, years of experience in ICU nursing (<1 year; 1 - 5 years; 6 - 10 years or >10 years), 
number of ICU beds in the hospital of employment (<8 beds, 8 - 15 beds, >15 beds), and 
whether nurses had a specialized qualification in emergency and intensive care. 
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Table 16: Questionnaire and results of the item analysis 
 D Q DV % of answers 
1. It is recommended to protect a primarily closed incision …   0.32  
A during the first 12 hours following surgery;  0.2  15.08 
B* during the first 24-48 hours following surgery; 0.5   45.54 
C  during the first 5 days after surgery;  0.2  35.08 
D I do not know.  0.0  4.00 
2. The appropriate time to shower or bathe with an uncovered incision is …   0.34  
A ≥ 48 hours  following surgery;  0.1  7.23 
B ≥ 96 hours following surgery;  0.2  18.00 
C* unresolved by lack of evidence; 0.4   39.38 
D I do not know.  0.4  35.23 
3. Surveillance succeeds in reducing the incidence of SSI.   0.41  
A* Yes it does, and without supplementary preventive measures. 0.1   10.46 
B Yes it does, but only when accompanied by supplementary preventive measures.  0.4  40.77 
C No it does not, surveillance only helps to gain insight into the prevalence of infection, but has no influence on incidence rates.  0.4  36.77 
D I do not know.  0.1  12.0 
4. Elective surgery on patients with remote site infections should be postponed until 
the infection has resolved.   0.27 
 
A* This is true for all patients. 0.3   34.77 
B This is only true for debilitated patients.  0.3  28.38 
C This is only true for patients infected with multi-resistant microorganisms.  0.2  20.15 
D  I do not know.  0.2  16.23 
5. SSIs are classified as …   0.50  
A* superficial incisional SSI, deep incisional SSI, and organ/space SSI; 0.1   6.8 
B superficial incisional SSI, SSI in subcutaneous to fascial layers, and subfascial SSI;  0.2  19.5 
C  superficial incisional SSI, deep incisional SSI, and necrotising SSI;  0.5  54.4 
D I do not know.  0.2  19.3 
6. Stitch abscesses (minimal inflammation and discharge confined to the points of 
suture penetration) are classified as SSI.   0.34 
 
A This is true.  0.2  21.23 
B* This is false. 0.5   46.15 
C  This is only true when the patient simultaneously has fever.  0.3  26.00 
D I do not know.  0.1  6.46 
7. To be classified as SSI, a superficial incisional infection needs to occur …   0.53  
A  within 7 days;  0.7  69.92 
B within 15 days;  0.1  6.92 
C* within 30 days; 0.02   2.31 
D I do not know.  0.2  21.54 
8. If the patient’s hair at or around the incision site interferes with the operation, it is 
recommended to remove it by …   0.31 
 
A razor shave;  0.3  28.00 
B  depilatory agents;  0.2  16.15 
C* electric clippers; 0.5   49.85 
D I do not know.  0.1  5.85 
9.The recommended time of pre-operative hair removal in elective surgery is …   0.38  
A* immediately before surgery; 0.3   25.85 
B ≤ 12 hours before surgery;  0.1  42.77 
C unresolved by lack of evidence;  0.2  20.15 
D I do not know.  0.1  11.08 
SSI: surgical site infection 
*: correct answer 
D: Difficulty of the item; Q: Quality of the option; DV: Discriminative value 
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In Belgium, this qualification can be achieved after the three years of basic nursing education 
(bachelor degree) and is acknowledged as a bachelor-after-bachelor degree. 
 
Expert validation 
The questionnaire was presented to seven experts to assess face and content validity. All 
experts had at least a master’s degree in nursing or medical-social sciences, and were, at 
least locally, involved in research on ICU acquired infections with special interest in SSI. In 
order to achieve face validity, experts were asked if all questions were clearly worded and 
would not be misinterpreted. For content validity, the experts evaluated the nursing 
relevance of the 10 items by using a scale of 1 to 3, where 1 = not relevant, 2 = relevant but 
not necessary, and 3 = absolutely necessary. Additionally, they were asked if, according to 
them, important issues that were relevant for our target group were lacking. Per item, an 
Index of Content Validity (CVI) was calculated,315 that reflects the proportion of consulted 
experts agreeing on the content validity of an item. When six or more experts are consulted, 
one or more can be in disagreement with the others while content validity is still established 
beyond the 0.05 level of significance. When seven experts are used, endorsement of at least 
five is needed.   
 
Item analysis 
Revising tests on the basis of their scores, is an essential part of improving instruction.314 
Therefore, the difficulty level and the discriminative value of the items of the questionnaire 
were analysed. The quality of the response alternatives was also assessed.314, 316, 317 
a) Difficulty level 
The difficulty level of a question is defined as the proportion of respondents who answer the 
question correctly.314, 316, 317 Possible values range from 0.0 to 1.0. Items that are answered 
correctly by more than 90% of the respondents (value >0.9) are considered to be too easy; 
items answered correctly by less than 10% of the respondents (value <0.1) are considered to 
be too difficult. 
b) Item discrimination 
The discriminative value indicates how well a question distinguishes between high-scorers 
and low-scorers.314, 316, 317 For calculating the discriminative value of each item, the 
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respondents were divided into a 27% group of high-scorers and a 27% group of low-scorers. 
Then, the following formula was used: 
number of correct answers in ‘high’ group – number of correct answers in ‘low’ group 
total number in both groups 
Values ranging 0.35 and higher are (very) good values; values ranging 0.25 to 0.35 are 
satisfying to good; values 0.15 to 0.25 are mediocre to satisfying; and values less than 0.15 
are bad to mediocre.358, 359 
c) Quality of the response alternatives 
The quality of a response alternative is defined by the proportion of respondents who 
choose the alternative. Values range from 0.0 to 1.0.314, 316, 317 Response alternatives with a 
value 0.0 are not attractive, and those with a value 1.0 might be too attractive. 
 
Sample 
The questionnaire was distributed among all 809 participants of the Flemish Society for 
Critical Care Nurses’ annual congress (Ghent, Belgium, 23 November 2007). These 
participants are nurses who work in ICUs in the whole of Flanders.  
 
Procedure 
A copy of the questionnaire was pre-included in every congress bag, and bags were handed 
to the participants when entering the congress hall. After the chairman’s introductory 
speech, a board member of the Society presented the questionnaire in a plenary session. All 
participants were invited to participate in the survey, and were asked to answer to the 
questions individually. Each question was read aloud and simultaneously projected in the 
congress hall with a 30-second time interval to write down answers between two questions. 
Then, all copies were collected immediately and anonymously. 
 
Statistical analyses 
Continuous variables are described as median (interquartile range). Chi-square test, Mann-
Whitney U test and Kruskal-Wallis test were used as appropriate. Relationships between 
total scores and demographic data were assessed using linear regression analysis. Statistical 
analysis was performed using SPSS for Windows 13.0.0 (SPSS, Chicago, IL, US). Two-tailed 
p<0.05 was considered statistically significant.  
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Results 
Expert validation 
The remarks of the expert panel were collected and discussed. The first version of the 
questionnaire contained ten questions. One question concerned the issue of pre-operative 
bowel preparation, which was identified by the experts as overruled by more recent 
evidence. This question was deleted from the questionnaire and minor revisions of the 
wording of some other questions were performed. The experts considered all nine 
remaining items of the questionnaire relevant for nursing practice. Calculation of the CVI 
reflected their unanimous agreement with the questionnaire’s content and clarity. The final 
questionnaire is shown in Table 16. 
 
Item analysis 
The results of the item analysis are integrated in Table 16.  
Overall values for item difficulty ranged from good to very good. Only for question seven 
(time frame in which a superficial incisional infection needs to occur to be classified as SSI), a 
very low value (0.02) was noted, indicating that only 2% of the nurses answered correctly. 
Values indicating the quality of the response alternatives ranged from 0.1 to 0.7, thus 
demonstrating a good overall quality. Moreover, the standard response alternative “I do not 
know” was selected by at least 10% of the sample in all questions but the first, suggesting 
that this phrase succeeded in discouraging the nurses from guessing. With values ranging 
between 0.27 and 0.53, all questions show to discriminate adequately between low scorers 
and high scorers in a good to very good way. 
 
Survey 
Of the 809 registered participants, 650 completed questionnaires were available for analysis 
(response rate: 80.3%). The mean test score was 2.61 on 9 questions (29%). Forty-five% of 
nurses knew that primarily closed incisions must be protected for 24 to 48 hours, and 39% 
that the appropriate time to shower or bathe with uncovered incisions is unresolved. Only 
10% knew that postoperative surveillance by itself succeeds in reducing the incidence of SSI, 
and 35% that elective operations on patients with remote site infections should be 
postponed until the infection has resolved. The correct classification of SSI was known by 7% 
only, while 46% knew that stitch abscesses are not to be reported as SSI. Only 2% recognized 
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the exact time frame in which emerging superficial incisional infections are classified as SSI. 
Twenty-six% knew that preoperative hair removal should take place immediately before 
surgery, and 50% knew that electric clippers are recommended.  
 
Table 16 shows the distribution of the nurses’ answers among the response alternatives. In 
Table 17, the demographics of the sample are shown, along with the test scores according to 
these characteristics. 
 
Table 17: Scores on nine questions according to respondents’ characteristics 
Characteristic n Mean (%) Median (interquartile range) p 
Total cohort 650 2.61 (29.00) 3 [2 – 4] - 
Gender    0.001 
 Female 169 2.50 (27.77) 2 [2 – 3]  
 Male 478 2.92 (32.44) 3 [2 – 4]  
 Missing 3    
Number of ICU beds    0.066 
 <8 beds 92 2.39 (26.55) 2 [1 – 3]  
 8 – 15 beds 171 2.76 (30.66) 3 [2 – 4]  
 >15 beds 328 2.61 (29.00) 2 [2 – 4]  
 Missing 59    
Years of ICU experience    0.202 
 <1 year 52 2.56 (28.4) 2,5 [1 – 4]  
 1 – 5 year 158 2.77 (30.77) 3 [2 – 4]  
 6 – 10 years 119 2.44 (27.11) 2 [1,5 – 3]  
 >10 years 314 2.63 (29.22) 2 [2 – 4]  
 Missing 7    
Specialised qualification    0.892 
 Yes 501 2.61 (29.00) 3 [2 – 4]  
 No 133 2.61 (29.00) 2.5 [2 – 3]  
 Missing 16    
ICU: intensive care unit 
 
Univariate analysis showed that male nurses performed significantly better than their female 
colleagues (p<0.001). Linear regression analysis (adjusted R² = 0.02) identified male, as 
compared to female gender, to be independently associated with better test scores 
(p<0.001; B ± standard error 0.51 points ± 0.12; 95% confidence interval 0.27 – 0.75). No 
significant differences in scores were found between other subgroups.  
 
Discussion and Limitations 
We evaluated knowledge of the evidence-based CDC recommendations20 for preventing SSI 
among 650 ICU nurses using a custom designed knowledge test. The questionnaire 
demonstrates face and content validity, and was shown to be reliable. The overall scores 
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were poor, thereby representing a significant obstacle to comply with guidelines. Also, as the 
answers of nurses who are unfamiliar with the guideline most probably reflect their daily 
practice, a substantial opportunity for improving SSI prevention seems to exist. 
Our sample consisted of intensive care nurses because they were the target group for 
whom, within the EVIDENCE-project, our e-learning module on infection prevention will be 
developed and whose educational needs we are analysing. Nurses who care for surgical ICU 
patients may be better aware of the evidence-based prevention recommendations than 
nurses who work in medical units, but as we did not ask our respondents in which type of 
ICU they worked, our findings cannot clarify this issue. Nevertheless, surgical patients are 
not exclusively found in the surgical ICU, and SSI prevention is assumed to be common 
knowledge among all nurses. In Flanders, surgical nursing care is included in the second of 
the three years basic nursing education (professional bachelor degree). As such, pre-
operative and postoperative SSI prevention strategies are considered common knowledge 
among nurses. Also, the questions of our survey were restricted to issues concerning pre-
operative and postoperative nursing care, while measures that concern patient care in the 
operating theatre were not taken into account. The reason for this selection was that the 
nursing tasks and responsibilities in the operating theatre are far too specific to be 
commonly known among nurses who do not work in this specific setting.  
The distribution of the answers among the response alternatives demonstrated that 
misconceptions concerning the correct measures to prevent SSI abound. First, only 10% of 
the nurses were aware of the fact that surveillance succeeds in reducing the incidence of SSI 
without supplementary preventive measures, while both answering options that were not 
the correct answer scored approximately 40% of responses. Also, more than half of the 
sample (54%) wrongly classified SSIs in superficial incisional SSI, deep incisional SSI, and 
necrotising SSI, while the correct classification was only checked by 7%. Moreover, it was 
commonly (by 70%) but falsely thought that superficial incisional infections need to occur 
within 7 days following surgery to be classified as SSI, while 30 postoperative days is  the 
correct time frame (2% only). Mapping out these kinds of misconceptions is important for 
understanding and meeting nurses’ specific educational needs.  
At the time of our investigation, the 1999 CDC guideline20 was the most recent directive for 
evidence-based SSI prevention measures. Recently, the Infectious Diseases Society of 
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America (IDSA) and the Society for Hospital Epidemiology of America (SHEA) jointly issued a 
compendium of strategies to prevent healthcare-associated infections,3 including a practice 
recommendation for SSI prevention,89 on the basis of a review of previously published 
guidelines and studies published after the existing guidelines. The British National Institute 
for Health and Clinical Excellence (NICE), however, also recently released a SSI prevention 
guideline,13 that differs from the CDC20 and IDSA/SHEA89 recommendations concerning the 
time frames for pre-operative hair removal and postoperative showering or bathing, 
respectively. Whereas the CDC recommend hair removal immediately before surgery,20 NICE 
broaden this time frame to the day of surgery.13 Also, whereas the CDC consider the time to 
shower or bath postoperatively an unresolved issue,20 NICE state that patients can shower 
safely 48 hours after surgery.13 By developing one encompassing, uniform guideline, 
controversies and contradictions between published recommendations could be addressed.  
Contrasting recommendations for identical interventions may induce confusion and 
uncertainty among healthcare professionals, thus hampering guideline adherence. However, 
it remains questionable whether a universal guideline would enhance implementation. 
Recently it was suggested to simultaneously implement several practice improvements in 
order to obtain a potential synergy between combinations of interventions.1 In this context, 
use of the World Health Organisation’s (WHO) Surgical Safety Checklist, which was 
developed within the framework of the WHO Safe Surgery Saves Lives Campaign  
(http://www.who.int/patientsafety/safesurgery/en/), has been shown to significantly reduce 
patient complications (from 11% to 7%) and prevent deaths (1.5% to 0.8%) in a study that 
was conducted in eight locations worldwide.360 Combined use of this checklist in the 
operating theatre and educational initiatives concerning preoperative and postoperative SSI 
prevention strategies for bedside nurses could offer an opportunity for nurses to contribute 
to a substantial reduction of infection and an enhancement of patient safety.  
To the best of our knowledge, our study was the first to evaluate nurses’ knowledge of SSI 
evidence-based prevention guidelines by means of a validated knowledge test. When 
interpreting our study results, a number of limitations should nevertheless be taken into 
account. Our sample consisted of nurses attending the annual congress of the Flemish 
Society of Critical Care Nurses. This convenience sampling may have led to including more 
motivated nurses, and thus better results. Therefore, our results cannot be extrapolated. 
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This selection bias may be limited by the fact that Belgian federal legislation obliges all ICU 
nurses who hold a specialized qualification in intensive care to attend at least 16 hours a 
year of continuing education to maintain this qualification. Moreover, our sample size is 
quite substantial and accounts for as many as 20% of all Flemish ICU nurses.  
Finally, guidelines can change over time. Adaptation and re-evaluation of the questionnaire 
will be needed every time new evidence for the prevention of SSI will be published. 
 
Conclusion 
A reliable questionnaire that has face and content validity was developed to assess intensive 
care nurses’ knowledge of evidence-based strategies for the prevention of SSI. Results of 
surveys using this questionnaire can be used to focus educational SSI prevention programs. 
The survey we conducted demonstrated that there is substantial room for improving Flemish 
ICU nurses’ knowledge of SSI prevention. Current guidelines should support their schooling 
and continuing education. 
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Conclusion of part two 
 
The needs analysis reported in part two of this thesis based performed by means of self-
developed multiple choice questionnaires.  
For all questionnaires, a first requirement for items to be included was that they had to 
consist of interventions of which the effectiveness had been investigated, and of which the 
results had been published at the time of questionnaire development. As our focus was on 
the promotion of evidence-based prevention practices, the correct answers on the questions 
in the knowledge tests were directly based on the then most recent evidence-based 
guidelines. This nevertheless caused us to restrict ourselves in the possibility of creating 
questions. Besides the focus on promoting evidence-based infection prevention practices, 
our choice had the underlying rationale that an undeniable proof should be available to 
demonstrate that all questions only had one single correct answer.  
 
An important limitation of our questionnaires, which is inherent to knowledge tests as such, 
and in particular to our questionnaires due to our choice to develop only questions that 
were strictly based upon evidence-based guidelines, is that their value diminishes 
substantially as soon as new knowledge, c.q. evidence, becomes available. In order to keep 
them up to date, they are constantly to be adapted to the latest evidence, followed by new 
validation processes. 
 
Additionally, the questionnaires could be submitted to additional validation procedures.  
Construct validity has not been assessed for any of the questionnaires. Construct validity 
indicates what construct a test actually measures and can be established using the known-
groups technique. In this procedure, groups that are expected to differ on the critical 
attribute take the test, and group scores are compared. In order to establish construct 
validity for our questionnaires, they had to be submitted to a group of other than critical 
care nurses. The scores of the non-critical care nurses should then have differed from those 
of a group of critical care nurses. Prevention of central venous catheter-related infection and 
surgical site infection, however, are topics that are to be considered as required common 
knowledge among all nurses, regardless their professional specialty, for central venous 
catheter-related infections and surgical site infections are not exclusively and specifically 
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ICU-related infections. Moreover, in Flanders, both nursing care for central venous catheters 
and wounds are included in the curriculum of the three basic years of nursing education. As 
for the questionnaire on the prevention of ventilator-associated pneumonia, the known-
groups technique could have been applied to assess construct validity as the care for 
ventilated patients is predominantly an ICU-specific issue. This additional procedure could 
have added to the validity of the questionnaire. 
 
As for the reliability testing of all three questionnaires, the method of item analysis was 
applied, which, to the best of our information, is the most suitable technique to assess the 
reliability of knowledge tests. 
In a pilot testing of the questionnaire related to the prevention of ventilator-associated 
pneumonia, which was the first questionnaire we developed, we attempted to assess the 
stability of the questionnaire by means of a test-retest procedure. We nevertheless soon 
realized that, by that procedure, we did not test the stability of the questionnaire but rather 
the stability of our respondents’ knowledge. Knowledge is not a stable attribute, and can 
change markedly from day to day. As an example, nurses who had completed the 
questionnaire at the test-phase may have been triggered to look up information and thereby 
have gained considerable knowledge by the time the questionnaire was re-presented to 
them for retesting. The test-retest procedure is not an appropriate technique if knowledge 
tests are involved. 
 
When we started to develop the questionnaires, we considered evaluating their internal 
consistency. Thereto, different methods are available, such as the determination of 
Cronbach’s alpha, Kuder-Richardson 20 and split-half techniques.  
As our questionnaires are no scales with different subscales or multiple traits, but straight-
forward knowledge tests with a single set of closed questions, it is not appropriate to submit 
them to an analysis for Cronbach’s alpha determination.   
We did submit the CVC-RI questionnaire to a homogeneity test using Kuder-Richardson 20 
(KR20), a special form of coefficient alpha that applies when the items are scored 
dichotomously as right or wrong. The KR20 value obtained revealed to be poor, thus 
suggesting limited homogeneity of the questionnaire. Nevertheless, several arguments are 
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available to discuss the impact of the low KR20 value obtained on the value of the 
questionnaire. First, we do believe that the low internal consistency is predominantly caused 
by the low variance in the respondent’s test results. The mean test result of the respondents 
(n=762) was 4.52/10 (interquartile range 4-5) with a variance of 2.06. Therefore, the lack of 
variance in the (poor) test results could be considered the major factor responsible for the 
low internal consistency, rather than the lack of homogeneity of the items in the 
questionnaire. Second, KR20’s value is strongly related to the amount of questions in the 
questionnaire: as the amount of questions in the questionnaire is quite limited (ten items), 
the chance of obtaining a low KR20 is substantial. Third and last, the questionnaire aims to 
evaluate ICU nurses’ knowledge on evidence-based guidelines for the prevention of CVC-RI. 
This renders the questionnaire quite fixed and the choice of items to be included restricted. 
Other factors that might influence KR20 values, such as the number and the choice of the 
response alternatives and the appropriateness of the population surveyed, were taken into 
consideration. However, knowing that a KR20 is not stable over time, is influenced by the 
population surveyed and by the respondents’ level of knowledge, and taking into account 
the fact that the questionnaire does not contain any subdivisions, we considered it justified 
to use the questionnaire as such. Additionally, we were strengthened by the fact that the 
items included had previously been acknowledged by a panel of content experts to cover the 
knowledge domain for this topic. 
We did not test the internal consistency of the test by means of the split-half technique, in 
which a test is split in two halves, and in which the correlation between these two split 
halves is used to estimate the reliability of the test. This approach must be used when tests 
that measure more than one trait are being developed because items measuring each trait 
must be present in each half-test.316 Our arguments for not submitting the questionnaires to 
this procedure are identical to those mentioned above.  
 
In all our questionnaires items and distractors were treated equally: all correct answers 
scored one point and all distractors scored no points. Nevertheless, some items relate to 
issues for which the impact on the infection risk may be larger than others (e.g. the use of 
endotracheal tubes with extra lumen for the suction of subglottic secretions versus the 
choice between open or closed suction systems in the VAP prevention questionnaire), or to 
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issues in which the nurses’ responsibility is larger than others (oral versus nasal intubation 
versus head of bed elevation in the VAP prevention questionnaire). Although it has been 
acknowledged that when comparing unweighted and weighted item scoring, the sets of 
scores are highly correlated, and that the differences between unweighted and weighted 
scores are small and usually observed in the upper and lower tails of the distribution of test 
scores,314 the accuracy of test scores might have been improved by item weight attributions.  
 
The results of our needs analysis clearly demonstrated low overall knowledge levels of 
evidence-based guidelines for the prevention of VAP, CVC-RI and SSI among European ICU 
nurses. Among 3405 European ICU nurses, the mean score on the 10-item test regarding the 
prevention of CVC-RI was 44%.  The mean score obtained by 3329 European nurses on the 9-
item VAP prevention questionnaire was 45%. The mean score on the questionnaire 
regarding the prevention of SSI among a sample of 650 Flemish ICU nurses was 29% only. 
These results led us to the conclusion that there was extensive room for an initiative aiming 
to enhance ICU nurses’ level of knowledge regarding the topic of healthcare-associated 
infection. 
 
Reflection about which resources could effectively and efficiently help to enhance ICU 
nurses’ knowledge of infection prevention led to an extensive literature search on which 
resources would be helpful to address the educational needs of healthcare workers. This 
resulted in the finding that e-learning has recently been acknowledged to be an important 
educational tool, that allows distant learners to study wherever and whenever they prefer, 
and at their own pace. 
 
Using open source software, a concise and interactive Web-based e-learning course that 
bundles the essentials on infection prevention in a comprehensible way was developed: the 
EVIDENCE Crash Course. Subsequently it was tested whether this course actually succeeds in 
increasing and sustaining knowledge among healthcare workers, as reported in Part three of 
this thesis.  
  
PART THREE 
 
 
E-LEARNING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
"O this learning, what a thing it is!" 
William Shakespeare (1564 - 1616)  
The Taming of the Shrew, c. 1590-94 
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Introduction 
Access to the right knowledge at the right time is a key factor for an effective and efficient 
healthcare system. Education of all members of the multidisciplinary team is therefore 
considered a first and crucial requirement when targeting implementation of interventions 
for infection prevention.74 A shift of emphasis in education has been witnessed in the mid-
nineties of the previous century from providing instruction to producing learning.361 Critical 
thinking, independent and evidence-based learning, and feedback are since being regarded 
as indispensable features of this new learning paradigm.362  
Quite simultaneously, a rise in the use of information technologies in (medical) education 
took a start. E-learning, a method which integrates information technology and the learning 
process by using material delivered through the internet,363 was soon acknowledged to be a 
valuable educational tool.364  
In order to help meeting the educational needs detected, the final step in the EVIDENCE-
project consisted of the development and assessment of an e-course on the prevention of 
nosocomial infection in critically ill patients. Therefore, part three of this thesis is dedicated 
to the topic of e-learning.  
The first chapter aims to introduce the reader to the concept of e-learning. As terminology 
used to describe Web-based learning, distance learning and e-learning is not standard, the 
chapter starts by outlining definitions. Next, a short historical overview is provided, aiming 
to elucidate the evolution of this recent educational resource over time into the concept it 
has become today. The first chapter is ended by listing the potential advantages and 
disadvantages associated with e-learning. 
Chapter two offers a non-extensive overview of the literature concerning the value of e-
learning in healthcare. After a general outline of the value of e-learning for healthcare 
professionals, the focus is on specific e-learning initiatives in the field of critical care, and 
infection prevention and control, respectively. 
The third and last chapter of part three is dedicated to our own experiences with e-learning, 
as it relates on the development of the EVIDENCE Crash Course, and on the acquisition and 
retention of knowledge in healthcare workers who volunteered to studied the course. 
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1. The concept of e-learning 
 
1.1. Definition 
In its broadest sense, e-learning is the use of the Internet for education. When conducting a 
literature search, the terminology in respect of web-based or e-learning education is, 
however, not standard. Different terminologies have been used for online learning, which 
makes it difficult to develop a generic definition.365 Besides e-learning, key words include 
Internet education, distance education, IT-learning, web-based education, web-based 
instruction and advanced distributed learning.366  
In so-called synchronous learning, the educational content of Internet-based learning is 
provided at the same time as it is delivered from an instructor; in asynchronous learning, on 
the contrary, it is disconnected from the actual time of instruction and provided by tools 
such as recorded and saved audio, video, or text presentations.367, 368 The separation of 
teacher and student in time and space clearly classifies web-learning as distance learning.369 
Reime and colleagues describe e-learning as a method which integrates information 
technology and the learning process by using material delivered through the internet to 
create, foster, deliver and facilitate learning, anytime and anywhere.363 In this thesis, the 
definition by Reime et al. has been used. 
 
1.2. A brief history of e-learning 
The seeds for distance learning have been sown as far back as the 1700s with the 
development of the first correspondence course. In England, in 1840, shorthand classes 
were being offered by correspondence courses through the mail, a method of distance 
learning that gained popularity in the early part of the last century.369  
In the centuries to follow, new technologies made distance learning easier. Radio, television, 
video recorders, all made significant contributions. As an example, in 1953 the University of 
Houston offered the first televised college credit classes. Most courses aired at night so that 
students who worked during the day could watch them.  
The genesis of e-learning as we know it today can be traced to the development of network 
communication in the late 1960’s.370  The invention of the World Wide Web, an internet-
based hypermedia initiative for global information sharing, by Tim Berners-Lee in 1989 has 
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significantly impacted on distance learning.371 These technological innovations introduced an 
unprecedented opportunity whereby people could communicate and collaborate despite 
differences in time and place. The first web-based course was developed in the United States 
of America in 1995.  
Often, the early web-based courses were criticized for poor standards and lack of quality 
control methods as they relied almost exclusively on the learner's ability to read information 
and to use that information to answer questions.369, 372 They have been gradually evolving 
over time and gaining in quality, following the evolution of the Internet through two phases, 
Web 1.0 and Web 2.0.  
Web 1.0 is often described as the ‘‘read-only Web’’, as it provides a relatively passive 
experience for the user. Web 1.0 technology allows users to search and read texts, to watch 
and listen to multi-media files, and to interact with preprogrammed games and simulators. It 
can be considered to have begun in the year 1991 with the introduction of the Worldwide 
web and is stated to have ended in the year 2003, just before the era when Web 2.0 began. 
Web 2.0 defines the more interactive and dynamic phase of the www. and is commonly 
referred to as the ‘‘read-write Web’’ for its concept of offering users a participatory 
platform. Hereby, users are able to generate Web site content, and to communicate 
interactively through wikis, blogs, podcasts, video-sharing, and social networking sites. 
Both Web 1.0 and 2.0 thus incorporate various technologies that are commonly used in e-
learning environments today.368 
 
1.3. Advantages and disadvantages of e-learning 
1.3.1. Advantages 
More than anything else, flexibility appears to make e-learning attractive to learners.373 
Flexibility related to e-learning is multifaceted. First, different learning styles can be 
addressed and learning can be facilitated through mixed activities. Learners may also have 
the option to select study materials that meet their level of knowledge and interest. 
Moreover, self-paced learning modules allow learners to work at their own pace. They do 
not have to work faster to keep up with more advanced students or hold their pace to wait 
for struggling learners. They can review the material as many times as desired to enhance 
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their own understanding.138 Thus, e-learning encourages students to take responsibility for 
their learning process. 
Next, learners are not required to travel to attend classes. They can learn from the comfort 
of their own home or from any place where technical accommodations allow them to. The 
just-in-time nature of e-learning allows to study wherever access to a computer and the 
Internet is available. E-learning thus reduces travel-related costs and time.138   
Healthcare professionals are expected to be computer and information literate at 
registration. As an additional asset, e-learning promotes the learners’ development of 
computer and Internet skills, and of skills in time management.363, 372, 374, 375 
Finally, e-learning contributes to methodological diversity and to changing the focus away 
from teaching to learning.376 
From the point of view of the organisation, e-learning overcomes issues such as class room 
or instructor availability, staffs’ combination of vacation schedules, current classes, or 
differing employee shifts. This can yield training that is accomplished more rapidly, while 
ensuring content consistency and standardization.138 Also, organisations have the 
opportunity to provide educational materials tailored to the employees’ specific needs. 
Another benefit pertaining to the organisation is that, if desired, learners’ activity is 
trackable. E-learning permits to log participants’ actual course attendance, study time, test 
scores and study progress. This can be an important asset for healthcare settings where 
clinicians’ activities for continuing education are (partially) funded, and therefore controlled,  
by the organisation. 
A recent study assessed the economic sustainability of e-learning within a large scale via 
personnel work hour saving, and yielded positive results.377 Costs associated with the 
development of e-modules will predominantly depend on the software used and the 
investment in personnel cost. In environments or economic climates with restricted 
resources for educational purposes, the use of open source software could prove to be 
highly advantageous.  
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1.3.2. Disadvantages 
When using e-learning, unmotivated students or those with poor study habits may fall 
behind or experience difficulties in getting used to the lack of familiar structure and routine 
of conventional classes.378 Also, learners may feel isolated or miss social interaction. 
Isolation of distance learners has been identified as a common reason for the high drop-out 
rate from online courses.376 Also, if studying from home, potential distractors are numerous. 
Particular student characteristics and factors that predict whether a student might drop out 
of or fail to achieve satisfactory results in e-learning courses include a lack of the course’s 
clarity of design, of interaction with instructors, and of active discussion in the context of the 
course; a lack of self-motivation and the inability to structure one’s own learning;379 an 
absence of previous experience with distance learning, and enrolled hours, with students 
taking more hours being significantly more likely to complete a course.380 
Technical barriers such as low performance computers or slow or unreliable Internet 
connections can be frustrating. Learners may experience a lack of technical support, can be 
hindered by (organisational) firewalls, or restricted available bandwidth.376 
Finally, implementing e-learning in an organisation can be associated with high upfront 
costs, related to both personnel investment and technological requirements. 
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2. E-learning and healthcare 
In past two decades, education for healthcare workers has witnessed a shift from one devoid 
of significant computer-based resources to that where such tools are regularly incorporated. 
Many nursing and medical students have reported e-learning to have been helpful toward 
their educational advancement.367, 368, 381 The need for continual learning to enable 
professionals to maintain and develop their knowledge and skills to function effectively has 
greatly contributed to the ever-growing importance of e-learning for healthcare 
professionals.368, 369 
 
2.1. The value of e-learning for healthcare professionals 
With the rising use of Internet-based learning, various studies have attempted to evaluate its 
benefit for healthcare workers compared to no control or as part of a blended-learning 
model. A recent meta-analysis by Cook and colleagues382 assessed the effect of Internet-
based instruction for healthcare professionals compared to either no intervention or to non-
Internet interventions. In total, 2193 studies were identified and 201 studies were included. 
Learners were students, postgraduate trainees, or health professionals in human or 
veterinary medicine, and the outcomes included learner satisfaction with the course, 
knowledge, clinical skills, and behaviors or effects on patients. In spite of the considerable 
heterogeneity in studies, this meta-analysis concluded that the strategies assessed in e-
learning appeared to be more effective than no intervention –which is hardly surprising– but 
are likely similar in efficacy to traditional educational methods.382 The authors 
recommended that further research should focus on the direct comparison of different 
Web-based interventions. 
Another meta-analysis by Cook and colleagues383 including 51 studies evaluating the effect 
of instructional design on learning outcomes among practicing and student physicians, 
nurses, pharmacists, dentists, and other health professionals. Internet-based interventions 
were compared with other Internet- or computer-based interventions and classified 
according to 22 different e-related instruction themes, including patient cases, games or 
simulation, interactivity, feedback, discussion, and audio. Although their findings were 
limited by methodological heterogeneity and small sample sizes, Internet-based resources 
incorporating features of interactivity, practice exercises, repetition, and feedback were 
associated with improvement in learning outcomes.  
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Cook and colleagues384 sought also to answer how e-learning compares with non-computer 
instructional methods in time spent learning, and what features are associated with 
improved learning efficiency for health professionals. Their systematic review and meta-
analysis included all studies published between 1990 and November 2008 investigating the 
use of the Internet to teach health professions learners in training or practice compared with 
another educational intervention. Health professionals included were students, 
postgraduate trainees, physicians, nurses, pharmacists, dentists, veterinarians, and physical 
therapists. Twenty eligible studies were identified. Random effects meta-analysis of eight 
studies comparing Internet-based with non-Internet-based instruction yielded a pooled 
effect size (ES) for time -0.10 (p=0.63) with positive numbers indicating a longer study time 
when use e-learning. Among comparisons of two e-learning interventions, providing 
feedback adds time (ES 0.67, p=0.003, two studies). Also, greater interactivity generally is 
associated with longer study time (ES 0.25, p=0.089, five studies). One study found that 
adapting to learner prior knowledge saves time without significantly affecting knowledge 
scores. Audio narration, video clips, interactive models, and animations were found to 
increase learning time but simultaneously facilitate higher knowledge and/or learners’ 
satisfaction. Across all studies included, time correlated positively with knowledge outcomes 
(r=0.53, p=0.021). The authors concluded that, overall, e-learning and traditional educational 
interventions require similar study time.384  
 
2.2. E-learning for critical care providers 
Wolbrink and colleagues368 conducted a MEDLINE/Pubmed systematic review from January 
2000 to July 2011, aiming to investigate the suitability of e-learning for critical care 
providers. Working in a critical care environment requires an important amount of 
knowledge and a significant set of technical skills that need to be mastered. Besides, other 
key skills such as clinical decision making and teamwork need to be developed. Therefore, 
the authors are convinced that the benefit of simulating low volume, high-risk events and 
the appropriateness for the adult learner makes e-learning uniquely suited to healthcare 
professionals caring for the critically ill patient. 
Six publications were identified assessing the use of e-learning specifically for critical care 
providers. These included the assessment of an online burn care module to medical students 
and interns in surgery and emergency medicine,385 an online course to teach medical 
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students how to properly fill out a death certificate,386 a Web-based intervention on 
recommended clinical guidelines for patients with acute respiratory distress syndrome,387 an 
e-course on sterile technique for central venous catheter placement,388 a difficult airway 
management course in anesthesia and internal medicine trainees,52 and an avatar-based 
training to teach principles of crisis resource management to medical students and first-year 
residents in emergency medicine.389 
The authors concluded that Web-based learning appears to be advantageous for the adult 
medical learner, especially in the field of critical care, if features such as interactivity, 
feedback and exercises are included. It was suggested that e-learning may become a vehicle 
for levelling of access to knowledge and information on the care of critically ill patients 
worldwide. Further work is esteemed necessary to develop a robust learning platform 
incorporating a variety of learning modalities for critical care providers.368  
A concise review by Kleinpell and colleagues390 aimed to identify, catalog, and critically 
evaluate Web-based resources for critical care education. As a result, an impressive list of 
over 135 tools specifically developed for ICU clinicians was generated, identifying a number 
of noteworthy educational websites and e-learning materials. All were meticulously 
reviewed to fulfill a set of stern requirements of quality and credibility. The authors 
concluded that e-learning today is being actively integrated into critical care medical and 
nursing training programs and for competency training purposes. Web-based resources are 
esteemed to help to serve as knowledge tools for educators, students, and clinicians. 
Although not objectively measured to date, it is suggested that awareness of available Web-
based educational resources may enhance critical care practitioners’ on-going learning and 
clinical competence.390 
 
2.3. E-learning in the field of infection prevention and control 
The impressive above-mentioned list of Web-based resources for critical care providers390 
was found to include only four tools related to the field of infectious diseases. Although of 
high quality, these sites mostly effectuate a passive transfer of knowledge, not possessing all 
components of a learning paradigm (critical thinking, independent learning, evidence-based 
learning, feedback). Moreover, they do not focus on infection prevention, but cover 
specialised topics mainly for advanced learners. Of all resources listed, only the Society for 
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Critical Care Medicine Infection Knowledge Line391 appears to include a broad range of 
items, and addresses both beginners and advanced learners. 
Besides for critical care providers, a number of local initiatives to integrate e-learning in the 
education of healthcare professionals concerning the prevention of infection has been 
reported on.  
In Bergen, Norway, a college of nursing aimed to combine the development of a new 
curriculum with the enhancement of students’ competences in cross-infection control. In 
collaboration with the Centre of Nosocomial Infection Control at the local hospital, they 
evaluated different approaches to acquiring and applying knowledge. In this context, Reime 
and colleagues363 account on a newly developed e-learning program on infection control, 
normally used among employees in the hospital, which was evaluated in the setting of 
bachelor nurse students. The students were allocated to one group that used the e-learning 
program, or to another group that was given three hours-long traditional lectures. Both 
groups took a multiple choice test following their respective courses. Additionally, the 
students were divided into three focus groups to assess their experiences. The students 
were found to be satisfied with both teaching approaches. They rated the e-learning 
program as good on design and academic content, and found the integrated tests 
motivating. As for the results of the multiple choice test, the lecture group however had a 
higher sum score compared to the e-learning group (p=0.01). The authors concluded that e-
learning and traditional lecturers both have to be regarded as equivalent educational 
resources. They underline the importance of students acquiring good computer skills as they 
will need to use these in clinical practice.363  
Recently, Pellowe and colleagues392 reported on the use of an e-learning project in the pre-
registration nursing programme in the United Kingdom. The project was initiated by the 
National Health System (NHS) University and intended to be the definitive infection 
prevention programme for all NHS staff, both clinical and non-clinical. However, as  lecturers 
at a higher education institution had been involved in the development of the programme, 
they saw its potential for use and trialled it among nurse students. The programme consisted 
of three parts. Parts 1 and 2 introduced the students to the topics of the problem of 
healthcare-associated infections; risk to patients; and how to protect patients and one’s self. 
Part 3 provided more detailed information about the EPIC project, that resulted in the 
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development of national evidence-based guidelines for the prevention of healthcare 
associated Infections in the UK,9 and included sections on hand hygiene; personal protective 
equipment; waste and sharps; and environmental cleanliness. The e-learning programme 
was embedded into a blended learning framework within the pre-registration nursing 
curriculum. To evaluate the e-learning programme, a short questionnaire was constructed 
using Likert-scale343, 396 questions, and students were encouraged to complete the 
questionnaire online on completion of their learning experience. 
Of the 495 students who had completed the programme, 57% filled out the questionnaire. 
Of these, 88% found it straightforward to register and access the programme; 91% were 
capable of easily selecting those sections they needed, and 62% reported no difficulty in 
working their way through the programme. Also, 84% of respondents were aware of their 
ability to revisit the programme at any time. As for the value of the programme, 88% of 
respondents reported having completed all mandatory sections of the e-learning course; 
94% either strongly agreed or agreed having enjoyed this alternative form of learning. The 
relevance of the programme for their current education was acknowledged by 94%. 
Confidence in understanding the infection prevention topics studied was enhanced in 97% of 
students and 96% reported applying the knowledge gained to clinical practice. 
The authors concluded that this e-learning infection prevention programme, although not 
originally intended for pre-registration nursing students, proved to be a useful additional 
resource in skills acquisition, especially when integrated into a blended learning framework. 
They esteem that this form of learning may become even more significant in nurse pre-
registration programmes in the future.392 
Another initiative to provide e-learning about infection control also emerged in the United 
Kingdom, where Desai and colleagues developed an Infection Control Training and Policies 
multimedia software package consisting of an introductory infection control training course 
and a hypertext version of a published book on infection control practices.393 Various 
modules were integrated, including information on hospital-wide policies, policies for 
medical and surgical wards, special organisms, hospital support services, and staff and 
student health. The course was implemented at the local hospital and at three campuses of 
medical schools. Frequency of access to the software at the hospital wards was monitored; 
besides, a questionnaire survey was conducted among 25 ward-based users and 23 students 
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to assess perception and satisfaction. Additionally, medical students understanding of 
infection control was evaluated by inviting 52 third-year medical students attending an 
infection control lecture to answer a pre-training 30-item multiple choice questionnaire. Of 
them, 23 students, randomly chosen, were asked to undertake the e-course whilst the 
remaining 29 attended a lecture with the same content. Subsequently, both groups were 
invited to complete a 30-multiple choice questions post-training questionnaire.  
During the first three months of the 18-month study period, the course was accessed 425, 
319 and 349 times per month, respectively. Subsequently, access rates dropped to 100 – 150 
per month. In a later phase of the study period, increased use by night-duty staff and at 
weekends was found. Of 23 medical students, only three reported not to enjoy using the 
software. Most users described the software as user friendly, and the three infection control 
staff involved in the ward-based assessment reported that the course covered all essential 
learning materials to introduce clinicians to infection control. While the evaluation of 
medical students’ knowledge found no significant differences in the groups’ pre-training 
scores, both forms of learning significantly increased students’ knowledge levels, with an 
increase from 62.1% to 79.5% (p<0.0001) among students who took the traditional class, and 
from 63.5% to 83.4% (p<0.0001) among those who completed the e-course. No significant 
difference was found for the overall post-test scores between groups, but for nine questions 
regarding the chapter Reducing the Risk the e-course group scored significantly better 
(81.6%) compared with the traditional learning group (71.6%; p=0.012). 
It was concluded that by implementing the e-course, evidence-based infection control 
practice information was been made readily available to staff and students in a new and 
acceptable format.393 
Atack and Luke developed an online course in infection control in Ontario, Canada, to 
facilitate the delivery of standardised training to large numbers of health providers.394, 395 
The course was developed as a  self-study course for workplace training and consisted of 
three modules: Hand Hygiene, Routine Practices, and The Chain of Transmission. The 
modules included text, photographs, video and graphics, as well as pre- and post-module 
knowledge tests and various exercises allowing students to self-evaluate their study 
progress. Twenty to 30 minutes of study time were required to complete one module.395 
Consequently, the authors examined the impact of the course on nurses’ and allied 
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healthcare professionals’ competency in infection prevention and control by means of 
Likert-scale343, 396 pre- and post-intervention questionnaires.  
Eighty-eight% (n=67) of the sample completed both the pre- and post-intervention 
competency questionnaires. The pre-course mean score was 64% and the post-course mean 
was 77.3% (p<0.001). The majority of participants reported to be highly satisfied with the 
course. They found it extremely useful (100%), and the learning activities were found to 
helpful (100%) and creative (95%). The questionnaire item I would recommend online 
learning as a way to learn about infection control was agreed upon by 100% of the 
respondents. Some dissatisfaction arose from receiving insufficient feedback at exercises, no 
opportunity to ask a question, the course taking longer than expected, and the hospital 
firewall making uploading slow or impossible. 
The open-ended questionnaire items asking participants in what ways the course had been 
useful to them identified three major themes: improvement of hand hygiene practices; 
improvement of the teaching participants gave to patients, visitors and staff about how to 
use personal protective equipment; and improvement of their own techniques. 
The authors conclude that interactive online learning can be a convenient and acceptable 
way for nurses to learn in the workplace. Moreover, they state that online learning can be 
considered an effective way to enhance knowledge and skills related to infection control and 
prevention.394, 395 
Also in Canada, Bryce and colleagues397 developed an e-learning module to deliver 
standardized infection control training to all healthcare professionals across a Canadian 
health authority. The course was developed by a multi-disciplinary team from a variety of 
health settings. Their objectives were reported to be to: (a) create a module that was 
relevant to day-to-day practice, accessible, clearly understood, consistent, and effective in 
transferring knowledge; (b) achieve acceptance and regular use of the course; and (c) 
demonstrate that the course transferred knowledge effectively. The course was interactive 
and included a variety of features such as drop and drag technology, animation and video. 
The learning objectives were fourfold: (1) awareness of the importance of infection; (2) 
familiarity with and application of routine infection control precautions in daily practice; (3) 
knowledge of how and when to use personal protective barriers; and (4) ability to describe 
the various types of isolation.  
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The outcomes identified as indicators of success of the online learning project were also 
fourfold: (1) obtain and demonstrate acceptance by key facility stakeholders; (2) assess, 
evaluate and document improvement in infection control knowledge after course 
completion; (3) document user satisfaction post-course; and (4) increase the number of 
clinicians that are taught the basic principles of infection control.  
The authors state that the development of the module showed to be instructive for both the 
students and the infection control/education team, yielding an enhancement of knowledge 
regarding delivery of healthcare education using Web-based technology. Throughout the 
implementation process, insights were gained into combining valuable content with product 
user friendliness, and the importance of engaging key stakeholders in the development 
process. User feedback revealed that quiz questions were to be carefully constructed in 
order to precisely reflect course content and participant learning. The course was concluded 
to make learning of infection prevention and control more efficient, economical, effective, 
and pleasant. According to the authors, it succeeded in overcoming geographic barriers, 
time constraints and varying professional needs. Due to the extensive positive response, use 
of the module has been extended since to various health facilities in the region.397 
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3. The EVIDENCE Crash Course 
 Based on the article:  Labeau S, Rello J, Dimopoulos G, Dicle A, Oztürk C, Vandijck D, 
Vandewoude K, Lipman J, Vogelaers D, Blot S, the EVIDENCE group. The value of E-learning for the 
prevention of healthcare-associated infections. Submitted. 
 
Introduction 
Healthcare-associated infections (HAIs) remain a major health threat as they affect 5% to 
10% of patients in acute care hospitals, and up to 33% of those admitted to the intensive 
care unit (ICU).1 The dreaded Big Four infection types accounting for more than 80% of all 
HAIs are ventilator-associated pneumonia (VAP), central line-associated bloodstream 
infection (CLABSI), surgical site infection (SSI) and catheter-related urinary tract infection 
(CAUTI).48 The impact of these adverse events in terms of excess morbidity and excess 
expenditures from both hospital and societal perspectives is highly detrimental.398 The 
staggering gravity of the problem has led to a transition from accepting HAIs as an inevitable 
outcome of hospital admission toward a goal of zero tolerance.1  
Fortunately, many HAIs are preventable. Up to 65%–70% of cases of CLABSI and CAUTI and 
55% of cases of VAP and SSI are esteemed to be avoidable if current evidence-based 
strategies are applied.7 Striving to raise awareness of these strategies among clinicians, 
authoritative organisations have bundled them into comprehensive evidence-based 
guidelines, which they made widely available and easily accessible.3, 15  
Unsolicited distribution of guidelines as such has however been proven not to change 
clinicians practice.21 Rello and colleagues investigated physicians’ adherence to evidence-
based guidelines for the prevention of VAP and found an overall self-reported non-
adherence rate of 37%.34 Ricart and colleagues repeated the same research in a sample of 
ICU nurses and found the non-adherence rate to be 22%.23 Given the fact that self-reports 
are known to suffer from social desirability bias, the actual rates might even be higher than 
those reported. Besides a lack of compliance, extensive gaps in knowledge about guideline 
contents have been reported.295-297, 333 Multiple choice knowledge tests about HAI 
prevention guidelines completed by a sample of over 3000 European ICU nurses yielded 
disappointing overall scores below the conventional 50% threshold to pass a test.296, 297  
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There is good evidence that effective educational interventions help to facilitate guideline 
implementation.399 A shift of emphasis in education has been witnessed in the mid-nineties 
of the previous century from providing instruction to producing learning.361 Critical thinking, 
independent and evidence-based learning, and feedback are since being regarded as 
indispensable features of this new learning paradigm.362 Quite simultaneously, a rise in the 
use of information technologies in (medical) education took a start. E-learning, defined as a 
method which integrates information technology and the learning process by using material 
delivered through the internet,363 was soon acknowledged to be a valuable educational 
tool.364  
Today, a plethora of e-learning modules are available. A recent review of Web-based 
educational resources yielded a list of over 135 tools specifically developed for ICU 
clinicians.390 Of these, none however focuses on the essentials of preventing HAI. We 
developed a Web-based crash course, bundling the essentials of evidence-based HAI 
prevention. This paper reports on the development of the EVIDENCE Crash Course and 
focuses on its contribution to the acquisition and retention of knowledge of evidence-based 
strategies for infection prevention. 
 
Methods 
Course development 
The EVIDENCE Crash Course was developed in Dutch language using open source software 
eXe (http://exelearning.org) release 1.04.0.3532. Subsequently its lay-out was embellished 
by a web-designer. To- and back-translations of the course were effectuated in English, 
Portuguese, Spanish and Turkish languages. To optimise accessibility, a computer with 
internet access and a web browser are all that are needed to study the course; no plug-ins, 
additional software nor downloads are required.  
Content validity was assessed and approved by an international team of experts in infection 
prevention (SB, DMV, JL, GD, JR). A sample of 50 potential users agreed upon its face validity 
and usability by means of the Software Usability Measurement Inventory® (SUMI®), a proven 
method of measuring software quality from the end user's point of view.400 
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Course contents 
The EVIDENCE course consists of seven chapters. As the focus is on evidence-based practice, 
the first chapter is dedicated to this concept. The second chapter introduces the problem of 
HAIs and stresses on the importance of their prevention. As hand hygiene is key to 
preventing infection, this topic is discussed in the third chapter. Chapters four to seven, 
finally, focus on each of the Big Four, respectively. Each chapter can be studied separately 
with icons indicating which information is to be memorised or merely informative. Different 
types of exercises with immediate feedback, such as case studies, cloze exercises and 
multiple choice tests, are integrated to allow self-evaluation during the learning progress.  
Depending on the participants’ level of pre-knowledge, it was estimated that it would take 
three to five hours to master the course. 
 
Recruitment of the sample  
An international sample of voluntary learners was recruited through repeated international 
promotional campaigns. These included blast e-mails to all members of the Flemish Society 
for Intensive Care Nurses and the European Society for Intensive Care Medicine (ESICM) by 
whom the study was endorsed, distribution of e-flyers to professional organisations and 
members of existing networks, spreading flyers at (inter)national congresses.  
As an incentive, a certificate of participation was acquired upon completion of the entire 
study path. The certificate was issued by European Society of Intensive Care Medicine 
(ESICM) who endorsed the EVIDENCE-project.  
 
Inclusion and exclusion criteria 
The course was originally designed for ICU clinicians. However, with the exception of VAP 
prevention, all topics included in the course are valid for non-ICU clinicians as well. In 
addition, numerous healthcare professionals working outside the ICU environment also 
explicitly showed interest. Therefore, involvement in in-patient care was set as the only 
inclusion criterion for study participation; no exclusion criteria were defined. As such, 
enrollment was open to all healthcare workers and students. 
Enrollment 
The study website www.evidenceproject.org was created to provide information about the 
study design, allow participants to grant informed consent, enroll and access the course. The 
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site also provided information on the background, aims and design of the study. The site was 
open for registration from 30 October 2010 till 31 December 2011. 
 
Study path 
Registered participants were guided through the study path by an automated e-mailing 
system: (a) a first e-mail invited them to log in to the study site and to complete a 50-item 
multiple choice knowledge test (Table 18) in order to measure baseline knowledge; (b) after 
electronic submission of this pre-test, access to the course was automatically granted for a 
maximal period of eight weeks. This period could, however, be ended earlier by the student 
whenever he felt mastering the course. After six weeks, students were alerted by automated 
e-mail about the imminent end of the study period; (c) access to the course was denied 
automatically after an eight weeks study period or as soon as the student himself indicated 
to be ready. Simultaneously, an automated e-mail was sent with the invitation to take a 
second 50-item multiple choice test. The questions of this test were identical to these of the 
pre-test, albeit differently ranked. This first post-test aimed to evaluate increase in 
knowledge immediately after studying the course; (d) twelve weeks after submission of the 
post-test, participants were invited by automated e-mail to complete a third and last 50-
item multiple choice test. Again, its questions were identical to these of the previous tests, 
but differently ranked. This second post-test aimed to evaluate the extent of decrease in 
knowledge as compared to the first post-test, and to determine the residual knowledge by 
comparing its results with the results of the pre-test.  
The multiple knowledge tests used had undergone face and expert content validation, and 
their reliability had been assessed using item analysis. Test scores were calculated as: correct 
answer = 1 point; wrong answer or ‘I do not know’ = 0 points. There was no correction for 
guessing.  
Participants’ actual study time was logged; time-outs with a need to re-log in occurred 
following five minutes of computer inactivity and with a warning popping up on the screen 
whenever such a time-out was near. 
All transactions on the study site were closed as of 15 July 2012. 
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The study flow is represented in Figure 7. 
 
 
Drop-out analysis 
Following the end of the study, a one-question survey was e-mailed to all participants who 
had not completed the entire study path to identify their reasons for opting out. 
 
Statistical analysis 
Statistical analysis was performed using IBM SPSS for Windows 20·0 (IBM Corp., NY, US). 
Tests were two-tailed and statistical significance was set at p<0·05. Not-normally distributed 
continuous variables are described as median (interquartile range; IQR). Univariate analysis 
was performed using Mann-Whitney U test, Wilcoxon Signed Ranks test or Kruskal-Wallis 
test as appropriate.  
 
30 Oct 2011 
deadline 31 Mar 1012 
Course enrollment at study website 
n = 3587 
Pre-test (T0)  access to course 
n = 2590 
 
Post-test 1 (T1) 
n = 1410 
“Immediate effect” 
 Post-test 2 (T2) 
n = 1011 
“Residual effect” 
15 Jul 2012 
Max. study time 8 weeks Fixed period 12 weeks 
Figure 7: Study flow 
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Table 18: Multiple choice knowledge test with correct answers underlined 
  
1. When a bedridden patient with an indwelling urinary catheter needs to be transported, the collector bag should be … 
a. placed in the bed to avoid traction. 
b. hung beneath the bladder level to avoid reflux. 
c. clamped in order to avoid reflux. 
d. I do not know. 
2. When neither lipid emulsions, nor blood products are administered through a central venous catheter, it is recommended to 
replace the administration set ... 
a. every 24 hours. 
b. every 48 hours. 
c. every 96 hours. 
d. I do not know. 
3. Concerning the use of gloves, which of the following statements is correct?  
a. Gloves must be changed in between separated tasks on one patient when going from a dirty/contaminated to a clean body site.  
b. Gloves must be changed in between separated tasks on one patient when going from a clean to a dirty/contaminated body site. 
c. Gloves must not be changed in between separated tasks on one patient. 
d. I do not know. 
4. Following the available evidence on the prevention of surgical site infection, the appropriate time to shower or bathe with an 
uncovered incision is … 
a. ≥ 48 hours following surgery. 
b. ≥ 96 hours following surgery. 
c. unresolved by lack of evidence. 
d. I do not know.  
5. Concerning the frequency of ventilator circuits changes in the prevention of ventilator-associated pneumonia … 
a. it is recommended to change circuits every 48 hours (or when clinically indicated). 
b. it is recommended to change circuits every week (or when clinically indicated). 
c. it is recommended to change circuits for every new patient (or when clinically indicated). 
d. I do not know. 
6. It is recommended to replace central venous catheters routinely.  
a. Yes it is, every seven days. 
b. Yes it is, every three weeks. 
c. No it is not, only when indicated. 
d. I do not know. 
7. Adequate handwashing with water and non-medicated soap should take … 
a. one minute. 
b. 35 seconds. 
c. 20 seconds. 
d. I do not know. 
8. When using a chlorhexidine gluconate impregnated sponge instead of a standard dressing to cover up the insertion site of a central 
venous catheter, the risk of infection is  … 
a. reduced. 
b. increased. 
c. identical. 
d. I do not know. 
9. In settings with a high rate of catheter-related infection it is recommended to use a central venous catheter coated or impregnated 
with an antiseptic agent. 
a. Yes it is, in patients whose catheter is expected to remain in place for more than five days. 
b. No it is not, because the use of such catheters is not cost-effective. 
c. No it is not, because the use of such catheters does not result in a significant decrease in the rate of catheter-related infections. 
d. I do not know. 
10. The need for continuing use of an indwelling urinary catheter must be assessed … 
a. daily. 
b. every 48 hours. 
c. every 96 hours. 
d. I do not know. 
11. Elective surgery on patients with remote site infections should be postponed until the infection has resolved. 
a. This is true for all patients. 
b. This is only true for debilitated patients. 
c. This is only true for patients infected with multi-resistant micro-organisms. 
d. I do not know. 
12. Concerning the use of open versus closed suction systems …  
a. open suction systems are recommended. 
b. closed suction systems are recommended. 
c. both systems can be recommended. 
d. I do not know. 
13. To prevent central venous catheter-related infection, replacing central venous catheters over a guidewire is recommended. 
a. Yes it is, every three days. 
b. Yes it is, every seven days. 
c. No it is not, only when indicated. 
d. I do not know. 
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14. Hospitalized patients at risk for healthcare-associated infections are ...  
a. only those who are immunocompromized. 
b. all patients, there are no prerequisite conditions. 
c. only critically ill patients at the intensive care unit. 
d. I do not know.  
15. To prevent central venous catheter-related infection, it is recommended to cover up the catheter insertion site with ... 
a. polyurethane dressing (transparent, semipermeable). 
b. gauze dressing. 
c. both are recommended because the type of dressing does not affect the risk of catheter-related infections. 
d. I do not know. 
16. In urinary catheterization, short-term catheterization is usually defined as catheter in place for less than …  
a. three days. 
b. seven days. 
c. ten days. 
d. I do not know. 
17. When performing endotracheal suctioning  …  
a. it is recommended to wear non-sterile gloves.  
b. it is recommended to wear sterile gloves. 
c. it is not recommended to wear gloves. 
d. I do not know.  
18. In order to prevent ventilator-associated pneumonia, it is recommended to elevate the head of the bed in mechanically ventilated 
patients to  …  
a. 5° to 15°. 
b. 30° to 45°.  
c. 50° to 60°.  
d. I do not know. 
19. In between fluffing up the pillows on the beds of two different patients, it is recommended to perform …  
a. handwashing with water and non-medicated soap only, no need to disinfect with alcoholic hand rub. 
b. handwashing with water and non-medicated soap, followed by hand antisepsis with alcoholic hand rub. 
c. hand antisepsis with alcoholic hand rub only. 
d. I do not know. 
20. To prevent central venous catheter-related infection, it is recommended to replace pressure transducers and tubing routinely. 
a. Yes it is, every four days. 
b. Yes it is, every eight days. 
c. No it is not, only when indicated. 
d. I do not know. 
21. To prevent surgical site infection, it is recommended to protect a primarily closed incision … 
a. during the first 12 hours following surgery. 
b. during the first 24-48 hours following surgery. 
c. during the first 5 days following surgery. 
d. I do not know. 
22. Surveillance succeeds in reducing the incidence of surgical site infection. 
a. Yes it does, and without supplementary preventive measures. 
b. Yes it does, but only when accompanied by supplementary preventive measures. 
c. No it does not, surveillance only helps to gain insight into the prevalence of infection, but has no influence on incidence rates. 
d. I do not know. 
23. In the prevention of healthcare-associated infection, so-called ‘Standard precautions’ apply to ...  
a.  all healthcare professionals in all healthcare settings when caring for infected patients. 
b. all healthcare professionals in all healthcare settings when caring for colonized patients. 
c. all healthcare professionals in all healthcare settings when caring for all patients. 
d. I do not know. 
24. If in the pre-operative period a surgical patient’s hair at or around the incision site interferes with the operation, it is 
recommended to remove it by … 
a. razor shave. 
b. depilatory agents. 
c. electric clippers. 
d. I do not know. 
25. Concerning oral versus nasal endotracheal intubation in the prevention of ventilator-associated pneumonia … 
a. oral intubation is recommended. 
b. nasal intubation is recommended. 
c. both routes of intubation can be recommended as the route of endotracheal intubation does not affect the risk of VAP. 
d. I do not know. 
26. When wearing non-sterile gloves during direct patient care, contamination of the skin on the healthcare worker’s hands  … 
a. is not possible. 
b. is possible, regardless the profile of the patient cared for.   
c. is possible, but only in case of contact with an infected patient. 
d. I do not know. 
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27. When using closed systems for endotracheal suctioning, which of the following statements is correct when aiming to prevent 
ventilator-associated pneumonia? 
a. Daily changes are recommended (or when clinically indicated). 
b. Weekly changes are recommended (or when clinically indicated). 
c. It is recommended to change systems for every new patient (or when clinically indicated). 
d. I do not know. 
28. When emptying the drainage bag of a patient with a urinary catheter, … 
a. it is recommended to wear non-sterile gloves. 
b. it is redommended to wear sterile gloves. 
c. it is not redommended to wear any gloves. 
d. I do not know. 
29. When aiming to prevent ventilator-associated pneumonia, which of the following statements concerning endotracheal tubes with 
an extra lumen for suctioning subglottic secretions is correct? 
a. These tubes reduce the risk of ventilator-associated pneumonia. 
b. These tubes increase the risk of ventilator-associated pneumonia. 
c. These tubes do not influence the risk of ventilator-associated pneumonia. 
d. I do not know. 
30. After moving a family picture on the bedside table of the patient, it is recommended to perform … 
a. handwashing with water and non-medicated soap only, no need to disinfect with alcoholic hand rub. 
b. handwashing with water and non-medicated soap, followed by hand antisepsis with alcoholic hand rub. 
c. hand antisepsis with alcoholic hand rub only. 
d. I do not know. 
31. In patients with an indwelling urinary catheter, it is recommended to … 
a. disinfect the meatus with an antiseptic solution. 
b. perform routine meatal hygiene only. 
c. disinfect the meatus with an antiseptic solution followed by application of an antibiotic ointment. 
d. I do not know. 
32. To prevent central venous catheter-related infection, it is recommended to change the dressing on the catheter insertion site ... 
a. on a daily basis. 
b. every three days. 
c. when indicated (soiled, loosened, ...) and at least weekly. 
d. I do not know. 
33. After bathing a patient infected with methicillin-resistant Staphylococcus aureus, healthcare workers with non-visibly soiled hands 
should perform …  
a. handwashing with water and non-medicated soap only, no need to disinfect with alcoholic hand rub. 
b. handwashing with water and non-medicated soap, followed by hand antisepsis with alcoholic hand rub. 
c. hand antisepsis with alcoholic hand rub only. 
d. I do not know. 
34. When lipid emulsions are administered through a central venous catheter, it is recommended to replace the administration set ... 
a. within 24 hours. 
b. every 72 hours. 
c. every 96 hours. 
d. I do not know. 
35. The prevalence of healthcare-associated infection in developed countries is about ...  
a. 1% to 5%. 
b. 5% to 15%. 
c. 15% to 20%. 
d. I do not know.    
36. Hospital-acquired infection is a synonym of  …  
a. healthcare-associated infection. 
b. nosocomial infection. 
c. community-acquired infection. 
d. I do not know. 
37. The most important risk factor identified in the development of catheter-associated urinary tract infection is … 
a. colonization of the drainage bag. 
b. diabetes mellitus. 
c. duration of catheterization. 
d. I do not know. 
38. To prevent central venous catheter-related infection, it is recommended to disinfect the catheter insertion site with an antiseptic 
containing ... 
a. 2% chlorhexidine. 
b. 0,5 % chlorhexidine. 
c. 10% povidone-iodine. 
d. I do not know 
39. Ventilator-associated pneumonia is defined as pneumonia that develops more than … to … hours after intubation and initiation of 
mechanical ventilation.  
a. 24 to 48. 
b. 48 to 72.  
c. 72 to 96.  
d. I do not know. 
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40. The term ‘primary bloodstream infection’ refers to  …  
a. a bloodstream infection in which there is no obvious source of infection. 
b. a bloodstream infection in which there is an obvious source of infection. 
c. the first episode of a bloodstream infection. 
d. I do not know. 
41. In urinary catheterization, long-term catheterization is usually defined as catheter in place for more than …  
a. 15 days. 
b. 20 days. 
c. 28 days. 
d. I do not know. 
42. In the pathogenesis of ventilator-associated pneumonia, the most significant treatment-related factor contributing to impaired 
host defences is …  
a. the use of a ventilator. 
b. the use of an endotracheal tube. 
c. the use of a nasogastric tube. 
d. I do not know. 
43. The pathogens that cause surgical site infection are usually microorganisms that originate from … 
a. the patient's endogenous flora. 
b. contaminated equipment. 
c. the hands of healthcare workers. 
d. I do not know. 
44. In patients with an indwelling urinary catheter, urinary tract infection is usually … 
a. non-existing. 
b. asymptomatic. 
c. easily clinically detectable. 
d. I do not know. 
45. In intubated and mechanically ventilated patients, it is recommended to maintain the pressure of the endotracheal tube cuff 
between  … 
a. 10 – 20 cmH2O. 
b. 20 – 30 cmH2O. 
c. 30 – 40 cmH2O. 
d. I do not know. 
46. After bathing a patient infected with Clostridium difficile,  healthcare workers’ non-visibly soiled hands should be …  
a. washed with water and non-medicated soap only, no need to disinfect with alcoholic hand rub. 
b. washed with water and non-medicated soap, then disinfected with alcoholic hand rub. 
c. disinfected with alcoholic hand rub only. 
d. I do not know. 
47. Nosocomial pneumonia is defined as  …  
a. pneumonia occurring 48 hours or less after hospital admission  
b. pneumonia occurring 48 hours or more after hospital admission  
c. pneumonia occurring at any time after hospital admission 
d. I do not know 
48. When comparing hand hygiene using alcohol-based hand rubs with handwashing using water and non-medicated soap …  
a. hand hygiene using alcohol-based hand rubs requires less time than handwashing with water and non-medicated soap. 
b. hand hygiene using alcohol-based hand rubs requires more time than handwashing with water and non-medicated soap. 
c. hand hygiene using alcohol-based hand rubs and handwashing with water and non-medicated soap require an equal amount of 
time. 
d. I do not know. 
49. Which of the following precautions is part of the universal transmission-based precautions?  
a. contact precautions. 
b. isolation precautions. 
c. colonization precautions. 
d. I do not know. 
50. During insertion of an indwelling urinary catheter, extraluminal contamination occurs … 
a. by the hands of healthcare professionals. 
b. by microorganisms ascending from the perineum or the urethral meatus. 
c. by microorganisms descending from the bladder. 
d. I do not know. 
 
To evaluate the course’s effect in relation to learners’ countries’ human development level, 
the Education and Health ranking from the 2011 Education and Health Human Development 
Report of the United Nations Development Program was used, which categorises countries 
into very high, high, medium or low human development.401  
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The immediate learning effect was calculated by subtracting the median score (%) at T1 from 
the median score at T0, and the residual learning effect by subtracting the median score at 
T2 from T0. The difference between the median test scores at T1 and T2 indicated the 
decrease in knowledge after 3 months without accessing the course. Learning effects are 
reported as percentages (either positive or negative) with corresponding interquartile 
ranges (IQR). All variables with p<0·05 in univariate analysis were included in a multivariate 
linear regression analysis using the Enter-method, and assessed for multicollinearity. A 
stepwise elimination of variables with p>0·20 was predefined to develop the final model.  
 
Ethical considerations 
Upon enrollment, potential participants were required to give informed consent by ticking a 
box in the electronic registration form in order to start the study. The study was reviewed 
and approved by the ethics committee at Ghent University Hospital (registration codes 
B67020072039 and B67020108358).  
 
Results 
Description of the sample 
3587 healthcare workers representing 79 nationalities enrolled in the course. Of these, 2590 
(72·2%) submitted the pre-test, 1410 (39·8%) actually studied the course and submitted 
post-test 1, and 1011 (28·2%) also submitted post-test 2, thus completing the entire study 
path.  
Of the actual learners (n=1410), 1184 (84·0%) were female; most students had >10 years of 
working experience (n=699; 49·6%), worked in a mixed ICU (n=495; 35·1%), and in a 
university hospital (n=685; 48·58%); 1046 (74·18%) were nurses, 125 (8·86%) were 
physicians, 60 (4·25%) students, and 179 (12·69%) were other healthcare professionals. Their 
median age was 33 years (IQR 28–40). The median study time was 194 minutes (IQR 96–
306). For further categorisation, study time quartiles were defined conveniently as  <100 
minutes (median 45; IQR 24–70; n=371), 100–200 minutes (156; IQR 127–178; n=353), 201–
300 minutes (243; IQR 223–269; n=318), and >300 minutes (405; IQR 344–502; n=368). 
Test scores and learning effects 
The median score on the pre-test was 52% (IQR 44–62; n=2590), increasing to 80% (IQR 68–
88) at post-test 1 (n=1410) and amounted to 74% (IQR 64–84) on post-test 2 (n=1011). The 
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overall immediate learning effect, defined as the difference in scores between the pre-test 
and post-test 1, was 24% (IQR 12–34; p<0.001; n=1410), decreasing with -6% (18%; IQR -12–
2; p<0.001; n=1011) after 3 months (difference in scores between post-test 1 and post-test 
2; n=1011). The overall residual effect, i.e. the difference in scores between the pre-test and 
post-test 2, remained 18% (IQR 8–28; p<0.001; n=1011).  
For all course topics, positive immediate and residual learning effects were found (Table 19). 
Gains in knowledge increased with study time. The immediate effect reached a maximum as 
from 200 study minutes (28%) while the residual effect was greater once study time 
exceeded 300 minutes (Table 20). 
Table 20 shows the median immediate and residual effects according to the learners’ 
characteristics, and the median decrease in knowledge after a 3 months period without 
accessing the course. 
 
Variables for which statistically significant differences between groups were found in 
univariate analysis were entered in a multivariate linear regression model (Table 21). For the 
immediate learning effect, an increase in age category showed to be independently 
associated with a smaller learning effect, and a longer study time was found to be associated 
with a better immediate learning effect (R²=0·18). Being female, longer study time and 
working in a non-ICU-related environment were found to predict better residual learning 
effects (R²=0·32). Multicollinearity analysis detected no correlations between the variables 
entered. 
 
Drop-out analysis 
The survey inquiring about learners’ reasons to end participation obtained 503 responses. A 
lack of time was identified as the main reason (n=211; 42%) for opting out. Further, learners 
indicated having forgotten their enrollment (n=146; 29%) and problems with computer / 
internet connection (n=52; 10%) as the main reasons for not completing the study path.
  
 
 
 
 
 
 
 
 
 
 
Table 19: Median scores and learning effect of the total course (overall) and per category of questions 
 
  
 
pre-test 
n = 2590 
 
 
post-test 1 
n = 1410 
Immediate effect 
 
∆ pre-test – post-test 1 
n = 1410 
 
 
post-test 2 
n = 1011 
Decrease in knowledge  
after 3 months 
∆ post-test 1 – post-test 2 
n = 1011 
Residual effect 
 
∆ pre-test – post-test 2  
n = 1011 
Overall (total course) (n = 50) 52 (44–62) 80 (68–88) 24 (12–34) 74 (64–84) -6 (-12–2) 18 (8–28) 
Urinary Tract Infection (n = 8) 50 (38–63) 88 (63–100) 25 (13–38) 75 (63–88) 0 (-25–0) 13 (0–38) 
Central Venous Catheter-related Infection (n = 11) 45 (36–67) 82 (64–91) 27 (9–36) 73 (55–91) -9 (-18–0) 18 (0-36) 
Ventilator-Associated Pneumonia (n = 10) 50 (40–70) 80 (70–90) 20 (10–40) 80 (70–90) 0 (-10–0) 20 (0–30) 
Surgical Site Infection (n = 6) 33 (17–50) 84 (50–100) 33 (17–-67) 67 (50–83) -17 (-33–0) 17 (0–50) 
Hand Hygiene (n = 10) 60 (50–70) 70 (60–80) 10 (0–20) 70 (60–80) 0 (-10–10) 10 (0–20) 
Theoretically oriented questions (n = 7) 43 (29–57) 71 (57–86) 29 (14–43) 71 (57–86) 0 (-14–0) 14 (0–43) 
Practically oriented questions (n = 43) 53 (47–63) 81 (70–88) 21 (12–33) 77 (65–86) -5 (-12–0) 16 (7–28) 
Data are reported as % (interquartile range) 
∆ pre-test – post-test 1: immediate learning effect; ∆ post-test 1 – post-test 2: mid-long-term learning effect; ∆ pre-test – post-test 2: residual learning effect  
IQR: interquartile range; n in rows: number of questions; n in columns: number of learners 
 
 
 
 
 
 
 
 
 
 
  
Table 20: Learning effects according to learners’ characteristics 
 
 Immediate effect 
∆ pre-test – post-test 1 
n = 1410 
p 
Decrease in knowledge 
∆ post-test 1 – post-test 2 
n = 1011 
p 
Residual effect 
∆ pre-test – post-test 2  
n = 1011 
p 
 % (IQR) n  % (IQR) n  % (IQR) n  
Sex 
male 
female 
 
22 (10–32) 
24 (12–34) 
 
226 
1184 
 
0·143 
 
 
-8 (-16–(-2)) 
-4 (-12–2) 
 
168 
843 
<0·001* 
 
12 (4–20) 
20 (8–30) 
 
168 
843 
<0·001* 
Age 
<29 years 
29–34 years 
35–41 years 
>41 years 
 
24 (8–35) 
25 (12–34) 
22 (14–32) 
20 (10–32) 
 
442 
364 
306 
198 
0·018* 
-6 (-14–0) 
-6 (-12–2) 
-6 (-12–0) 
-4 (-12–2) 
275 
273 
232 
231 
0·290 
20 (8–30) 
20 (10–32) 
15 (6–26) 
16 (6–26) 
275 
273 
232 
231 
0·003 
Work experience 
<1 year 
1–5 years 
6–10 years 
>10 years 
 
22 (6–36) 
26 (10–36) 
24 (12–32) 
22 (12–32) 
 
103 
321 
287 
699 
0·185 
 
 
-8 (-14–0) 
-8 (-14–0) 
-4 (-12–2) 
-4 (-12–2) 
 
55 
214 
203 
539 
0·039* 
 
18 (6–28) 
20 (8–30) 
18 (8–28) 
18 (8–28) 
 
55 
214 
203 
539 
0·797 
Profession 
Nurse 
Physician 
Student 
Other  
 
24 (12–34) 
24 (12–32) 
30 (11–42) 
22 (12–30) 
 
1046 
125 
60 
179 
 
0·096 
 
 
-6 (-12–2) 
-10 (-16–(-4)) 
-8 (-16–2) 
-4 (-10–2) 
 
739 
86 
40 
146 
0·001* 
 
18 (8–28) 
14 (8–20) 
18 (6–30) 
17 (8–28) 
 
739 
86 
40 
146 
0·144 
Work environment 
ICU and ICU-related 
non-ICU-related 
 
22 (12–32) 
24 (12–34) 
 
878 
532 
 
0·019* 
 
 
-6 (-14–0) 
-4 (-10–2) 
 
628 
383 
 
0·032* 
 
 
16 (6–26) 
20 (8–32) 
 
628 
383 
<0·001* 
Study time 
<100 min. 
100–200 min. 
201–300 min. 
>300 min. 
 
10 (2–22) 
22 (14–32) 
28 (18–36) 
28 (20–36) 
 
371 
353 
318 
368 
<0·001* 
 
-2 (-8–4) 
-8 (-14–0) 
-8 (-14–(-2)) 
-4 (-10–2) 
 
191 
276 
241 
303 
<0·001* 
 
10 (2–24) 
14 (6–24) 
18 (8–28) 
24 (16–34) 
 
191 
276 
241 
303 
<0·001* 
Education & health index  
Low and medium HD 
High HD 
Very high HD 
 
22 (6–33) 
24 (12–34) 
22 (12–32) 
 
74 
809 
527 
 
0·466 
 
-6 (-12–0) 
-4 (-10–3) 
-6 (-14–(-2)) 
 
51 
562 
398 
 
<0·001* 
 
16 (6–26) 
20 (8–32) 
14 (6–26) 
 
51 
562 
398 
 
<0·001* 
∆: increase / decrease in test scores (%) reported as median (interquartile range) 
Study time and age: intervals based on quartiles 
n: number of participants; ICU: intensive care unit; HD: human development; *statistical significance 
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Table 21: Multivariate linear regression analysis  
 
Immediate learning effect 
 B ± standard error 95% confidence interval p 
Age (per class increase) * -1·8% ± 0·3 -2·4–(-1·1) <0.001 
Study time (per class increase) † 5·6% ± 0·3 4·9–6·2 <0.001 
R²: 0·176  
  
Residual learning effect 
 B ± standard error 95% confidence interval p 
Female gender 4·3% ± 1·3 1·8–6·9 0·001 
Non-ICU related work environment 2·3% ± 1·0 0·3–4·3 0·026 
Study time (per class increase) † 4·0% ± 0·4 3·1–4·8 <0·001 
R²: 0·325    
* <29 years, 30–34 years, 35–41 years, or >41 years of age 
† <100 min., 101–200 min., 201–300 min., or >300 min. study time 
 
 
Discussion 
The present study found that limited time invested in studying a Web-based course on the 
essentials of HAI prevention with good usability and exercises for self-evaluation yielded 
significant increases in immediate (+24%) and residual (+18%) learning effects among nurses, 
physicians and students. Although the course was originally developed for ICU clinicians, 
healthcare professionals working outside the ICU also showed significant benefit from 
studying the course. 
A 2009 systematic review of 130 articles published between 1990 and 2007 reported 
comparisons of internet-based instructional methods against no intervention, of which 126 
evaluated knowledge outcomes.402 The pooled effect size for these studies was 1·0, meaning 
that, overall, e-learning improved knowledge by one standard deviation. The standard 
deviation found in the review being 12% consequently suggests that an average 
improvement of test scores by about 12% can be expected from an e-learning 
intervention.402  
Our study resulted in an overall immediate learning effect of 24%, thereby doubling the 
expected improvement. The effect decreased to 18% after three months without accessing 
the course, thereby still yielding an enhancement in knowledge that equals 150% of the 
expectations. However, as studying our course was voluntary, selection bias needs to be 
taken into account when interpreting our results. Presumably, participants who enrolled 
were motivated and interested in the topic. In turn, the most motivated and most interested 
among them might have completed the entire study path, thus generating better learning 
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effects than if participation had been obligatory among a random sample. On the other 
hand, this may also imply that the pre-knowledge level of our participants was higher as 
compared to the general population of healthcare workers. If so, the learning effects in a 
random sample of clinicians might exceed these identified in the current study. Selection 
bias is nevertheless, at least partially, corrected for by the fact that during the study course 
numerous clinicians indicated to participate in order to obtain the certificate of participation 
issued by the ESICM. This motive for participation might partly alleviate the bias caused by 
voluntary enrollment.  
Education of all members of the multidisciplinary team is considered a first and crucial 
requirement when targeting implementation of interventions for infection prevention.74 
Thought should however be given to the fact that clinicians may find it problematic to attend 
conventional educational sessions. They often work irregular shifts, may have assignments in 
different hospitals or find it hard to prioritise attending sessions in times of restricted 
staffing. E-learning offers a solution as it allows healthcare workers to study where and 
when they prefer to, and at their own pace.364 Besides, e-learning has additional important 
assets as it combines important learning principles such as student activity, individual 
learning, rapid response, and repetition according to requirements. It promotes independent 
skills, allows flexible working and encourages the development of skills in time management, 
organisation, and self-pacing.363 Finally, it provides an opportunity for practising computer 
skills, and encompasses a pedagogical approach that typically aspires to be flexible, engaging 
and learner-centred.363, 372, 374, 375 
Using e-learning for staff education can also be advantageous for the healthcare setting. 
Institutions may provide tailor-made educational packages in order to meet employees 
specific learning objectives.403 If desired, e-learning allows to log participants’ actual course 
attendance, study time, test scores and study progress. Costs associated with the 
development of e-modules will predominantly depend on the software used and the 
investment in personnel cost. Developed by the researcher (SL) using open source software, 
the development costs for the EVIDENCE course were very limited. In environments or 
economic climates where restricted resources for educational purposes are to result in both 
efficient and effective learning, the use of open source software could prove to be highly 
advantageous. In addition, as e-learning allows repetition of study activities at institution- or 
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ward-tailored basis, the concept may contribute to an increase in general awareness about 
the problem of HAIs and as such, to a positive change in attitudes towards the problem. 
The drop-out rate from our course was high. Of all clinicians enrolled, only 40% actually 
studied the course (1410/3587). Isolation of learners has been identified as a common 
reason for high drop-out rates.376 Our drop-out survey identified a lack of time as the main 
reason for opting out. As our sample merely consisted of voluntary students, a high drop-out 
rate is hardly unexpected as work, family life and personal commitments are easily 
prioritised.  
Additional research comparing different Web-based interventions is needed to elucidate 
how to implement e-learning most effectively. In the meantime, our study strongly suggests 
that moderate time invested in a low-cost e-course with good usability features and 
exercises for self-evaluation can significantly enhance knowledge of HAI prevention. We 
therefore encourage institutional decision-makers to consider the use of e-learning in 
healthcare settings.  
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Conclusion of part three 
 
In the past decades, e-learning has been acknowledged as a valuable tool for adult learning. 
Also education for healthcare workers has witnessed a shift from one devoid of significant 
computer-based resources to that where such tools are regularly incorporated.  
 
Among its advantages, e-learning allows learners to study at the place and time best 
meeting their requirements, and at their own pace. Also for the health facility, multiple 
advantages are associated with the use of Web-based resources for education of staff. 
 
In the field of e-learning for healthcare professionals, the considerable heterogeneity and 
small sample sizes in studies comparing e-learning with non-Web-based interventions 
hampers meta-analyses to draw clear-cut results. Internet-based resources incorporating 
features of interactivity, practice exercises, repetition, and feedback were however shown to 
be overall associated with improvements in learning outcomes. 
 
Specifically for critical care providers, an extensive list of educational e-resources appears to 
be available. Among these, only four relate to the broad field of infectious diseases, covering 
specialised topics mainly for advanced learners. A number of local initiatives to develop and 
evaluate e-learning on the prevention and control of infection have been reported. Of these, 
none has specifically been focusing on the prevention of healthcare-associated infection. 
 
A concise and comprehensible course focussing on the prevention of HAIs that is easily 
accessible and based on international evidence-based guidelines appeared to be missing 
from the list of e-courses available today for healthcare workers. By developing the 
EVIDENCE Crash Course, we attempted to fill this gap. An assessment of the course’s 
effectiveness in increasing knowledge yielded positive findings, with overall significant 
learning effects that were sustained after three months without access to the course. 
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EPILOGUE 
 
Throughout the EVIDENCE-project, knowledge of healthcare professionals was the common 
outcome of all studies conducted. The project started off with a needs analysis, investigating 
ICU nurses’ knowledge about the prevention of VAP, CVC-RI and SSI, partially on a European 
scale.  Regrettably, overall low knowledge levels were found, with test scores not reaching 
the conventional 50% threshold to pass a test.  
The e-learning EVIDENCE Crash Course developed aimed to meet the needs detected by 
offering healthcare workers worldwide a comprehensive and comprehensible educational 
resource that would be readily available to study the essentials of evidence-based infection 
prevention whenever and wherever learners prefer, and at their own pace. Immediately 
after studying the course, knowledge levels demonstrated a significant increase which was 
substantially sustained after three months without access to the course. 
There is no hard evidence available that allows for a direct linking of the low rates in 
adherence to evidence-based guidelines reported in the literature to low levels of 
knowledge about guidelines’ contents. Nevertheless, it is merely logical to assume that 
compliance needs to be preceded by a thorough knowledge about the related 
recommendations. Thereby, knowledge is a condition sine qua non for compliance, a first 
and primordial requirement that needs to be fulfilled. 
Healthcare workers will only be able to provide excellent patient care if they are well 
equipped with knowledge to underpin their daily care routines. Evidence-based guidelines 
for the prevention of HAI have acknowledged education of healthcare workers to be a first 
requirement that needs to precede the initiation of structured programs for infection 
prevention or overall quality improvement.14, 15, 86, 88, 89, 92 One method proposed is to require 
healthcare personnel to complete an educational program including a posteducation test to 
ensure their knowledge and competency.88 For such purposes, the use of e-courses could be 
of great benefit.  
The value of increasing healthcare workers knowledge for the reduction of HAIs has largely 
been demonstrated by the results of educational programs worldwide.38, 39, 41, 68, 72, 341 Also 
systematic reviews that synthesised the results of separate studies concluded in favour of 
adequate education and training of healthcare workers. 
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A 1995 systematic review of relevant data sources from 1975 to 1994 investigated the 
effectiveness of education strategies designed to change physician performance and health 
care outcomes.105 Of 99 trials included (160 interventions) almost two thirds of the 
interventions (101/160) revealed an improvement in at least one major outcome measure: 
70% demonstrated a change in physician performance, and 48% of interventions aimed at 
health care outcomes yielded a positive change.105 
A more recent systematic review dated 2008149 focussed on the field of infection prevention 
by determining the effect of educational strategies of healthcare providers on the reduction 
of HAI rates. Multiple computerised databases for the years 1966 to 2006 were searched, 
and supplemented by manual searches for relevant materials. A total of 26 studies using 
various educational programs for varied study populations of healthcare workers were 
included, most of them implemented in the ICU. Infection rates significantly decreased 
following the educational program in 21 studies, with risk ratios ranging from 0 to 0.79. The 
authors conclude that the implementation of educational interventions may reduce HAI 
rates considerably. They recommend to cluster randomized trials using validated educational 
interventions and costing methods to determine the independent effect of education on 
reducing HAI rates and the cost-savings that may accompany this approach.149 
Our needs analysis on a European scale revealed that, overall, more experienced nurses had 
a better knowledge of prevention guidelines than their less experienced colleagues. 
Participants with less than one year working experience in the ICU yielded the lowest scores. 
A potential positive interpretation of this finding could be that the ICU is a stimulating work 
environment that encourages learning and promotes gathering of knowledge during the 
course of nurses’ careers.  
A more negative interpretation, however, could be that European institutes for nursing 
education do not succeed in satisfactorily preparing students to work in the complex ICU 
environment. Thereby, newly recruited nurses would struggle with a considerable lack of 
general knowledge when making their first steps in the job and would need at least a couple 
of years to catch up with their more experienced colleagues.  
Throughout Europe, there is indeed an enormous variety in the duration, level and content 
of the courses leading to a specialised degree in ICU nursing, as well as in the nature and 
level of the institutions providing this education.296, 404, 405 Although regrettable, this is not 
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surprising given the fact that in Europe even for the preregistration, basic nursing education 
programs a myriad of arrangements is still available.406  
Back in 2004, the European federation of Critical Care Nursing associations (EfCCNa) 
launched a position statement on the post-registration ICU nursing education within Europe 
to overcome this issue and promote uniformity.405, 407 To date, however, national and even 
local disparities still abound, while in today’s globalising society the need for a pan-European 
high quality qualification for ICU nurses has only become more pressing. Therefore we plea 
for a pan-European curriculum for (post-registration ICU) nurses, in order to obtain equal 
educational requirements and thereby ensure high quality care across contemporary 
Europe.  
Besides a pan-European curriculum, developing pan-European guidelines for infection 
prevention would help to rationalize conflicting recommendations. Based on the results of 
our needs analysis, it can be assumed that international recommendations may not always 
accord with countries’ national or even local institutional guidelines. Although guidelines 
doubtlessly need to be tailored to institutions’ specific cultural and organisational context, 
the evidence base of recommendations will remain unchanged. As a consequence, besides a 
lack of knowledge or deficiencies in training, the poor test scores obtained by European 
nurses in our studies may reflect differences in what is regarded as good practice, and/or a 
lack of consistent policy.  
Throughout the EVIDENCE-project, the overall limitation of studies was the use of 
convenience samples. The related selection bias undeniably has to be taken into account 
when interpreting any of our results. The major strength of the project is the large numbers 
of participants in all studies conducted.  
Also, the EVIDENCE-project revealed to contribute to the enhancement of nursing practice 
worldwide. In the course of years, we received various requests to use the questionnaires 
developed for the needs analysis in local research or quality improvement initiatives. Table 
22 shows the list of countries from which requests were received to use the EVIDENCE 
questionnaires in local quality improvement initiatives. Besides, it is not improbable that 
similar initiatives have been taken in other countries as, once published, the questionnaires 
became available for all healthcare workers interested in their use. 
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Table 22: Known countries with quality improvement initiatives using the EVIDENCE questionnaires 
 
 
 
 
Continent Country 
Europe Austria 
 Belgium 
 Cyprus 
 Denmark 
 Finland 
 Germany 
 Ireland 
 Italy 
 Malta 
 Netherlands 
 Norway 
 Scotland 
 Spain 
 Switzerland 
Eurasia Turkey 
Asia Indonesia 
 Iran 
 Japan 
 Jordan 
 Korea 
 Malaysia 
 Pakistan 
 Palestine 
 Philippines 
 Taiwan 
Africa Botswana 
 Egypt 
 Kenya 
 South-Africa 
North America Canada 
 Mexico 
 United States 
  Arizona 
  California 
  Florida 
  Illinois 
  Kentucky 
  Massachusetts 
  New York 
  Oklahoma 
  Rhode Island 
  South Carolina 
  Virginia 
  Wisconsin 
South America Argentina 
Oceania Australia 
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In conclusion, some recommendations can be made, based upon the outcomes of this thesis. 
Institutions for nursing education, and for the healthcare professions in general, could be 
recommended to stress the importance of prevention of HAIs throughout their curricula. 
Today, the topic is often addressed in the basic module of the educational trajectories only, 
merely focussing on the main principles of hospital hygiene and microbiology. Given the 
poor knowledge levels as revealed by our knowledge tests, educational institutions should 
consider integrating repeated courses on the prevention of HAIs throughout the various 
modules of the curricula. These courses should be based on the latest evidence and discuss 
more detailed issues, such as site-specific infections. Preferably, education should not be 
restricted to traditional lectures but include activating and interactive learning methods, 
including cases, skills training, and simulation to optimise learning effects. Courses should be 
followed by regular and scheduled assessments in order to evaluate students’ learning 
process and levels of knowledge.  
Additionally, and as mentioned above, institutions for nursing and healthcare education 
throughout Europe should be encouraged to join in a more comprehensive debate about the 
implementation of transparent higher educational programmes which are comparable and 
compatible. The Sorbonne declaration of 25th of May 1998 emphasised the creation of the 
European area of higher education, and the objectives of the subsequent Bologna 
Declaration (19 June 1999) included the promotion of the necessary European dimensions in 
higher education, including curricular development and interinstitutional co-operation of 
study, training and research. With respect to education on infection prevention, 
standardized high quality education could help to enhance and equate knowledge levels 
among healthcare providers, which, in turn, might lead to pan-European improved practice. 
If higher education must scale up with curricula that equip teachers to provide individuals 
with the knowledge and skills needed in the twenty-first century, educational approaches 
such as distance learning and e-learning are required. Therefore, it is recommended that 
educational institutions fully invest in training of staff to fulfil these functions in evolving 
teaching and learning systems. 
The EVIDENCE course developed within this project, could prove a valuable instrument for 
both regular and distance learning students, and the knowledge tests could be used as 
reliable assessment tools. However, as all are based on evidence-based guidelines, they 
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require regular updating according to new evidence, whenever this becomes available. 
Modifications and updating need to be followed by new validation and reliability testing 
processes. Therefore, systematic reconsideration of these tools is necessary in order to 
maintain their value for educational purposes. 
Education on the prevention of HAIs should not take a halt after healthcare professionals’ 
graduation. Provision of evidence-based care in daily practice implies continuing and 
continuous efforts to remain aware of the latest recommendations. Healthcare facilities 
could therefore be recommended to systematically include topics on the prevention of 
infections in their programmes for employees’ continuing education, for example by means 
of e-learning. Nurses, and healthcare professionals in general, should consider it a 
professional responsibility to keep themselves updated on the most recent, evidence-based 
information in order to ensure patient safety and provide high quality standards of care. An 
up-to-date e-learning course containing this information and provided by their employers 
could offer an excellent compromise between reducing the burden of individual and 
repeated searches for the latest information and taking responsibility for their personal 
professional development. 
Recently, hospitals in Flanders started to strive, on a voluntary basis but strongly encouraged 
by Flemish governmental policy, towards accreditation. Accreditation is a process in which a 
third party provides a certificate of guarantee that a product, process or product meets 
specifically set standards of quality. In Flanders, hospitals aim to obtain accreditation 
through an organisation certified by the International Society for Quality in Healthcare 
(ISQua), i.e. the Joint Commission International (JCI) or the NIAZ (Nederlands Instituut voor 
Accreditatie in de Zorg). While in Flanders quality indicators are being established and 
validated today to guide the accreditation processes, the JCI has included documented HAI 
prevention strategies and training of staff as basic requirements for determining the quality 
standards of healthcare facilities.408 As e-learning allows for objectively demonstrating and 
documenting of employee educational processes and outcomes, it may be recommended to 
include this learning method among training tools of hospitals striving to obtain 
accreditation.     
Future research based upon the current results of the EVIDENCE-project could focus on 
determining outcomes in terms of infection rates in units or healthcare facilities where the 
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Crash Course is used as an educational tool. As various potential confounders could easily 
bias the results of such pre-postdesign study, a solid surveillance system and an extensive 
support on both the level of the unit and the organisation would be crucial prerequisites for 
all institutions participating in these proposed further evaluations. Cost-benefit analyses 
should accompany or follow investigations on clinical outcomes in order to determine and 
support most optimal implementation. 
Due to restricted financial resources, the EVIDENCE course was developed with open source 
software and by the author of this thesis. Cooperation with industrial partners, various 
stakeholders and funding sources would allow to develop a more interactive instrument 
including video and sound, simulation, chat technology and online teacher-student 
communication tools. These activating learning methods could improve the course, and 
potentially reduce high drop-out rates caused by students feeling isolated when studying 
online. Moreover, it is important to stress that the current format of the EVIDENCE course 
does not allow for obtaining nor evaluating complex levels of knowledge about HAI 
prevention. The integration of cases and more complex, practice-guided and interactive 
learning materials might contribute to alleviate this limitation and is therefore 
recommended as an additional subject for further investigations. Also, and as mentioned 
above, future research focussing on the maintenance of the topical value, validity and 
reliability of the questionnaires and course developed within this project is required.  
 
Healthcare-associated infections are a major, world-wide and timely societal problem. With 
the EVIDENCE project, we have aimed to enhance knowledge of healthcare professionals 
with respect to this issue. Although the project has various limitations, we hope to have 
contributed to raising awareness of the problem and, hopefully, to enhancing patient safety. 
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ADDENDUM 1: LIST OF ABBREVIATIONS 
 
BSI  BloodStream Infection 
CAUTI  Catheter-Associated Urinary Tract Infection 
CDC   Centers for Disease Control and Prevention 
CLABSI  Central Line-Associated BloodStream Infection 
CR-BSI  Catheter-Related BloodStream Infection 
CVC  Central Venous Catheter 
CVC-RI  Central Venous Catheter-Related Infection 
CVI  Content Validity Index 
EfCCNa  European federation of Critical Care Nursing associations 
EPIC II   Extended Prevalence of Infection in Intensive Care 
ESICM  European Society for Intensive Care Medicine 
GRADE  Grades of Recommendation, Assessment, Development, and Evaluation 
System 
HAI  Healthcare-associated infection 
ICU   Intensive Care Unit 
IDSA  Infectious Diseases Society of America 
IHI  Institute of Healthcare Improvement 
IOM  Institute of Medicine 
NHSN  National Healthcare Safety Network 
SHEA  Society for Healthcare Epidemiology of America 
SSI  Surgical Site Infection 
UTI  Urinary Tract Infection 
VAP  Ventilator-Associated Pneumonia 
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Formulier II: beoordeling randomised controlled trial (RCT) 
 
Dit formulier is bestemd voor het beoordelen van randomised controlled trials (RCT’s). RCT’s 
worden uitgevoerd ter bepaling van het effect van een therapeutische of preventieve interventie. 
Soms wordt het effect van een diagnostische interventie ook door middel van een RCT 
onderzocht. 
 
Dit formulier is ontwikkeld door een werkgroep bestaande uit vertegenwoordigers van het Dutch 
Cochrane Centre, het Kwaliteitsinstituut voor de Gezondheidszorg CBO, het Nederlands 
Huisartsen Genootschap, het institute for Medical Technology Assessment, de Werkgroep 
Onderzoek Kwaliteit, het College voor Zorgverzekeringen, Zorgonderzoek Nederland (ZonMw) 
en de Orde van Medisch Specialisten en wordt ondersteund door het Nederlands Paramedisch 
Instituut, de Vereniging voor Integrale Kankercentra en de Werkgroep Infectieziektenpreventie. 
 
Voor het beoordelen van de kwaliteit van andere typen onderzoek zijn eveneens formulieren 
ontwikkeld. Deze staan samengevat in onderstaande tabel. 
 
Type onderzoek  Formulier 
Dwarsdoorsnedeonderzoek (waarde diagnostische test)   I 
Randomised controlled trial (RCT)   II 
Cohortonderzoek    III 
Patiënt-controleonderzoek  IV 
Systematische review van 
RCT’s (therapie en preventie)  Va 
diagnostisch onderzoek  Vb 
observationeel onderzoek (etiologie/“harm”/prognose) Vc 
Economische evaluatie  VI 
 Richtlijn  AGREE   
 
 
Instructie beoordeling 
• De bruikbaarheid van een publicatie voor een richtlijn wordt in de formulieren op drie 
facetten beoordeeld: validiteit, toepasbaarheid in de praktijk en toepasbaarheid in de 
Nederlandse gezondheidszorg 
• Daarnaast wordt gevraagd om de belangrijkste kwantitatieve gegevens te extraheren en 
op een uniforme wijze te presenteren. 
• De opmaak van de beoordelingsformulieren  maakt het u makkelijk: 
a)  op diverse plaatsen is een beslismoment ingebouwd: indien een publicatie op dat 
moment niet aan de vereisten van validiteit of toepasbaarheid voldoet hoeft u met de beoordeling 
niet verder te gaan. 
b)  de criteria en manier van data-extractie worden telkens op de tegenoverliggende pagina 
kort toegelicht. 
 
Zend opmerkingen of suggesties aangaande dit formulier naar cochrane@amc.uva.nl. 
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Vraag 1. Randomisatie. Randomisatie is een methode waarbij gebruikgemaakt wordt van het toeval om de 
te onderzoeken interventie en de controlebehandeling(en) toe te wijzen aan de patiënt. Randomisatie 
houdt in dat ieder individu (of andere eenheid van randomisatie) een gelijke kans heeft om elk van de 
interventies te krijgen. Een goede randomisatie kan bijvoorbeeld gebruikmaken van een tabel met 
aselecte (random) getallen of van een door een computer aangemaakte randomisatielijst. 
Er dient gewaarschuwd te worden voor andere methoden van allocatie die soms wel als randomisatie 
beschreven zijn, maar dit niet echt zijn: allocatie op geboortedatum, volgorde van binnenkomst, dag 
van de week, maand van het jaar, dossiernummer. Deze methoden heten wel “quasi random”. In dat 
geval is het belangrijk om extra aandacht te geven aan de vergelijkbaarheid van de groepen (vraag 6). 
 
Vraag 2. Blindering van de randomisatie. Procedure waarbij wordt voorkomen dat degene die de patiënt 
beoordeelt en insluit op de hoogte kan zijn van de randomisatievolgorde. Goede manieren zijn: gebruik 
van centrale randomisatieschema’s; randomisatieschema’s die door een trial-apotheek 
worden beheerd; genummerde en gecodeerde verpakkingen met identieke placebo- en verum- 
medicatie (= werkzame medicatie); genummerde, niet-doorzichtige enveloppen; een op locatie 
aanwezige computer waarvan de randomisatievolgorde pas wordt vrijgegeven na opgave van de 
patiëntenkarakteristieken. 
De in de toelichting bij vraag 1 genoemde “quasi random” procedures zijn per definitie niet blind voor 
randomisatie omdat degene die de patiënt in het onderzoek insluit, kan voorzien welke behandeling de 
patiënt zal krijgen. 
Blindering van randomisatie (concealment of allocation) dient te worden onderscheiden van blindering 
van patiënten, behandelaars en effectbeoordelaars. 
 
Vraag 3. Blindering patiënten. Door blindering van de patiënt wordt voorkomen dat: a) deze bewust of 
onbewust een grotere compliance met het protocol zal hebben, b) de uitkomstmeting door voorkeuren 
voor behandeling wordt beïnvloed. Blindering van de patiënt wordt bereikt door de verumbehandeling (= 
werkzame behandeling) en placebobehandeling identiek te maken. Medicatie moet dezelfde kleur, 
grootte, smaak en consistentie hebben. Ook niet-medicamenteuze placebo-interventies, zoals 
bijvoorbeeld fysiotherapie of ruggordels, dienen voldoende identiek te zijn om geloofwaardig over te 
komen. Evaluatie van het succes van blindering is gewenst, maar is voor dit item niet noodzakelijk. Indien 
een onderzoek als dubbelblind wordt beschreven dient u goed na te gaan om wie het gaat: patiënt, 
behandelaar en/of effectbeoordelaar. Dit is op voorhand niet altijd duidelijk. 
 
Vraag 4. Blindering behandelaars. Door blindering van de behandelaar wordt voorkomen dat deze, omdat 
hij op de hoogte is van de aard van de toegewezen behandeling: a) een bepaald enthousiasme zal 
uitstralen (selectieve vergroting van het placebo-effect), b) verschillende mate van adherentie aan het 
onderzoeksprotocol zal hebben (door bijvoorbeeld aan de placebogroep aanvullende behandeling aan te 
bieden). Evaluatie van het succes van blindering is gewenst, maar is voor dit item niet noodzakelijk. 
Indien een onderzoek als dubbelblind wordt beschreven dient u goed na te gaan om wie het gaat: 
patiënt, behandelaar en/of effectbeoordelaar. Dit is op voorhand niet altijd duidelijk. 
 
Vraag 5. Blindering effectbeoordelaars. Door blindering van de effectbeoordelaar wordt voorkomen dat 
deze de effecten van interventie en controlebehandeling verschillend zal beoordelen. Evaluatie van 
het succes van blindering is gewenst, maar is voor dit item niet noodzakelijk. 
Indien een onderzoek als dubbelblind wordt beschreven dient u goed na te gaan om wie het gaat: 
patiënt, behandelaar en/of effectbeoordelaar. Dit is op voorhand niet altijd duidelijk. 
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Beoordeling van de kwaliteit van een randomised clinical trial (RCT) 
 
 
Naam beoordelaar:......................................................................... Datum:...................................  
Titel:...................................................................................................................................................... 
Auteurs:..........................................................................................................................................  
Bron: .............................................................................................................................................. 
 
Beoordeling van de validiteit 
 
Korte beschrijving van de interventie: ................................................................................... 
..............................................................................................................................................  
Korte beschrijving van de controlebehandeling(en): ............................................................. 
.............................................................................................................................................. 
 
 
VALIDITEIT 
 
1.   Was de toewijzing van de interventie aan de patiënten gerandomiseerd? 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
2.   Degene die patiënten in het onderzoek insluit hoort niet op de hoogte te zijn van de 
randomisatievolgorde.  Was dat hier het geval? 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
3.   Waren de patiënten geblindeerd voor de behandeling? 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
4.   Waren de behandelaars geblindeerd voor de behandeling? 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
5.   Waren de effectbeoordelaars geblindeerd voor de behandeling? 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
 
 
 184 
 
Vraag 6. Vergelijkbaarheid groepen. De groepen moeten aan het begin van het onderzoek op 
belangrijke prognostische kenmerken voldoende gelijk zijn. Theoretisch zou alleen de toegewezen 
behandeling tussen de groepen verschillend moeten zijn. 
Bij beoordeling kan worden gelet op: 
a)   Belangrijke prognostische variabelen, waaronder bijvoorbeeld ziekteduur, ernst, co-medicatie, co- 
morbiditeit 
b)   Uitgangswaarden van de belangrijkste uitkomstmaten c)   
Demografische gegevens (geslacht, leeftijd) 
Kleine verschillen kunnen op basis van toeval optreden. Bij grote verschillen dient beredeneerd te 
worden in welke mate en in welke richting de resultaten beïnvloed kunnen worden. 
Er kan door de onderzoekers ook door middel van multivariate analyses gecorrigeerd zijn voor 
verschillen in prognostische factoren tussen de groepen. 
 
NB: Als sprake is van quasi randomisation (zie vraag 1), is het belangrijk om extra aandacht te geven 
aan de vergelijkbaarheid van de groepen. 
 
Vraag 7. Loss-to-follow-up. Het is belangrijk om per groep de aantallen patiënten bij randomisatie en bij 
follow-up te vergelijken. Relatief grote uitval (loss-to-follow-up) maakt een onderzoek gevoelig voor 
selectieve loss-to-follow-up. Aantallen en redenen voor uitval dienen gerapporteerd te zijn. Ook als er 
geen uitvallers waren dient dit te zijn beschreven. 
Indien de redenen van uitval uit het onderzoek of de absolute aantallen uitvallers tussen de groepen 
verschillend zijn en tot een vertekening van de uitkomsten kunnen leiden, heet dit selectieve loss-to- 
follow-up. 
Het is niet mogelijk om op voorhand per indicatiegebied aan te geven welk percentage loss-to-follow- up 
nog acceptabel is. 
 
Vraag 8. Intention-to-treat analyse. Bij de analyse dient de allocatie door randomisatie gerespecteerd te 
worden. De patiënt hoort bij de oorspronkelijk door randomisatie gevormde groep, ongeacht eventuele 
co-interventies, non-compliance en dergelijke (zie vraag 9). 
Naast intention-to-treat analyse kan ook nog een per-protocol analyse worden gepresenteerd. Hierbij 
worden alleen gegevens van patiënten gebruikt die volgens het onderzoeksprotocol zijn behandeld. 
Bedenk, dat een per-protocolanalyse zeer misleidend kan zijn. 
 
Vraag 9. Vergelijkbaarheid behandeling. De behandeling van de patiënten in de verschillende groepen 
dient behalve het door randomisatie beoogde contrast geen verschillen te vertonen. Bij goed geblindeerde 
behandelingen is de vergelijkbaarheid van behandelingen in de regel geen probleem. 
Bij de beoordeling kan worden gelet op: 
a)   Co-interventies. Verdeling van behandelingen anders dan de door randomisatie toegewezen. 
Soms worden deze door de onderzoekers onder controle en dus gelijk gehouden. In andere 
gevallen worden de co-interventies per groep gerapporteerd. Indien er geen melding van co- 
interventies wordt gemaakt dient men op de hoede te zijn. 
b)   Contaminatie. In geval van contaminatie krijgt of zoekt de patiënt in de loop van het onderzoek 
precies de behandeling die eigenlijk aan de andere groep toegewezen is. 
c)   Compliance. Indien de compliance met de toegewezen behandeling in de ene groep veel groter is 
dan in de andere kan dit de interpretatie van de gegevens verstoren. 
 
Vraag 10. Algemeen oordeel. Hier wordt een inschatting van de validiteit en toepasbaarheid gevraagd. Let 
hierbij ook op eventuele fouten in het onderzoek die funest zijn voor de validiteit ervan (red flags, fatal 
flaws). Er zijn geen regels te geven voor welke items positief gescoord moeten worden of welk aantal 
items tenminste positief gescoord moeten worden. Dit is deels afhankelijk van de “state-of-the- art” met 
betrekking tot het betreffende onderwerp. Het gaat er hier om het samenvattend oordeel van wat de 
beoordelaar de werkgroep zou willen mededelen over de bruikbaarheid van het artikel voor de 
besluitvorming. 
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6.   Waren de groepen aan het begin van de trial vergelijkbaar? 
[ ] Ja 
[ ] Nee, maar  in de analyses is hiervoor wel gecorrigeerd 
[ ] Nee, en in de analyses is hiervoor niet gecorrigeerd 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
7.   Is van een voldoende proportie van alle ingesloten patiënten een volledige follow-up 
beschikbaar? 
[ ] Ja 
[ ] Nee ⇐  Is selectieve loss-to-follow-up voldoende uitgesloten? 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden / loss-to-follow-up niet 
beschreven 
 
 
8.   Zijn alle ingesloten patiënten geanalyseerd in de groep waarin ze waren 
gerandomiseerd? 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
9.   Zijn de groepen, afgezien van de interventie, gelijk behandeld? 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
TUSSENOORDEEL 
 
 
 
10. Zijn de resultaten van het onderzoek valide en toepasbaar? 
[ ] Voldoende valide en toepasbaar  ⇐ ga verder bij 11 
[ ] Twijfelachtig  ⇐ ga verder bij 11 
[ ] Onvoldoende valide en toepasbaar  U kunt stoppen met het invullen van de checklist, 
tenzij er geen betere artikelen op dit gebied zijn 
(terugkoppelen naar de werkgroep) 
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Vraag 11. Resultaten 
 
Keuze uitkomst en follow-up duur. Auteurs zijn soms geneigd de meest in het oog springende 
(significante) resultaten als belangrijkste te presenteren. Het is als beoordelaar belangrijk om vooraf een 
indruk te vormen van de klinisch of beleidsmatig meest relevante uitkomst(en) en follow- upmoment. Dit 
zijn de belangrijkste parameters die meegenomen dienen te worden in de rapportage naar de groep. 
Pas ervoor op niet slechts op de hiërarchie van de auteurs van het artikel af te gaan. 
 
Dichotome uitkomsten. In geval van dichotome uitkomsten (uitkomsten die slechts 2 waarden kunnen 
aannemen, bijvoorbeeld wel of niet genezen) kunnen verschillende associatiematen berekend 
worden: relatieve risico, relatieve risicoreductie, absolute risicoreductie en number needed to treat. Als 
de oorspronkelijke getallen gepresenteerd worden (voor notatie: zie Tabel), kan men deze associatie- 
maten zelf berekenen. Is dit niet het geval, dan moet men volstaan met het overnemen van de door de 
auteurs gepresenteerde associatiemaat (inclusief het 95%-betrouwbaarheidsinterval). Dit moet u ook 
doen, indien de auteurs een multivariate statistische analyse hebben uitgevoerd ter correctie voor 
verschillen in prognostische factoren tussen de groepen. 
De formules voor het zelf berekenen van een 95%-betrouwbaarheidsinterval staan in de appendix. (Zie 
ook de verschillende rekenmachientjes op internet, bijv. op http://minerva.minervation.com/cebm/ of 
http://www.cebm.utoronto.ca/practise/ca/statscal/.) 
 
Formules voor het berekenen van verschillende 
associatiematen in een RCT 
Uitkomst * 
aanwezig afwezig 
Totaal 
Interventiegroep a b a + b 
Controlegroep c d c + d 
Kans op gebeurtenis (risico) in de interventiegroep a / (a + b) 
Kans op gebeurtenis (risico) in de controlegroep c / (c + d) 
Absolute risico reductie (ARR) a/(a + b) – c/(c + d) 
Number needed to treat (NNT) 1/ ARR = 1 / [ | a/(a + b) – c/(c + d) | ] 
Relatieve risico (RR) [ a/(a + b) ] / [ c/(c + d) ] 
Relatieve risico reductie (RRR):  
- in geval van een ongunstige uitkomst 1 – RR 
- in geval van een gunstige uitkomst RR – 1 
 
* De uitkomst (of het eindpunt) kan zowel gewenst (bijvoorbeeld genezing) als ongewenst zijn 
(bijvoorbeeld bijwerking van een medicijn, overleden). 
 
Absolute risico reductie (ARR) = risicoverschil = verschil in absolute risico op de uitkomst tussen de 
interventie- en controlegroep. Indien de bestudeerde uitkomst (eindpunt) een gunstige is (genezen), 
wordt ook wel gesproken van een absolute benefit increase (ABI). 
Number needed to treat (NNT) = aantal patiënten dat met de interventie behandeld dient te worden om 
één ongewenste gebeurtenis minder of één gewenste gebeurtenis meer te bereiken dan met de 
controlebehandeling verkregen zou zijn. 
Relatieve risico (RR) = verhouding van absolute risico op de uitkomst tussen interventie- en 
controlegroep. Indien de bestudeerde uitkomst (eindpunt) een gunstige is (genezen), wordt ook wel 
gesproken van een benefit ratio (BR). 
Relatieve risico reductie (RRR) = relatieve risicoverschil. In geval van een ongunstige uitkomst (bijv. 
overleden) en een gunstig effect van de onderzochte interventie (RR < 1 en ARR < 0) is RRR de 
proportionele verlaging van het risico op de slechte uitkomst (dan: RRR = 1 – RR). Bij een gunstige 
uitkomst (bijv. genezen) en een gunstig effect van de onderzochte interventie (RR > 1 en ARR > 0) 
spreekt men van “relative benefit increase” (RBI). RBI is de proportionele verhoging van het “risico” 
(kans) op de gunstige uitkomst (dan: RBI = RR – 1). 
 
Continue uitkomsten. Bij continue uitkomsten wordt per behandelarm het gemiddelde effect berekend. De 
hier van toepassing zijnde associatiemaat is het verschil van beide gemiddelden. Voor het berekenen van 
een 95%-betrouwbaarheidsinterval zijn ook nog – per behandelarm – de standaard- deviatie (SD) en het 
aantal patiënten nodig (N). NB: Let er bij de dataextractie voor op dat de standaarddeviatie [SD] iets anders 
is dan de standard error (of the mean) [SE(M)]! De standaard- deviatie is de standard error of the mean 
maal de wortel uit het aantal patiënten in de groep. In formule: SD = SEM * √N. 
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11. Resultaten 
In de onderstaande tabellen kunt u de meest relevante resultaten weergeven. Niet alle 
parameters zullen echter in het artikel vermeld staan. Deze zijn echter vaak zelf uit te 
rekenen met de gegevens uit het artikel (zie toelichting). 
 
DICHOTOME UITKOMSTEN (genezen / niet-genezen; in leven / overleden) 
 
Uitkomst:  .............................................................................................................................. 
Follow-up: ......... weken / maanden / jaar 
 
 
Groep 
                Uitkomst  
   aanwezig  afwezig 
       Totaal 
Interventiegroep    
Controlegroep    
 
Kans op gebeurtenis in de interventiegroep  
Kans op gebeurtenis in de controlegroep  
Absolute risico reductie (ARR)  
Number needed to treat (NNT)  
Relatieve risico (RR)  
Relatieve risico reductie (RRR)  
 
 
CONTINUE UITKOMSTEN (bijvoorbeeld bloeddruk, pijnscore, kwaliteit-van-leven score) 
 
Uitkomst:  .............................................................................................................................. 
Follow-up: ......... weken / maanden / jaar 
 
 
Groep 
 
Gemiddelde 
 
SD 
 
Aantal (N) 
Interventiegroep    
Controlegroep    
  
Verschil van gemiddelden + 95%-BI  
 
 
Vraag 12 en 13. Toepasbaarheid in de Nederlandse gezondheidszorg. Beide vragen zijn een 
belangrijk onderdeel van richtlijnontwikkeling en dienen daarom in de werkgroep bediscussieerd te 
worden. 
 
Vraag 14. Conclusie met betrekking tot het artikel en de waarde van de interventie 
Geef hier een globale samenvatting van het eindoordeel over het artikel. Probeer, indien aanwijzingen 
bestaan voor vertekening van de resultaten, tenminste een inschatting te maken van de richting van 
de vertekening (overschatting of onderschatting van het effect van de interventie) en zo mogelijk ook 
over de grootte van de vertekening. Eventuele aanwijzingen voor mogelijke belangenverstrengeling 
van de auteurs met belanghebbende opdrachtgevers, kunt u hier ook rapporteren. Ook is het 
verstandig ingezonden brieven en/of redactionele commentaren op het hier door u beoordeelde 
onderzoek te raadplegen bij het formuleren van uw conclusie. 
 
Voorbeeld: “Eindoordeel voldoende. Goed opgezet artikel. Door de aard van de interventie 
(oefentherapie bij lage rugpijn) is blindering van de behandelaar en patiënt vrijwel onmogelijk. Door te 
vergelijken met een gespreksgroep wordt echter wel goed gecorrigeerd voor aandachtseffecten. 
Oefentherapie lijkt effectief bij subacute en chronische lage rugpijn”. 
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TOEPASBAARHEID  IN DE NEDERLANDSE GEZONDHEIDSZORG 
 
12. Kan het gevonden resultaat worden toegepast op de Nederlandse situatie? 
(hierbij valt bijvoorbeeld te denken aan de beschikbare therapeutische faciliteiten) 
 
[ ] Ja 
[ ] Nee 
[ ] Te weinig informatie in het artikel om dit te beantwoorden 
 
 
13. Op welk(e) echelon(s) kan het resultaat worden toegepast? 
(meerdere opties tegelijk mogelijk) 
 
[ ] algemene bevolking 
[ ] eerste lijn 
[ ] tweede lijn 
[ ] academische ziekenhuizen 
[ ] perifere ziekenhuizen 
[ ] derde lijn 
 
 
 
 
CONCLUSIE 
 
14. Conclusie met betrekking tot het artikel en de waarde van de interventie 
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APPENDIX: 
 
Formules voor het zelf berekenen van een 95%-betrouwbaarheidsinterval (95%-BI) 
 
 
DICHOTOME UITKOMSTEN: 
 
NB : op diverse internetsites zijn voor deze berekeningen ook rekenmachientjes beschikbaar 
bijvoorbeeld op http://minerva.minervation.com/cebm/ of 
http://www.cebm.utoronto.ca/practise/ca/statscal/ 
 
 
Absolute risicoreductie (ARR): 
 
 
SE[ARR] =   √  [ ab / (a+b)3 + cd / (c+d)3 ] 
 
95%-BI voor ARR: ARR ±  1,96 * SE[ARR] 
 
Relatieve Risico (RR) (via natuurlijke log-transformatie): 
SE[LN(RR)]  =  √  [ 1/a – 1/(a+b) + 1/c – 1/(c+d) ] 
 
95%-BI voor RR: e LN(RR) ±  1,96 * SE[LN(RR)] 
 
 
 
 
 
CONTINUE UITKOMSTEN: 
 
 
Verschil van gemiddelden: 
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